Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3007080	s-ebvabg	U/ml (u/ml)	6092	7321	0.00%
3007080	s-ebvabg	— (—)	4188	5413	100.00%	Distribution not available
3007080	s-ebvnabg	U/ml (u/ml)	235	260	2.31%
3007080	s-ebvabg	U/ml______ (u/ml)	190	216	0.00%
3007080	s-ebvnabg	— (—)	147	153	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

2139

4828

2.65

320.64

1.4

1.2

280.37

247.90

u/ml

4.56

1330

3081

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

2139

4828

2.65

320.64

1.4

1.2

280.37

247.90

u/ml

4.56

1330

3081

Condition for Implicit Sepsis (Organ dysfunction codes)

2019

5405

2.65

317.35

1.5

1.3

270.01

255.63

u/ml

1.31

1342

3356

Any reimbursement code in KELA

1586

2528

3.23

316.00

1.4

1.2

255.66

220.68

u/ml

4.45

985

1616

Mucosal proctocolitis

641

1251

5.61

315.34

1.2

1.3

258.81

255.79

u/ml

0.08

385

806

Crohn disease

647

1281

5.52

313.10

1.2

1.3

288.80

243.77

u/ml

2.41

377

819

Ulcerative colitis

1074

2354

4.89

307.65

1.3

264.72

258.46

u/ml

0.25

642

1495

Other bacterial diseases

2703

5594

3.30

307.65

1.5

1.3

275.03

251.79

u/ml

3.11

1769

3500

Enlarged lymph nodes

653

1059

6.62

307.65

1.3

272.04

255.40

u/ml

0.53

367

659

General symptoms and signs

2826

4590

3.17

307.65

1.3

269.33

242.58

u/ml

4.04

1814

2925

L04AD Calcineurin inhibitors

1856

931

32.22

307.65

2.0

1.2

269.23

246.49

u/ml

1.38

1423

528

Second line medication for Crohn's disease

1953

5616

3.63

307.65

1.5

1.3

279.72

255.02

u/ml

2.55

1186

3600

GASTRO-related operations

2262

2789

4.20

307.65

1.4

1.2

249.36

230.58

u/ml

1.94

1425

1753

Nephropathy related operations

1648

837

28.25

307.65

2.0

1.2

265.81

258.03

u/ml

0.30

1249

500

Transplanted organ and tissue status

1917

742

46.03

307.65

2.1

1.2

265.19

249.47

u/ml

0.72

1427

423

Explicit Sepsis, including avohilmo

1373

3081

4.21

307.65

1.7

1.2

274.95

258.47

u/ml

1.15

900

1884

Implicit viral Sepsis

772

1482

5.53

307.65

1.7

1.2

284.59

259.37

u/ml

1.33

549

896

Heart failure, not strict

2158

3537

4.27

307.65

1.6

1.2

278.63

262.28

u/ml

1.46

1511

2150

Glomerular disorders in diseases classified elsewhere

779

832

10.87

307.65

1.9

1.2

251.91

261.75

u/ml

0.35

559

527

Noninfective enteritis and colitis

1771

4631

4.02

307.65

1.3

1.4

265.32

255.31

u/ml

0.64

1068

2942

Viral Sepsis

777

1484

5.56

307.65

1.7

1.2

284.35

259.37

u/ml

1.32

552

896

ILD medications: prednisolone, methylprednisolone, prednisone

3697

4710

4.54

307.65

1.6

1.1

273.32

239.06

u/ml

7.72

2473

2930

Implicit viral Sepsis, including avohilmo

979

2219

4.62

307.65

1.6

1.2

271.74

259.43

u/ml

0.61

675

1353

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

806

1691

5.20

307.65

1.3

261.54

251.41

u/ml

0.39

476

1085

Cytomegalovirus infection, IBD co-morbidity

331

196

26.38

307.65

1.8

1.4

253.94

244.24

u/ml

0.14

225

118

Other septicaemia

1186

2302

5.09

307.65

1.7

1.3

280.72

256.67

u/ml

1.75

781

1389

Non-Hodgkin lymphoma, all, including Hilmo

497

691

7.76

307.65

1.3

286.91

277.03

u/ml

0.22

302

412

Chronic kidney disease

1740

1674

11.05

307.65

1.9

1.2

257.41

273.36

u/ml

1.03

1242

993

Liquid cancers, including Hilmo

1322

2132

5.80

307.65

1.3

267.80

270.88

u/ml

0.11

787

1315

Dialysis

650

300

36.08

307.65

2.3

1.3

248.63

254.06

u/ml

0.09

488

171

Glomerular diseases

1040

1391

8.40

307.65

2.0

1.2

252.04

263.26

u/ml

0.52

737

857

Implicit bacterial Sepsis, including avohilmo

1262

2493

4.37

307.65

1.5

1.2

274.75

267.07

u/ml

0.37

829

1534

Extracorporeal dialysis

880

433

31.30

307.65

2.1

1.3

269.98

268.73

u/ml

0.02

656

253

Autoimmune diseases related-to ILD

2525

6905

3.15

307.65

1.3

275.07

247.12

u/ml

4.28

1577

4434

Any gastric operation

2262

2789

4.20

307.65

1.4

1.2

249.36

230.58

u/ml

1.94

1425

1753

Other viral diseases

1203

3543

3.58

307.65

1.6

1.3

237.32

247.83

u/ml

0.59

769

2172

Other disorders of kidney and ureter

575

900

6.99

307.65

2.0

1.2

259.65

284.65

u/ml

1.08

424

542

Anaemias

1055

1184

6.09

307.65

1.7

1.2

255.75

225.69

u/ml

2.12

689

748

Liquid cancers

1241

1808

6.99

307.65

1.3

260.71

267.47

u/ml

0.27

736

1109

Dental caries

1229

1848

6.78

307.65

1.7

1.2

280.85

254.37

u/ml

1.94

863

1171

Caries of dentine

1064

1678

6.60

307.65

1.6

1.2

284.15

254.53

u/ml

2.08

739

1055

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

2993

6038

3.46

307.65

1.5

1.3

263.09

255.28

u/ml

0.66

1947

3778

Preparatory care for dialysis

618

287

33.45

307.65

1.8

1.3

251.88

271.98

u/ml

0.43

451

167

Other dialysis

507

267

33.00

307.65

2.1

1.4

245.64

250.93

u/ml

0.09

387

149

ILD medications

4013

4958

4.55

307.65

1.5

1.2

265.30

235.72

u/ml

6.41

2615

3059

Implicit Sepsis

1896

4672

3.07

307.65

1.5

1.3

270.04

259.14

u/ml

0.81

1247

2893

Used for control exclusion in common control thyroid runs

2731

5265

2.68

307.65

1.4

1.3

268.97

239.68

u/ml

4.95

1706

3365

L04AX Other immunosuppressants

1740

5480

3.30

307.65

1.5

1.3

285.59

256.01

u/ml

3.00

1036

3537

Other septicaemia, including avohilmo

1209

2347

5.06

307.65

1.7

1.3

279.66

256.53

u/ml

1.67

798

1416

Acute renal failure

813

1196

7.26

307.65

1.6

1.1

271.71

278.68

u/ml

0.23

565

726

Care involving dialysis

1246

473

40.96

307.65

2.1

1.2

256.76

252.35

u/ml

0.11

931

273

Autoimmune diseases excluding thyroid diseases, strict definition

3000

5420

3.10

307.65

1.3

268.05

240.04

u/ml

4.99

1895

3472

Other/unspecified cytomegaloviral diseases

309

173

29.68

307.65

1.8

1.4

246.37

244.59

u/ml

0.02

214

L04AA Selective immunosuppressants

1832

1894

11.45

307.65

1.9

1.2

268.71

258.77

u/ml

0.57

1363

1125

Budesonide

711

1082

7.19

307.65

1.2

1.3

272.05

239.17

u/ml

1.75

443

680

Dialysis, with operation codes

1638

817

28.01

307.65

2.0

1.2

266.05

263.36

u/ml

0.09

1242

488

Implicit bacterial Sepsis

1182

2234

4.72

307.65

1.5

1.2

277.11

267.04

u/ml

0.49

775

1383

Renal tubulo-interstitial diseases

2663

5822

3.47

307.65

1.7

1.2

262.22

256.84

u/ml

0.39

1813

3586

Autoimmune diseases

2908

5594

2.70

307.65

1.3

267.87

239.59

u/ml

4.93

1803

3583

Azathioprine

892

1234

8.10

307.65

1.8

1.3

301.26

237.95

u/ml

5.10

554

765

Inflammatory bowel disease

1437

3198

4.82

307.65

1.3

269.81

254.82

u/ml

0.94

864

2044

Aplastic and other anaemias

1229

2952

3.95

307.65

1.6

1.2

268.23

272.86

u/ml

0.18

782

1811

Malaise and fatigue

1262

2849

3.59

307.65

1.3

285.97

257.08

u/ml

2.45

837

1782

Bacterial infection, other or unspecified, including avohilmo

1940

3510

4.74

307.65

1.5

1.3

267.57

256.50

u/ml

0.75

1271

2171

Bacterial Sepsis

1324

2681

4.24

307.65

1.5

1.2

273.98

263.78

u/ml

0.54

858

1640

Oral corticosteroids

2749

5640

2.93

307.65

1.3

283.85

243.33

u/ml

8.43

1726

3634

IBD patients in KELA-register

1220

2366

5.63

307.65

1.3

269.57

250.30

u/ml

1.24

730

1501

First line medication for Crohn's disease

3793

4909

4.32

307.65

1.5

1.2

263.28

235.90

u/ml

5.55

2490

3006

Autoimmune diseases excluding thyroid diseases

3057

5550

3.07

307.65

1.3

267.95

240.23

u/ml

5.00

1927

3555

Certain infectious and parasitic diseases

2306

4084

2.89

307.65

1.4

1.2

259.95

247.26

u/ml

1.12

1499

2509

Inflammatory bowel disease, strict (require KELA)

1220

2407

5.54

307.65

1.3

269.57

247.57

u/ml

1.53

730

1531

Diseases of liver

1401

2770

5.40

307.65

1.3

289.30

263.88

u/ml

2.08

853

1773

Disorders resulting from impaired renal tubular function

444

271

23.33

307.65

2.1

1.3

266.20

262.89

u/ml

0.05

334

153

Bacterial infection, other or unspecified

1810

3139

5.10

307.65

1.5

1.3

270.22

258.94

u/ml

0.71

1189

1939

5-aminosalicylic acid

1015

1821

6.03

307.65

1.3

271.35

242.80

u/ml

1.97

601

1158

Cytomegaloviral disease

332

199

25.48

307.65

1.8

1.4

253.83

250.72

u/ml

0.04

226

115

ILD medications: immunosuppressive drugs

3490

4310

7.95

307.65

1.6

1.2

268.05

240.26

u/ml

5.05

2344

2650

Renal failure

2075

2449

7.76

307.65

1.8

1.1

260.57

275.19

u/ml

1.09

1457

1447

Cytomegaloviral disease, including avohilmo

340

200

26.08

307.65

1.8

1.4

256.02

251.23

u/ml

0.07

229

116

Ulcerative colitis (strict definition, require KELA)

819

1741

5.12

307.65

1.3

263.02

252.22

u/ml

0.43

482

1117

Implicit Sepsis, including avohilmo

1980

5256

2.76

307.65

1.5

1.3

269.58

255.40

u/ml

1.27

1310

3270

Other bacterial diseases, including avohilmo

2809

6018

3.00

307.65

1.5

1.3

267.34

250.02

u/ml

2.05

1845

3773

Septicaemia

1295

2607

4.73

307.65

1.7

1.3

278.50

253.30

u/ml

2.03

845

1564

Other diseases of blood and blood-forming organs, wide

807

1742

4.94

307.65

1.4

1.3

251.85

266.35

u/ml

0.69

520

1070

Infections, IBD-co-morbidities

713

767

7.00

307.65

1.6

1.3

269.65

241.40

u/ml

1.29

469

519

Failure and rejection of transplanted organs and tissues

254

132

36.34

307.65

2.1

1.5

261.17

242.91

u/ml

0.22

186

All kidney diseases

2835

6407

3.05

307.65

1.7

1.2

263.22

252.27

u/ml

1.08

1923

3968

ILD medications: azathioprine

892

1028

9.75

307.65

1.8

1.1

301.26

237.11

u/ml

5.07

554

625

Primary_lymphoid and hematopoietic malignant neoplasms

1112

1537

7.90

307.65

1.3

259.84

273.13

u/ml

0.57

662

941

Kidney transplant status

1184

462

57.02

307.65

2.3

1.3

246.76

258.26

u/ml

0.31

919

264

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

847

1858

4.94

307.65

1.3

265.92

254.14

u/ml

0.48

499

1185

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

2850

6173

3.01

307.65

1.7

1.1

266.95

246.85

u/ml

2.76

1967

3753

Persons encountering health services for specific procedures and health care

3140

6312

3.02

307.65

1.6

1.2

263.35

245.92

u/ml

2.33

2167

3799

Explicit Sepsis

1347

3027

4.22

307.65

1.7

1.2

275.46

258.72

u/ml

1.15

881

1854

Fever of other and unknown origin

2532

3791

6.15

307.65

1.4

1.3

264.57

245.37

u/ml

2.08

1586

2379

All chronic kidney diseases

2096

3341

5.28

307.65

1.8

1.2

260.38

260.35

u/ml

0.00

1462

2003

Secondary hypertension

680

466

17.30

307.65

2.1

1.2

265.05

243.00

u/ml

0.80

508

274

Inflammatory bowel disease treatment related agents

3460

6017

3.29

307.65

1.4

1.3

276.36

238.83

u/ml

8.80

2190

3856

Other viral diseases, including avohilmo

1397

4749

3.04

303.49

1.6

1.3

236.05

247.56

u/ml

0.78

887

2981

Influenza and pneumonia

2612

7142

2.30

297.30

1.4

1.3

271.70

245.06

u/ml

4.19

1658

4516

Ulcerative colitis, NAS

635

1303

5.28

294.17

1.3

281.28

251.08

u/ml

1.42

373

822

Cystic kidney disease

304

286

13.69

292.05

2.0

1.3

268.53

239.34

u/ml

0.63

234

161

Ulcerative colitis (strict definition, all Crohn cases excluded)

663

1423

5.05

291.28

1.3

249.54

250.61

u/ml

0.03

402

924

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

2119

5900

2.48

289.32

1.4

1.3

267.41

251.29

u/ml

1.66

1409

3659

Other and unspecified anaemias

1010

2722

3.59

288.56

1.5

1.2

275.55

273.33

u/ml

0.07

632

1671

Other anaemias

1014

2738

3.58

287.31

1.5

1.2

275.21

273.68

u/ml

0.05

635

1681

Polycystic kidney disease

272

223

16.31

286.64

1.9

1.4

271.05

241.15

u/ml

0.56

210

124

Cystic kidney disease, including avohilmo

305

302

12.70

281.98

2.0

1.3

268.53

246.62

u/ml

0.44

234

174

Hypertensive diseases (excluding secondary)

1394

2647

3.16

281.91

1.8

1.2

252.75

246.37

u/ml

0.33

960

1668

Covid-19 confirmed case

1044

3176

3.41

277.32

1.5

1.3

253.89

262.26

u/ml

0.37

713

1946

Pneumonias (Asthma/COPD co-morbidities)

2419

7049

2.29

274.96

1.4

1.3

279.64

244.58

u/ml

6.19

1530

4472

Unspecified kidney failure

374

482

8.32

274.38

1.8

1.1

259.17

289.36

u/ml

0.88

277

274

Glomerulonephritis

472

793

6.57

272.98

2.2

1.3

255.60

259.93

u/ml

0.10

336

484

Gastrointestinal diseases

1439

2395

3.08

267.46

1.4

1.2

245.86

235.34

u/ml

0.62

893

1503

Other diseases of liver

638

1426

4.75

264.92

1.3

286.38

264.36

u/ml

1.03

394

893

All pneumoniae

2436

7221

2.24

262.28

1.4

1.3

277.47

245.00

u/ml

5.52

1544

4585

Acute myeloid leukaemia and myelodysplastic syndromes

198

105

23.45

259.45

1.4

1.3

254.71

227.04

u/ml

0.35

113

Heart failure and antihypertensive medication

674

911

5.01

258.53

1.5

1.2

286.25

246.54

u/ml

2.33

477

570

Autoimmune hepatitis, wide definition

274

261

12.02

256.20

1.3

299.45

251.58

u/ml

1.22

168

153

Donors of organs and tissues

204

124

24.14

255.61

1.8

1.2

207.26

229.21

u/ml

0.37

124

Diabetic nephropathy

563

1154

5.17

255.49

1.8

1.3

269.00

295.82

u/ml

1.21

394

709

Pneumonia, organism unspecified

2128

6420

2.32

253.02

1.4

1.3

280.90

249.77

u/ml

4.45

1333

4074

Diabetic nephropathy, excluding more controls

560

900

5.44

251.71

1.8

1.2

270.12

294.58

u/ml

0.90

391

545

Intestinal infectious diseases

2264

7717

2.23

248.84

1.5

1.3

252.94

253.10

u/ml

0.01

1483

4827

Provisional assignment of new diseases of uncertain etiology

1411

5369

2.68

246.16

1.5

1.3

250.51

257.80

u/ml

0.41

956

3369

Codes for special purposes

1411

5373

2.68

245.73

1.5

1.3

250.51

257.75

u/ml

0.41

956

3371

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

521

1052

5.29

244.95

1.4

1.3

327.15

274.86

u/ml

2.43

309

651

Fibrosis and cirrhosis of liver

337

453

8.18

239.86

1.4

1.2

337.75

261.81

u/ml

2.54

190

270

Myeloid leukaemia

222

175

15.82

237.22

1.4

1.3

254.26

270.42

u/ml

0.20

137

Acute peritonitis

316

405

8.71

234.97

1.9

1.3

250.68

278.00

u/ml

0.67

227

240

6-mercaptopurine

279

311

10.68

234.64

1.2

1.3

230.47

204.39

u/ml

0.72

187

180

Congenital malformations of the urinary system

392

646

7.04

234.12

2.0

1.5

255.96

228.97

u/ml

0.91

290

367

Hypertension

1754

4048

2.50

231.78

1.7

1.2

260.04

264.17

u/ml

0.22

1188

2585

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

2302

7207

2.17

231.60

1.4

1.3

280.06

246.44

u/ml

5.52

1447

4584

Other inflammatory liver diseases

325

438

8.27

231.50

1.3

1.2

304.38

250.69

u/ml

1.74

197

266

Hypertensive diseases

1754

4052

2.49

231.40

1.7

1.2

259.86

264.06

u/ml

0.22

1189

2587

Congenital malformations of the urinary system, including avohilmo

397

676

6.75

228.95

2.0

1.5

256.21

226.77

u/ml

1.07

291

382

Secondary and unspecified malignant neoplasm of lymph nodes

341

495

7.49

226.10

1.3

272.82

255.95

u/ml

0.40

204

303

Anaemia in chronic diseases classified elsewhere

203

152

16.69

223.58

2.0

1.3

236.93

278.69

u/ml

0.58

138

Non-follicular lymphoma

355

555

6.92

219.39

1.3

1.2

277.41

262.93

u/ml

0.29

213

323

Agranulocytosis

432

831

5.61

215.27

1.5

1.3

242.92

272.59

u/ml

1.20

278

490

Acute myeloid leukaemia, including Hilmo

147

32.93

213.89

1.4

1.3

250.56

201.38

u/ml

0.51

Acute myeloid leukaemia

147

32.93

213.89

1.4

1.3

250.56

201.38

u/ml

0.51

Acute myeloid leukaemia, helper endpoint

147

32.93

213.89

1.4

1.3

250.56

201.38

u/ml

0.51

Certain infectious and parasitic diseases, including avohilmo

1420

2688

2.69

210.74

1.3

1.2

262.57

253.77

u/ml

0.47

906

1636

Cardiovascular diseases (excluding rheumatic etc)

1742

4269

2.39

210.49

1.7

1.2

248.74

230.83

u/ml

1.75

1175

2641

Abnormal findings on examination of blood, without diagnosis

1109

3658

2.82

209.71

1.4

1.3

278.84

266.29

u/ml

0.59

676

2288

Primary Sclerosing Cholangitis, IBD and UDCA required

210

188

14.32

208.31

1.5

371.35

216.05

u/ml

4.37

133

107

Other disorders involving the immune mechanism, not elsewhere classified

261

314

10.22

208.28

1.9

1.5

232.10

250.74

u/ml

0.36

196

178

Hernia of abdominal wall, postoperative

380

660

5.90

206.56

1.6

1.2

294.33

249.38

u/ml

1.86

253

413

Headache

1386

4308

2.53

206.32

1.3

254.60

244.33

u/ml

0.61

900

2745

Hepatic failure, not elsewhere classified

223

219

11.78

204.61

1.3

271.19

231.41

u/ml

0.82

144

124

Other Crohn's disease

372

661

6.26

203.70

1.2

1.3

283.10

247.17

u/ml

1.11

220

409

Lung transplantation

147

38.28

201.62

1.3

1.4

361.06

214.37

u/ml

3.25

111

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

249

295

10.45

201.36

1.9

1.5

233.09

244.35

u/ml

0.19

189

165

Hyperparathyroidism

479

1045

4.74

200.54

1.8

1.2

276.06

294.25

u/ml

0.60

327

612

Acute upper respiratory infections of multiple and unspecified sites

1792

5950

2.24

199.78

1.4

1.3

262.00

251.37

u/ml

0.78

1153

3792

Lung transplant status

146

38.02

199.66

1.3

1.4

361.06

214.37

u/ml

3.25

111

Heart failure,strict

946

2199

3.07

195.51

1.5

1.2

290.81

268.43

u/ml

1.34

626

1315

Certain disorders involving the immune mechanism

606

1642

3.89

194.11

1.6

1.3

251.44

263.59

u/ml

0.44

418

1003

Examination and observation for other reasons

1316

2878

2.63

193.96

1.4

1.2

269.32

247.58

u/ml

1.75

905

1852

Secondary uncertain malignant neoplasm

384

726

5.57

193.67

1.3

276.36

272.51

u/ml

0.08

229

445

COPD/asthma/ILD related infections

2058

4828

2.17

193.49

1.3

1.2

267.81

247.90

u/ml

2.03

1292

3081

COPD/asthma related infections

2058

4828

2.17

193.49

1.3

1.2

267.81

247.90

u/ml

2.03

1292

3081

Gout, FINNGEN

619

1688

3.76

192.35

1.5

1.2

267.86

276.96

u/ml

0.32

430

1019

Cholangitis (primary sclerosing, PSC)

291

431

7.43

190.09

1.5

1.3

345.69

247.23

u/ml

3.26

179

240

Diarrhoea and gastroenteritis of presumed infectious origin

1672

6879

2.21

188.90

1.6

1.3

253.51

252.47

u/ml

0.05

1118

4316

Disorders of parathyroid gland

513

1237

4.27

188.45

1.8

1.2

278.47

287.21

u/ml

0.25

352

724

Cardiovascular diseases

1700

3988

2.32

187.53

1.6

1.2

235.45

227.82

u/ml

0.53

1132

2437

Other heart diseases

1184

2945

2.68

187.23

1.6

1.2

272.48

240.04

u/ml

3.18

801

1797

Cirrhosis of liver, NAS

256

338

8.44

185.69

1.4

1.3

326.51

271.71

u/ml

1.28

148

192

Crohn disease (strict definition, require KELA)

365

697

5.86

185.48

1.2

1.3

272.89

242.49

u/ml

1.01

223

423

Crohn disease (strict definition, require KELA, min 2 HDR)

363

691

5.89

185.17

1.2

1.3

273.62

242.03

u/ml

1.07

222

417

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

373

735

5.65

182.75

1.2

1.3

272.72

241.82

u/ml

1.08

228

451

Purpura and other haemorrhagic conditions

479

1146

4.45

182.72

1.3

277.34

265.29

u/ml

0.29

308

691

Chronic nephritic syndrome

231

278

9.61

182.22

1.9

1.2

258.39

267.22

u/ml

0.13

173

164

Coagulation defects, purpura and other haemorrhagic conditions

619

1775

3.66

182.03

1.4

1.3

262.36

263.44

u/ml

0.03

410

1097

Bronchitis

2315

7096

1.99

181.68

1.4

1.2

263.28

252.33

u/ml

0.96

1510

4459

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

348

649

5.91

180.63

1.2

192.62

264.57

u/ml

7.32

280

428

Nausea and vomiting

720

2211

3.28

180.01

1.7

1.3

259.46

252.98

u/ml

0.22

485

1328

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

2160

6975

2.02

179.59

1.4

1.3

248.19

257.11

u/ml

0.69

1410

4345

Metabolic disorders

1937

5597

2.11

178.47

1.5

1.3

267.31

261.19

u/ml

0.36

1284

3538

Diseases of peritoneum

352

671

5.61

176.83

1.8

1.2

253.97

270.47

u/ml

0.45

250

411

Gout

619

1507

3.63

175.97

1.5

1.2

267.86

279.41

u/ml

0.42

430

937

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

361

724

5.41

172.07

1.2

195.03

263.46

u/ml

6.83

285

465

Acute upper respiratory infections

2128

6448

2.01

172.03

1.3

267.23

253.33

u/ml

1.20

1342

4080

Hypertension, essential

1514

3787

2.30

168.82

1.5

1.2

269.21

266.39

u/ml

0.13

1004

2440

IgA nephropathy (IgA glomerulonephritis)

197

217

11.27

168.53

1.9

1.2

249.83

257.18

u/ml

0.10

151

128

2250

5849

1.98

167.29

1.3

266.76

253.21

u/ml

1.20

1435

3695

Diseases of arteries, arterioles and capillaries (FINNGEN)

522

891

4.17

166.80

1.6

1.2

299.61

263.42

u/ml

1.62

364

534

Intestinal infectious diseases, including avohilmo, including avohilmo

2349

6877

1.93

166.77

1.4

1.3

251.44

257.55

u/ml

0.43

1525

4287

Acute tubulo-interstitial nephritis

1249

4504

2.39

166.76

1.6

1.2

281.11

258.46

u/ml

1.79

821

2723

Diffuse large B-cell lymphoma

208

243

9.45

166.49

1.3

1.2

268.12

264.41

u/ml

0.05

138

135

Diffuse large B-cell lymphoma, including Hilmo

208

243

9.45

166.49

1.3

1.2

268.12

264.41

u/ml

0.05

138

135

Diffuse large B-cell lymphoma, helper endpoint

208

243

9.45

166.49

1.3

1.2

268.12

264.41

u/ml

0.05

138

135

Other disorders of fluid, electrolyte and acid-base balance

659

1933

3.30

165.90

1.6

1.2

277.20

279.32

u/ml

0.06

420

1188

Symptoms and signs involving the digestive system and abdomen

2068

5168

2.04

165.68

1.4

1.3

264.55

246.90

u/ml

1.73

1316

3255

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

407

927

4.60

164.54

1.3

281.62

272.49

u/ml

0.23

247

586

Intrahepatic Cholestasis of Pregnancy (ICP)

348

715

5.35

162.05

1.2

192.62

262.80

u/ml

7.09

280

466

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2273

6323

1.94

161.45

1.4

1.3

257.58

250.29

u/ml

0.54

1493

3947

Thrombocytopenia, unspecified

289

513

6.11

157.47

1.3

284.76

251.87

u/ml

0.79

187

292

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

301

336

6.57

155.74

1.2

342.59

253.23

u/ml

2.75

193

232

Percutaneous Coronary Intervention

1462

4048

2.23

155.68

1.5

1.3

287.91

262.97

u/ml

2.12

1002

2463

Crohn disease (strict definition, all UC cases excluded)

276

478

6.46

155.57

1.2

1.3

277.33

239.23

u/ml

1.17

173

288

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

776

1234

3.22

155.30

1.3

1.2

247.55

218.46

u/ml

1.85

488

795

Medical observation and evaluation for suspected diseases and conditions

1326

2896

2.38

155.13

1.4

1.2

266.88

247.15

u/ml

1.42

829

1861

Ascites

256

408

6.71

154.98

1.3

1.2

329.73

289.81

u/ml

0.95

171

241

Nephrotic syndrome

214

288

8.80

154.74

2.7

1.5

264.27

253.72

u/ml

0.14

152

156

Excluding asthma or asthma-COPD overlap

1539

3515

2.23

154.55

1.3

267.57

246.84

u/ml

1.78

966

2258

Other pulmonary diagnosis

1538

3515

2.23

154.22

1.3

266.99

246.84

u/ml

1.68

962

2258

Other noninfective gastroenteritis and colitis

680

2278

3.09

154.21

1.4

250.09

250.52

u/ml

0.01

415

1387

Coronary revascularization (ANGIO or CABG)

1458

4050

2.22

153.57

1.5

1.3

287.86

263.08

u/ml

2.11

998

2464

Polyarthropathies

1523

4585

2.17

153.51

1.4

1.3

281.73

258.14

u/ml

2.29

978

2959

Tramadol

1553

4381

2.17

153.10

1.4

1.2

279.80

259.62

u/ml

1.67

1045

2805

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

361

800

4.88

152.87

1.2

195.03

265.11

u/ml

6.93

285

516

Care involving use of rehabilitation procedures

1208

4780

2.31

152.61

1.4

1.2

271.82

255.94

u/ml

1.05

826

2844

Persons encountering health services in other circumstances, wide

2297

6328

1.89

150.87

1.4

1.3

259.77

250.23

u/ml

0.80

1496

3949

COPD differential diagnosis

1528

3516

2.21

150.81

1.3

268.32

246.57

u/ml

1.90

958

2259

ILD differential diagnosis

1528

3516

2.21

150.78

1.3

268.32

246.57

u/ml

1.90

958

2259

Non-Hodgkin lymphoma, all

175

186

10.27

150.22

1.3

1.2

285.47

250.45

u/ml

0.46

101

Other special examinations and investigations of persons without complaint or reported diagnosis

1319

2896

2.35

149.18

1.4

1.2

266.42

247.15

u/ml

1.43

820

1861

ILD, hospital admission 2, with pulmonary infections

257

426

6.34

148.94

1.3

1.2

356.13

288.10

u/ml

1.46

166

260

Antihypertensive medication - note that there are other indications

1612

4012

2.14

148.13

1.6

1.2

245.38

224.30

u/ml

2.20

1045

2489

Emergency coronary revascularization (for ACS)

1513

4304

2.16

147.72

1.5

1.3

288.75

261.77

u/ml

2.52

1033

2636

Ischemic heart diseases

1520

4270

2.15

147.44

1.5

1.3

281.21

262.84

u/ml

1.37

1036

2601

General examination and investigation of persons without complaint and reported diagnosis

1288

2895

2.35

147.24

1.5

1.2

260.09

247.15

u/ml

0.85

842

1861

Oedema, not elsewhere classified

591

1829

3.23

145.66

1.5

1.2

286.94

260.21

u/ml

1.10

389

1151

Opioids

2032

5465

1.95

145.58

1.3

1.2

257.52

247.78

u/ml

0.79

1345

3476

Oesophageal varices

204

277

8.27

144.76

1.4

374.55

261.59

u/ml

2.89

128

156

Hard cardiovascular diseases

1548

4382

2.12

144.25

1.5

1.3

288.85

259.51

u/ml

2.90

1051

2714

Abdominal and pelvic pain

1981

5165

1.95

142.01

1.4

1.3

261.03

246.90

u/ml

1.24

1252

3255

Biological medication for rheuma

618

2068

3.14

141.73

1.2

1.3

274.93

247.28

u/ml

1.49

368

1298

Major coronary heart disease event

1500

4282

2.13

141.58

1.5

1.3

286.94

262.81

u/ml

2.08

1024

2613

All influenza

647

2214

3.01

141.13

1.6

1.3

268.51

254.14

u/ml

0.55

438

1362

Crohn's disease of small intestine

304

634

5.21

138.69

1.2

1.3

312.21

250.66

u/ml

1.91

186

392

Heart failure and coronary heart disease

723

1784

2.90

135.94

1.5

1.2

290.31

274.66

u/ml

0.67

480

1066

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1223

4936

2.19

135.16

1.3

297.55

264.75

u/ml

2.60

734

3148

Other medical care

858

2853

2.57

134.72

1.3

1.2

294.74

259.56

u/ml

2.32

564

1659

Endocrine, nutritional and metabolic diseases

1776

4613

1.97

131.20

1.5

1.2

253.08

234.47

u/ml

1.83

1123

2893

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

593

1960

3.09

131.02

1.9

1.4

253.86

235.91

u/ml

0.83

425

1136

Disorders of other endocrine glands

1050

4622

2.29

130.79

1.7

1.3

261.46

254.14

u/ml

0.36

693

2849

Lymphoid leukaemia

233

406

6.29

129.88

1.3

1.5

241.93

261.18

u/ml

0.32

128

211

Systemic connective tissue disorders

732

2793

2.69

129.69

1.3

272.45

272.96

u/ml

0.01

451

1739

Abnormal serum enzyme levels

641

2202

2.89

128.95

1.3

273.86

265.63

u/ml

0.27

392

1381

Other ulcerative colitis

254

484

5.73

128.60

1.4

1.3

268.70

252.11

u/ml

0.32

142

306

Heart failure, strict

971

2838

2.42

128.42

1.4

1.2

292.15

273.86

u/ml

1.04

635

1745

Crohn's disease NAS

279

580

5.23

127.81

1.3

320.61

250.68

u/ml

2.05

152

351

Chronic lymphocytic leukaemia

132

119

12.36

127.56

1.2

328.92

280.66

u/ml

0.51

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

132

119

12.36

127.56

1.2

328.92

280.66

u/ml

0.51

Chronic lymphocytic leukaemia, helper endpoint

132

119

12.36

127.56

1.2

328.92

280.66

u/ml

0.51

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

605

2064

2.99

126.51

1.9

1.4

253.41

236.16

u/ml

0.80

431

1207

Noninfectious colitis NAS

417

1174

3.72

126.27

1.3

255.73

257.20

u/ml

0.03

262

730

Other bacterial intestinal infections

445

1304

3.54

126.11

1.5

1.2

285.64

265.85

u/ml

0.58

274

799

Reimbursement for rheumatic diseases

1143

5360

2.16

124.36

1.3

292.08

262.80

u/ml

2.20

683

3430

Complications of medical and surgical care

1405

6385

2.01

124.03

1.5

1.3

278.54

262.43

u/ml

1.17

920

4066

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

899

2310

2.50

123.98

1.4

1.2

290.64

248.75

u/ml

3.58

580

1471

Primary biliary cholangitis, wide definition

121

101

13.65

123.27

1.6

1.3

399.21

229.55

u/ml

2.94

Other diseases of intestines

2203

6981

1.78

122.27

1.3

258.96

247.88

u/ml

0.99

1403

4430

Asthma, excluding more controls

1343

3285

2.13

122.04

1.3

1.2

275.11

244.80

u/ml

2.81

859

2108

ILD, hospital admissions 3, with pneumonia sepsis

214

362

6.20

121.57

1.3

1.2

353.14

255.45

u/ml

2.91

138

216

Myelodysplastic syndrome, including Hilmo

124

111

12.31

120.16

1.3

1.2

337.37

269.41

u/ml

0.55

Chronic hepatitis, not elsewhere classified

170

232

8.22

120.15

1.3

346.01

236.77

u/ml

2.50

131

Insulin, combination of fast acting with intermediate-acting or long-acting

1197

5248

2.10

120.04

1.5

1.3

289.24

254.41

u/ml

3.22

774

3298

Hypertensive Renal Disease

138

146

10.23

118.70

1.7

1.1

287.81

298.26

u/ml

0.11

Complications of surgical and medical care, not elsewhere classified

1888

6985

1.83

118.63

1.5

1.3

276.63

256.28

u/ml

2.06

1248

4425

Genitourinary diseases

1288

3060

2.15

118.45

1.7

1.2

241.32

238.41

u/ml

0.13

832

1859

Abnormalities of breathing

1844

5754

1.86

118.10

1.3

270.87

243.86

u/ml

3.22

1164

3661

Pain, not elsewhere classified

568

1999

2.91

117.42

1.3

1.2

267.32

253.74

u/ml

0.42

357

1257

Bleeding

1520

5552

1.95

117.24

1.5

1.3

281.23

258.45

u/ml

2.23

998

3455

Other heart diseases, wide

1895

6360

1.83

116.74

1.5

1.3

267.75

249.39

u/ml

1.78

1254

4006

Oxycodone

703

2334

2.62

115.71

1.3

1.2

295.27

271.01

u/ml

1.14

456

1449

Insulin, fast-acting

832

3556

2.40

115.71

1.6

1.3

269.19

253.26

u/ml

0.87

563

2233

Colitis, primary sclerosing

131

140

11.96

115.19

1.5

1.4

358.99

184.41

u/ml

3.57

Erysipelas

888

3320

2.34

115.07

1.4

1.2

278.76

260.49

u/ml

0.95

583

2107

Viral pneumonia

359

974

3.85

114.63

1.5

1.3

266.68

250.52

u/ml

0.46

245

610

All-cause Heart Failure

920

2768

2.35

114.36

1.4

1.2

288.59

274.91

u/ml

0.67

591

1695

Other respiratory diseases principally affecting the interstitium

370

1024

3.73

114.24

1.3

1.2

324.49

278.84

u/ml

1.27

238

618

Crohn's disease of large intestine

230

448

5.62

113.82

1.3

323.16

244.19

u/ml

2.31

140

283

Viral infections characterized by skin and mucous membrane lesions

964

4423

2.23

112.99

1.6

1.3

271.73

255.65

u/ml

0.84

617

2764

Asthma

1366

3486

2.05

112.74

1.3

275.16

246.93

u/ml

2.56

873

2241

Bacterial intestinal infections, IBD co-morbidities

439

1370

3.32

112.54

1.5

1.3

283.31

271.51

u/ml

0.29

269

841

Alcoholic liver disease

278

638

4.59

111.77

1.2

1.3

311.35

271.28

u/ml

1.12

171

403

Hyperkalaemia

182

286

6.76

111.63

1.6

1.2

305.42

289.75

u/ml

0.20

123

161

Insulin medication

1197

4906

2.06

111.40

1.5

1.3

289.24

251.47

u/ml

3.69

774

3126

Haemolytic anaemias

173

264

7.34

110.54

1.4

264.35

232.13

u/ml

0.57

112

151

Autoimmune hepatitis

24.06

109.91

1.3

1.6

270.00

220.08

u/ml

0.46

Implicit fungal Sepsis, including avohilmo

216

408

5.61

109.54

1.5

1.2

292.52

263.26

u/ml

0.58

148

242

Ulcerative rectosigmoiditis

285

682

4.45

109.02

1.2

253.15

257.74

u/ml

0.09

176

427

Insulin, fast-acting or short human

834

3662

2.33

108.95

1.6

1.3

268.97

256.32

u/ml

0.63

564

2284

Other viral diseases, not elsewhere classified

557

2025

2.85

108.77

1.8

1.4

255.93

244.43

u/ml

0.37

365

1220

Fungal Sepsis

167

248

7.33

108.71

1.6

1.3

290.65

274.81

u/ml

0.20

113

138

Tumor necrosis factor alpha inhibitors

528

1881

2.94

108.23

1.2

1.3

275.08

251.35

u/ml

1.03

307

1180

Erysipelas, including avohilmo

1162

4210

2.07

108.17

1.3

1.2

280.12

257.83

u/ml

1.61

760

2663

Symptoms and signs involving the circulatory and respiratory systems

2021

5789

1.77

107.58

1.3

265.44

243.39

u/ml

2.48

1302

3684

Other bacterial intestinal infections, including avohilmo

532

1899

2.88

107.56

1.4

1.2

272.81

265.95

u/ml

0.18

326

1168

Disorders of gallbladder, biliary tract and pancreas

1749

6051

1.82

107.37

1.3

278.86

262.84

u/ml

1.32

1102

3912

Acquired haemolytic anaemia

136

165

9.46

106.57

1.4

1.3

270.07

256.64

u/ml

0.14

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

1828

8158

1.77

106.09

1.4

1.3

259.67

251.70

u/ml

0.55

1141

5170

Other viral diseases, not elsewhere classified, including avohilmo

754

3199

2.42

105.65

1.6

1.3

252.54

248.88

u/ml

0.12

488

1967

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1118

5449

2.04

105.39

1.5

1.2

277.00

265.82

u/ml

0.58

747

3470

Implicit fungal Sepsis

154

222

7.56

103.06

1.6

1.3

297.77

271.64

u/ml

0.33

103

122

Asthma (mode)

1321

3516

2.00

102.80

1.3

268.48

246.57

u/ml

1.78

839

2259

Diseases of the skin and subcutaneous tissue

1850

5240

1.79

102.65

1.3

263.51

248.23

u/ml

1.34

1153

3362

Parasetamol

1549

4186

1.90

102.48

1.3

241.91

246.50

u/ml

0.25

957

2647

Atrial fibrillation and flutter

543

1227

2.91

100.92

1.4

1.2

281.51

260.15

u/ml

0.82

361

761

Enterocolitis due to Clostridium difficile

272

665

4.27

100.45

1.5

1.2

298.90

270.25

u/ml

0.61

168

402

Other disorders of skin and subcutaneous tissue

1305

5817

1.92

100.37

1.5

1.3

276.29

264.07

u/ml

0.77

831

3681

Diseases of oesophagus, stomach and duodenum

1969

6805

1.73

100.24

1.4

1.3

287.32

250.51

u/ml

5.65

1259

4351

Gout, idiopatic and unspecified

458

1565

3.00

100.17

1.5

1.2

285.12

281.42

u/ml

0.09

314

963

Leukaemia of unspecified cell type

17.62

100.08

1.3

1.2

255.62

248.04

u/ml

0.04

ILD, hospital admissions

311

840

3.83

99.69

1.2

342.12

282.90

u/ml

1.52

198

502

ILD, hospital admissions 1, main diag only

293

760

4.00

99.62

1.2

349.80

287.88

u/ml

1.51

188

447

Cholangitis (primary sclerosing, PSC), with reimbursement 202

138

187

8.85

99.57

1.6

1.5

364.56

237.59

u/ml

1.90

Interstitial lung disease endpoints

313

852

3.80

99.18

1.2

341.75

283.96

u/ml

1.48

199

509

Interstitial lung disease

313

852

3.80

99.18

1.2

341.75

283.96

u/ml

1.48

199

509

Other interstitial pulmonary diseases

313

853

3.80

99.01

1.2

341.75

282.44

u/ml

1.54

199

509

Malignant neoplasm, including Hilmo

1579

5065

1.84

98.60

1.4

1.3

268.39

260.84

u/ml

0.43

993

3288

Malignant neoplasm

1526

4875

1.86

98.39

1.3

274.41

263.10

u/ml

0.68

954

3183

Infections of the skin and subcutaneous tissue

1282

6748

1.90

97.72

1.5

1.3

264.56

252.48

u/ml

0.82

821

4257

Infliximab

155

244

7.46

97.32

1.2

1.3

246.69

230.17

u/ml

0.26

141

Ulcer of lower limb, not elsewhere classified

314

868

3.75

97.30

1.6

1.2

273.04

280.13

u/ml

0.17

223

530

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

169

283

6.28

97.15

1.3

1.2

331.25

284.74

u/ml

0.82

114

166

Malignant neoplasm

1521

4879

1.85

96.83

1.4

1.3

274.89

263.08

u/ml

0.72

951

3186

Cardiomyopathy

372

1149

3.34

96.82

1.5

1.3

275.32

261.98

u/ml

0.39

266

724

Asthma (only as main-diagnosis), excluding more controls

1186

3285

2.02

96.57

1.3

1.2

273.21

244.80

u/ml

2.31

748

2108

Other diseases of biliary tract

228

505

4.73

95.78

1.6

1.2

323.12

279.41

u/ml

1.02

169

292

Asthma, unspecified (mode), excluding more controls

897

2975

2.19

95.32

1.3

1.2

282.56

248.86

u/ml

2.54

563

1911

Diabetic maculopathy, excluding more controls

303

834

3.80

94.97

1.8

1.2

268.00

254.09

u/ml

0.39

213

526

Multiple myeloma, including Hilmo

138

192

7.69

94.96

1.5

1.2

207.12

267.52

u/ml

1.00

108

Malignant neoplasm, wide definition

1568

5080

1.82

94.66

1.4

1.3

269.17

261.60

u/ml

0.42

986

3305

Other acute lower respiratory infections

1128

5558

1.97

94.59

1.5

1.3

263.84

252.51

u/ml

0.61

747

3423

Insulin, intermediate and long-acting

1016

4909

2.03

93.74

1.5

1.3

279.96

256.13

u/ml

1.81

654

3092

Anxiety disorders

1804

7277

1.72

93.52

1.3

259.23

253.26

u/ml

0.39

1170

4617

Neurotic, stress-related and somatoform disorders

1792

7253

1.72

93.23

1.3

259.15

252.71

u/ml

0.43

1166

4596

Gout, unspecified

376

1196

3.23

93.21

1.6

1.2

288.46

283.95

u/ml

0.10

262

736

Disorders of lens

1110

3451

2.02

93.06

1.5

1.3

281.80

271.20

u/ml

0.52

726

2193

Anxiety disorders, excluding more controls

1615

5875

1.78

92.39

1.3

261.45

250.15

u/ml

0.86

1055

3725

Diseases of the digestive system

857

4030

2.15

92.38

1.5

1.3

279.12

260.88

u/ml

0.94

536

2480

Dependence on enabling machines and devices, not elsewhere classified

104

109

12.08

92.21

3.9

1.2

233.68

212.70

u/ml

0.18

Type 2 diabetes, wide definition

1286

4297

1.91

92.16

1.4

1.2

288.65

264.83

u/ml

1.91

824

2786

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

146

224

6.93

91.70

1.4

1.2

322.21

279.40

u/ml

0.68

126

Gout, strict definition

346

1058

3.37

91.62

1.6

1.2

278.79

290.90

u/ml

0.30

232

655

Persons encountering health services for examination and investigation

1153

2896

2.02

91.61

1.3

1.2

260.37

247.15

u/ml

0.80

707

1861

Other disorders of white blood cells

189

375

5.42

91.21

1.3

243.00

245.55

u/ml

0.04

126

228

Colitis, primary sclerosing, strict definition

100

102

12.59

90.99

1.5

1.3

347.24

196.07

u/ml

2.24

Maternal care for other conditions predominantly related to pregnancy

570

2234

2.57

90.94

1.2

205.97

257.24

u/ml

7.24

429

1439

Unspecified jaundice

160

272

6.26

90.91

1.4

1.3

294.78

253.06

u/ml

0.69

100

147

Infectious mononucleosis

359

1155

3.31

88.99

1.3

190.23

231.03

u/ml

1.97

210

707

Infectious mononucleosis, including avohilmo

359

1155

3.31

88.99

1.3

190.23

231.03

u/ml

1.97

210

707

395

1334

3.08

88.91

1.5

1.2

288.02

260.26

u/ml

1.04

304

812

Factors influencing health status and contact with health services

513

895

2.92

88.73

1.3

1.1

263.60

227.80

u/ml

1.54

304

540

Neoplasms

1678

5066

1.76

88.62

1.4

1.3

246.13

237.77

u/ml

0.57

1093

3219

Asthma (only as main-diagnosis)

1199

3486

1.95

88.18

1.3

272.77

246.93

u/ml

2.02

755

2241

Cerebrovascular diseases (FINNGEN)

536

1425

2.69

88.12

1.4

1.2

273.55

251.27

u/ml

0.98

360

884

Pneumocystosis, including avohilmo

110

131

9.77

87.74

1.4

1.3

264.12

267.75

u/ml

0.03

Pneumocystosis

110

131

9.77

87.74

1.4

1.3

264.12

267.75

u/ml

0.03

Diseases of arteries, arterioles and capillaries

1041

3878

2.00

87.33

1.4

1.3

286.19

270.03

u/ml

0.95

696

2421

Rare circulating lymphoid malignancy, including Hilmo

146

239

6.83

87.25

1.4

1.6

205.43

213.86

u/ml

0.09

114

Gingival hyperplasia

182

369

5.49

86.64

3.2

1.4

218.12

241.95

u/ml

0.39

122

192

IBD (strict) with PSC

13.38

86.49

1.4

440.46

158.34

u/ml

4.08

Asthma, unspecified (mode)

904

3155

2.10

86.42

1.3

282.83

251.43

u/ml

2.28

565

2026

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

1399

7246

1.79

86.28

1.5

1.3

250.58

251.00

u/ml

0.02

933

4582

Other necrotizing vasculopathies

194

411

4.98

86.28

1.4

1.2

263.02

281.34

u/ml

0.29

126

240

Pneumonia due to other infectious organisms, not elsewhere classified

131

193

7.40

86.01

1.4

1.3

256.22

238.81

u/ml

0.25

110

Abnormal findings on diagnostic imaging of lung

745

3242

2.21

85.99

1.3

307.63

273.17

u/ml

1.78

447

2035

Congenital malformations, deformations and chromosomal abnormalities

1309

6954

1.81

85.45

1.5

1.3

253.14

249.59

u/ml

0.18

876

4382

Toxic liver disease

11.68

85.39

1.3

234.89

224.33

u/ml

0.10

Pain (limb, back, neck, head abdominally)

1345

3651

1.87

85.28

1.3

247.57

243.27

u/ml

0.21

842

2293

Codeine

1678

5284

1.74

85.22

1.3

1.2

265.01

250.06

u/ml

1.21

1096

3380

Diabetic retinopathy, strict definition

413

1290

2.96

84.15

1.7

1.3

269.58

288.48

u/ml

0.66

288

789

Osteopathies and chondropathies

1035

4943

1.94

83.65

1.4

1.3

264.47

263.58

u/ml

0.03

676

3082

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

138

220

6.62

83.43

1.3

1.2

342.02

278.09

u/ml

1.06

125

Streptococcal septicaemia, including avohilmo

217

515

4.39

83.40

1.6

1.3

249.17

251.14

u/ml

0.03

142

298

Dyspnoea

1589

6741

1.72

83.22

1.3

288.47

257.70

u/ml

3.51

1008

4298

Nutritional anaemias

851

3989

2.07

82.42

1.5

1.3

276.41

267.91

u/ml

0.38

528

2485

Explicit bacterial Sepsis, including avohilmo

256

691

3.84

82.31

1.6

1.2

251.07

258.61

u/ml

0.15

161

411

Hypothyroidism (congenital or acquired)

574

1271

2.58

81.71

1.3

1.2

257.21

225.03

u/ml

1.65

337

804

Iron deficiency anaemia

759

3551

2.13

80.29

1.5

1.3

277.25

263.79

u/ml

0.64

474

2209

Disorders of lipoprotein metabolism and other lipidaemias

1281

4298

1.83

80.26

1.4

1.2

273.75

270.26

u/ml

0.14

864

2714

Cardiomyopathies, Primary/intrinsic

264

741

3.69

80.12

1.6

1.3

282.76

271.50

u/ml

0.26

191

470

Adjustment and management of implanted device

282

826

3.49

79.76

1.4

1.2

290.44

268.69

u/ml

0.59

198

471

Nonalcoholic fatty liver disease

302

935

3.39

79.23

1.2

1.3

279.38

262.45

u/ml

0.50

179

577

Ulcerative ileocolitis

160

312

5.57

79.05

1.2

331.67

244.52

u/ml

1.89

195

Malignant neoplasm of liver and intrahepatic bile ducts

107

138

8.36

78.78

1.4

1.2

330.94

275.34

u/ml

0.69

Cardiomyopathy (excluding other)

270

780

3.58

78.43

1.6

1.3

281.90

263.79

u/ml

0.48

195

498

Symptoms and signs involving the skin and subcutaneous tissue

1315

7135

1.76

78.42

1.3

260.67

260.20

u/ml

0.02

850

4531

Hypoplasia of dental enamel

128

218

8.96

78.28

4.2

1.8

189.98

158.07

u/ml

0.46

Streptococcal septicaemia

209

506

4.30

78.26

1.6

1.3

242.06

252.82

u/ml

0.21

137

295

Acute sinusitis

1049

5116

1.89

78.24

1.4

1.3

267.96

253.47

u/ml

0.80

660

3302

Hepatocellular carcinoma, including Hilmo

106

137

8.39

78.02

1.3

1.2

329.50

277.38

u/ml

0.62

Other and unspecified dermatitis

989

5242

1.92

77.86

1.4

1.3

267.29

264.01

u/ml

0.13

620

3382

Type 1 diabetes

619

2767

2.29

77.72

1.6

1.3

262.75

242.99

u/ml

0.98

428

1724

Dermatitis and eczema

2057

7704

1.60

77.71

1.4

1.3

256.99

253.71

u/ml

0.20

1274

4926

Explicit bacterial Sepsis

246

676

3.77

77.08

1.6

1.2

245.60

259.56

u/ml

0.31

155

403

Venous thromboembolism

840

4061

2.02

76.89

1.4

1.2

279.80

276.07

u/ml

0.13

550

2539

Hypothyroidism, levothyroxine purchases

559

1261

2.54

76.89

1.3

1.2

260.06

224.40

u/ml

1.93

333

799

Hypothyroidism and >3 levothyroxin purchases

559

1261

2.54

76.89

1.3

1.2

260.06

224.40

u/ml

1.93

333

799

Dermatitis

1139

6189

1.82

76.72

1.4

1.3

267.27

261.91

u/ml

0.26

715

3989

Molar incisor enamel hypoplasia, with caries

120

194

9.28

76.62

4.0

1.6

192.27

137.29

u/ml

1.03

Other diseases of the digestive system

564

2438

2.36

76.46

1.5

1.3

298.65

263.42

u/ml

1.74

357

1518

Acute bronchitis

794

3855

2.05

76.10

1.4

1.3

276.07

257.62

u/ml

0.89

536

2379

Bacterial pneumonia (organism specified)

787

3497

2.07

76.05

1.4

1.3

275.78

261.34

u/ml

0.69

525

2169

Diseases of the respiratory system

1110

2939

1.92

75.95

1.3

1.2

263.20

245.08

u/ml

1.15

680

1882

Postviral fatigue syndrome

12.66

75.92

1.3

1.4

258.05

170.03

u/ml

2.34

Atrial fibrillation and flutter with reimbursement

375

785

3.07

75.81

1.3

1.2

271.29

273.81

u/ml

0.05

241

469

Any event in cancer register

1626

5698

1.68

75.65

1.3

271.23

257.82

u/ml

0.96

1025

3709

Depression medications

661

1442

2.35

75.05

1.3

1.2

233.42

220.59

u/ml

0.60

411

914

GI-bleeding

558

2421

2.35

74.97

1.5

1.3

299.22

263.49

u/ml

1.75

353

1502

Multiple myeloma

110

9.23

74.94

1.6

1.2

178.79

260.37

u/ml

1.21

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

110

9.23

74.94

1.6

1.2

178.79

260.37

u/ml

1.21

Pain in throat and chest

1563

5516

1.70

74.74

1.3

267.23

246.21

u/ml

1.80

1008

3522

Ulcerative proctitis

209

527

4.21

74.73

1.2

1.3

251.07

252.99

u/ml

0.03

135

327

Bacterial pneumonia, not elsewhere classified

655

2645

2.21

74.49

1.4

1.3

276.63

257.86

u/ml

0.87

436

1657

Hypertensive heart and/or renal disease

386

988

2.90

74.39

1.6

1.2

266.23

280.03

u/ml

0.39

257

580

Bacterial pneumoniae

688

2835

2.16

74.31

1.4

1.3

277.43

259.26

u/ml

0.85

459

1790

Idiopathic pulmonary fibrosis

166

350

4.94

74.03

1.2

339.33

278.27

u/ml

1.12

115

194

Vitreous haemorrhage

254

736

3.60

73.77

1.7

1.2

248.81

276.72

u/ml

0.85

177

451

Coronary atherosclerosis

900

2883

1.99

73.10

1.4

1.2

282.85

272.63

u/ml

0.41

601

1759

Amputation

209

533

4.06

72.80

1.7

1.2

260.58

273.14

u/ml

0.26

153

307

Drug-induced neutropenia

199

495

4.24

72.32

1.4

1.2

255.65

269.50

u/ml

0.26

137

300

Syncope and collapse

657

2547

2.18

71.99

1.3

1.2

277.16

255.95

u/ml

1.07

430

1596

Depression

1794

7529

1.61

71.89

1.3

260.37

254.72

u/ml

0.34

1142

4772

Diseases of the eye and adnexa

1643

4989

1.67

71.29

1.4

1.3

254.34

242.59

u/ml

0.88

1044

3144

Diabetic retinopathy, excluding more controls

517

1166

2.55

71.24

1.6

1.2

277.27

292.15

u/ml

0.48

362

701

Drug-induced cataract

115

182

7.10

71.18

2.1

1.3

293.60

266.49

u/ml

0.32

103

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

152

311

5.30

71.16

1.6

1.2

283.73

266.13

u/ml

0.29

111

205

Myelodysplastic syndrome

16.22

71.08

1.3

1.1

273.42

287.58

u/ml

0.07

Multiple myeloma and malignant plasma cell neoplasms

136

253

5.71

70.37

1.5

1.2

209.13

284.09

u/ml

1.31

136

Other and unspecified polyneuropathies, also in other diseases

356

1290

2.83

70.16

1.4

1.2

286.08

280.25

u/ml

0.12

229

825

Other reaction to severe stress, and adjustment disorders

828

4289

1.97

70.08

1.4

1.3

271.00

249.74

u/ml

1.29

548

2786

Polyneuropathies and other disorders of the peripheral nervous system

401

1546

2.66

69.94

1.4

1.3

278.43

276.68

u/ml

0.04

257

976

Complications of procedures, not elsewhere classified

1367

6552

1.70

69.94

1.4

1.2

281.26

259.20

u/ml

1.77

909

4161

Osteoporosis

412

1464

2.64

69.84

1.4

1.2

282.20

281.03

u/ml

0.02

285

847

Primary biliary cholangitis (PBC)

11.03

69.73

1.4

1.3

360.50

242.10

u/ml

1.22

Non-ischemic cardiomyopathy

482

1572

2.48

69.53

1.5

1.2

276.29

276.42

u/ml

0.00

322

945

Pericarditis

121

205

6.33

69.21

1.4

1.2

280.92

256.97

u/ml

0.35

127

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

172

395

4.53

69.06

1.3

1.2

307.59

269.43

u/ml

0.76

102

229

Protozoal diseases

125

221

6.23

68.95

1.4

1.3

259.35

257.87

u/ml

0.02

128

Peripheral artery operations in Hilmo

225

630

3.67

68.33

1.6

1.2

260.52

274.47

u/ml

0.33

166

373

Pain in joint

1055

3549

1.85

68.21

1.3

272.64

245.35

u/ml

1.94

648

2254

Need for immunization against other single viral diseases

105

159

7.54

68.02

1.7

1.3

223.39

254.61

u/ml

0.45

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

251

761

3.44

68.00

1.6

1.2

261.61

271.92

u/ml

0.21

162

467

Anxiety (asthma-related co-morbidities)

1278

5713

1.72

67.91

1.3

252.34

247.58

u/ml

0.24

826

3646

Hepatocellular carcinoma

9.43

67.79

1.3

1.2

351.76

254.38

u/ml

1.28

Finngen Rheumatological endpoints

1771

6330

1.60

67.74

1.3

272.97

249.93

u/ml

2.49

1109

4097

Protozoal diseases, including avohilmo

127

232

6.01

67.63

1.4

1.3

257.93

255.33

u/ml

0.03

135

All anxiety disorders

1323

6121

1.70

67.09

1.3

249.25

247.64

u/ml

0.07

860

3893

Other cataract

689

2481

2.09

66.26

1.5

1.2

271.67

273.47

u/ml

0.05

449

1545

Other diseases of pericardium

137

271

5.37

66.23

1.7

1.3

296.70

249.34

u/ml

1.02

158

Other infectious diseases, including avohilmo

226

653

3.61

65.97

1.5

1.3

277.07

263.85

u/ml

0.24

154

394

Any death

939

3535

1.88

65.96

1.3

300.85

268.95

u/ml

2.37

633

2169

Pulmonary heart disease, diseases of pulmonary circulation

503

2207

2.32

65.87

1.3

1.2

295.49

277.31

u/ml

0.66

336

1334

Other and unspecified iron deficiency

602

2836

2.16

65.87

1.4

1.3

266.12

264.97

u/ml

0.03

373

1751

Viral hepatitis, IBD co-morbidity

169

401

4.42

65.27

1.3

1.2

271.51

246.46

u/ml

0.48

123

281

Disorders of mineral metabolism

212

592

3.73

65.15

1.7

1.2

277.18

275.94

u/ml

0.02

129

352

Other soft tissue disorders, not elsewhere classified

1759

6352

1.59

65.11

1.3

266.08

247.44

u/ml

1.73

1125

4037

Asthma-related infections

1132

6429

1.74

64.84

1.3

272.76

252.58

u/ml

1.33

708

4039

Asthma, hospital admission 2, infections

1132

6429

1.74

64.84

1.3

272.76

252.58

u/ml

1.33

708

4039

Other autoimmune haemolytic anaemias

11.96

64.82

1.3

1.2

271.29

280.87

u/ml

0.06

Mood disorders, excluding more controls

1640

6035

1.61

64.71

1.3

263.40

250.08

u/ml

1.01

1069

3823

Neurological diseases, wide definition

699

1664

2.15

64.66

1.3

238.46

222.71

u/ml

0.76

436

1068

Senile cataract

887

2838

1.92

64.59

1.5

1.2

286.42

275.74

u/ml

0.44

568

1784

Cardiomyopathy, other and unspecified

182

462

4.11

64.09

1.5

1.3

291.83

251.75

u/ml

0.99

131

286

Mood [affective] disorders

1843

7645

1.56

64.06

1.3

262.72

254.42

u/ml

0.57

1180

4843

Hypo-osmolality and hyponatraemia

289

977

3.00

63.55

1.7

1.2

264.87

283.61

u/ml

0.50

190

576

Other and unspecified disorders of white blood cells

136

279

5.23

63.31

1.3

246.57

262.42

u/ml

0.22

162

Acute pharyngitis

446

1881

2.42

63.20

1.4

1.3

235.91

241.09

u/ml

0.14

270

1169

Mood disorders

1842

7651

1.55

63.14

1.3

262.77

254.37

u/ml

0.58

1180

4845

Ulcerative colitis (strict) with PSC

12.71

63.13

1.4

360.91

156.00

u/ml

2.12

Other infectious diseases

188

495

3.97

62.98

1.5

1.3

298.06

255.68

u/ml

0.93

131

295

Other necrotizing vasculopathies (FG)

144

312

4.83

62.32

1.4

1.3

267.52

269.04

u/ml

0.02

179

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

933

5199

1.81

62.05

1.5

1.3

279.88

267.95

u/ml

0.56

620

3307

Other diseases of pleura

663

2860

2.04

61.66

1.3

297.02

270.96

u/ml

1.48

428

1741

Idiopathic thrombocytopenic purpura

120

227

5.76

61.47

1.3

1.4

327.28

263.69

u/ml

0.54

127

Adalimumab

309

1123

2.88

61.36

1.3

288.30

247.30

u/ml

1.49

184

708

Sub-endpoint used in defining T1D endpoints

620

2994

2.08

61.23

1.6

1.4

262.52

249.93

u/ml

0.52

427

1849

929

5171

1.81

61.10

1.3

269.42

250.32

u/ml

1.06

583

3219

Type 1 diabetes, wide definition, subgroup 1

512

2342

2.24

61.06

1.7

1.3

255.95

241.43

u/ml

0.62

358

1442

SLE (Finngen)

105

175

6.39

61.00

1.3

336.64

244.91

u/ml

1.03

105

Other diseases of arteries and capillaries

204

581

3.64

60.80

1.6

1.2

280.84

268.23

u/ml

0.22

141

342

Other and unspecified aplastic anaemias

11.78

60.54

1.4

281.58

253.55

u/ml

0.19

Other and unspecified types of non-Hodgkin lymphoma, hilmo

121

234

5.51

60.09

1.2

311.22

275.10

u/ml

0.38

124

Type 1 diabetes, wide definition

526

2451

2.20

59.83

1.7

1.4

257.07

240.71

u/ml

0.71

367

1516

Insulin, fast-acting (human)

359

1423

2.61

59.59

1.7

1.2

276.53

254.99

u/ml

0.71

253

908

Mycoses

557

2659

2.14

59.50

1.4

1.3

276.83

262.78

u/ml

0.53

348

1671

Cutaneous abscess, furuncle and carbuncle

582

2829

2.10

59.36

1.5

1.3

268.95

257.98

u/ml

0.43

401

1791

Diabetic maculopathy

292

982

2.92

59.23

1.8

1.3

271.89

286.26

u/ml

0.39

204

612

Zoster [herpes zoster]

341

1319

2.65

59.17

1.3

1.2

267.33

271.11

u/ml

0.08

215

795

DVT of lower extremities and pulmonary embolism

618

3055

2.04

58.93

1.3

1.2

279.62

277.66

u/ml

0.06

412

1894

Peripheral artery disease

565

2108

2.14

58.80

1.5

1.2

296.68

275.83

u/ml

0.86

381

1267

Collagenous colitis

217

661

3.41

58.34

1.3

264.98

262.14

u/ml

0.04

125

403

Abnormal results of function studies

242

789

3.20

58.28

1.3

277.02

251.80

u/ml

0.54

148

484

Codeine or tramadol medication

1918

6903

1.52

58.08

1.3

261.84

255.56

u/ml

0.41

1247

4469

Ischaemic heart disease, wide definition

1081

3854

1.74

57.97

1.4

1.3

286.59

275.19

u/ml

0.53

728

2430

Disorders of calcium metabolism

161

403

4.18

57.92

1.7

1.2

291.27

274.86

u/ml

0.25

101

245

Other arthritis (FG)

570

2774

2.09

57.71

1.4

1.3

267.94

258.35

u/ml

0.34

359

1743

Cardiac arrhythmias

1099

4120

1.73

57.62

1.4

1.3

274.98

244.09

u/ml

2.56

722

2597

Diseases of the musculoskeletal system and connective tissue

1156

3392

1.73

57.29

1.3

1.4

255.21

231.96

u/ml

1.79

724

2138

Gout due to impairment of renal function

11.19

57.23

1.7

1.1

304.20

299.07

u/ml

0.02

Other systemic involvement of connective tissue (FG)

434

1865

2.33

57.09

1.2

1.3

273.58

270.99

u/ml

0.05

263

1162

All influenza (not pneumonia)

337

1331

2.60

56.23

1.6

1.3

264.26

245.82

u/ml

0.46

226

815

Arthropathies in other diseases classified elsewhere

114

223

5.45

55.96

1.7

1.2

307.24

242.42

u/ml

1.49

137

Diverticular disease of intestine

991

3524

1.77

55.90

1.3

278.82

277.13

u/ml

0.06

644

2251

Presence of cardiac and vascular implants and grafts

535

1847

2.16

55.69

1.3

1.1

291.23

264.83

u/ml

1.07

358

1099

Heart failure and bmi 25plus

479

1426

2.27

55.21

1.3

1.2

290.72

278.37

u/ml

0.38

303

879

Chronic tubulo-interstitial nephritis

106

196

5.72

55.21

1.6

1.1

260.42

270.11

u/ml

0.11

110

Asthma-related pneumonia

623

3171

1.99

54.99

1.3

295.72

257.61

u/ml

1.97

396

1951

Symptoms and signs concerning food and fluid intake

209

642

3.34

54.97

1.7

1.2

269.61

261.86

u/ml

0.09

122

371

Pure hypercholesterolaemia

1052

3905

1.73

54.94

1.4

1.2

269.59

271.64

u/ml

0.07

694

2458

Zoster [herpes zoster], including avohilmo

806

4312

1.83

54.77

1.3

254.96

271.90

u/ml

1.05

495

2712

Dilated cardiomyopathy

236

785

3.11

54.68

1.4

1.3

279.54

264.79

u/ml

0.35

170

479

Asthma, hospital admissions 3, pneumonia

623

3180

1.98

54.54

1.3

295.72

257.42

u/ml

1.99

396

1954

Asthma-related pneumonia or sepsis

623

3180

1.98

54.54

1.3

295.72

257.42

u/ml

1.99

396

1954

Urinary track infection

1057

3070

1.75

54.06

1.3

266.45

249.97

u/ml

1.01

681

1917

Amputation of toe

155

398

4.05

53.79

1.7

1.2

246.58

293.54

u/ml

1.27

116

221

Hyperlipidaemia, other/unspecified

521

2245

2.11

53.61

1.5

1.2

271.95

285.97

u/ml

0.54

354

1387

Other diseases of intestine

280

1037

2.77

53.03

1.4

1.3

259.47

278.20

u/ml

0.45

172

644

Valvular heart disease excluding rheumatic fever

693

2599

1.93

52.81

1.5

1.3

282.16

266.68

u/ml

0.68

458

1576

Viral pneumonia (unknown virus, not influenza)

196

600

3.42

52.57

1.4

1.3

250.80

256.58

u/ml

0.10

141

375

Non-rheumatic valve diseases

679

2537

1.93

52.20

1.5

1.3

284.65

268.35

u/ml

0.71

449

1547

Other disorders of urethra and urinary system

1141

4835

1.66

52.20

1.4

1.3

263.20

257.19

u/ml

0.30

735

3025

Non-invasive ventilation

432

1674

2.26

52.20

1.5

1.3

330.65

247.04

u/ml

3.98

258

1067

Other and unspecified tonsillitis

801

3735

1.81

51.46

1.4

1.3

219.88

237.39

u/ml

1.20

498

2396

Pain in limb

1486

6131

1.55

51.19

1.3

264.25

249.29

u/ml

1.10

955

3891

Pacemaker

477

2099

2.14

51.10

1.4

1.3

299.14

273.97

u/ml

1.08

316

1265

Pulmonary embolism

441

2038

2.20

51.05

1.3

1.2

288.62

280.71

u/ml

0.22

295

1245

Pulmonary heart disease

441

2044

2.19

50.68

1.3

1.2

288.62

282.45

u/ml

0.16

295

1250

Other skin changes

352

1487

2.42

50.67

1.4

1.3

295.01

273.38

u/ml

0.51

233

905

Statin medication

1189

4109

1.65

50.61

1.5

1.2

257.60

252.13

u/ml

0.26

811

2625

Other specified/unspecified arthritis

502

2452

2.08

50.45

1.4

1.3

267.58

260.14

u/ml

0.23

324

1560

Acute pancreatitis

339

1412

2.45

50.34

1.3

287.15

271.95

u/ml

0.39

207

875

Other viral hepatitis, including avohilmo

215

716

3.16

50.29

1.3

255.00

242.18

u/ml

0.24

150

468

Cough

716

3669

1.85

50.06

1.4

1.3

246.83

252.59

u/ml

0.21

436

2274

Paroxysmal tachycardia

397

1451

2.31

50.00

1.4

1.2

261.24

241.23

u/ml

0.77

271

853

Congenital malformations of gallbladder, bile ducts and liver

8.80

49.68

2.5

1.9

264.44

200.08

u/ml

0.62

Viral hepatitis, including avohilmo

228

792

3.01

49.38

1.3

260.56

249.06

u/ml

0.22

158

512

Other retinal disorders

938

4204

1.71

49.26

1.5

1.2

265.34

270.82

u/ml

0.25

642

2619

Other diseases of urinary system

1643

6140

1.51

49.15

1.4

1.3

268.14

254.47

u/ml

1.10

1051

3879

Other anxiety disorders

996

5130

1.67

48.71

1.3

241.26

245.74

u/ml

0.22

665

3277

Persons encountering health services for specific procedures, not carried out

220

755

3.02

48.43

1.4

1.2

264.40

239.24

u/ml

0.48

164

453

ILD-related respiratory insufficiency

169

5.78

48.37

1.3

1.2

368.11

286.42

u/ml

0.66

Disorders of choroid and retina

1187

5213

1.61

48.26

1.5

1.3

265.75

268.79

u/ml

0.14

797

3287

Other gastritis (incl. Duodenitis)

355

1537

2.35

48.25

1.4

1.2

317.37

261.11

u/ml

1.88

236

962

Diabetes, varying definitions

1712

6703

1.49

48.13

1.4

1.3

289.37

248.52

u/ml

5.85

1095

4317

Cystitis

1364

5229

1.56

47.89

1.3

273.78

254.53

u/ml

1.58

872

3279

Other systemic involvement of connective tissue

446

2125

2.14

47.89

1.2

1.3

274.65

274.59

u/ml

0.00

272

1329

Nonischemic cardiomyopathy

196

633

3.19

47.71

1.6

1.3

238.13

270.94

u/ml

1.06

144

382

Cerebral cysts

175

532

3.46

47.59

1.5

1.4

281.15

236.43

u/ml

1.12

118

330

Diabetes mellitus

1717

6717

1.49

47.50

1.4

1.3

287.05

248.95

u/ml

5.63

1102

4327

Endocarditis

101

206

5.18

47.21

1.3

290.12

236.72

u/ml

1.01

124

Type 2 diabetes

1543

5933

1.52

46.95

1.4

1.2

292.57

255.86

u/ml

4.63

973

3881

Myocarditis

119

278

4.46

46.91

1.3

1.2

274.86

251.05

u/ml

0.38

170

Convulsions, not elsewhere classified

418

1933

2.17

46.82

1.4

1.3

244.06

240.95

u/ml

0.08

242

1176

Presence of other functional implants

686

2551

1.86

46.67

1.4

1.1

287.23

267.87

u/ml

1.00

432

1514

Other or ill-defined heart diseases

146

401

3.80

46.17

1.5

1.3

248.67

248.36

u/ml

0.00

106

245

Phlebitis and thrombophlebitis (not including DVT)

385

1762

2.23

45.90

1.4

1.3

280.70

269.45

u/ml

0.32

254

1118

Osteomyelitis

157

455

3.60

45.84

1.6

1.3

256.15

255.10

u/ml

0.01

107

262

Hypothyroidism, strict autoimmune

1038

4178

1.64

45.69

1.3

1.2

279.80

248.18

u/ml

2.36

622

2713

Gingivitis and periodontal diseases

1556

5353

1.51

45.62

1.4

1.3

261.41

253.87

u/ml

0.47

998

3322

Cholelithiasis, broad definition with cholecystitis

1251

5350

1.57

45.49

1.3

275.24

267.23

u/ml

0.40

775

3467

Unspecified nephritic syndrome

156

5.94

45.09

1.8

1.2

322.82

282.19

u/ml

0.35

Atherosclerosis, excluding cerebral and coronary sclerosis

487

1891

2.05

45.04

1.4

1.2

308.85

274.82

u/ml

1.51

321

1129

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

191

5.18

44.94

1.4

1.2

289.30

261.13

u/ml

0.30

108

STROKE

753

2867

1.79

44.86

1.4

1.2

282.69

260.37

u/ml

1.06

496

1806

Systemic lupus erythematosus

105

232

4.80

44.71

1.3

336.64

264.52

u/ml

0.71

136

Diabetic retinopathy

571

1831

1.97

44.67

1.6

1.3

277.97

294.85

u/ml

0.67

396

1102

Other CVD (FINNGEN)

178

411

3.38

44.66

1.4

1.2

280.91

255.92

u/ml

0.46

112

232

Soft tissue disorders

1831

6483

1.46

44.62

1.3

258.42

246.80

u/ml

0.91

1151

4098

Other viral hepatitis

195

661

3.10

44.26

1.3

258.06

238.48

u/ml

0.39

141

431

Neurological diseases

1596

5399

1.50

44.20

1.3

1.4

257.09

242.61

u/ml

1.17

990

3459

Immunodeficiency with predominantly antibody defects

102

224

4.94

44.10

1.7

1.4

237.28

241.53

u/ml

0.04

129

Acute pancreatitis (for exclusion)

339

1498

2.31

44.05

1.3

287.15

279.47

u/ml

0.17

207

924

Follicular lymphoma, hilmo

108

248

4.60

43.77

1.2

250.89

273.88

u/ml

0.33

129

Haemorrhage from respiratory passages

522

2387

1.96

43.70

1.4

1.3

284.52

256.51

u/ml

1.40

336

1468

Persons encountering health services in other circumstances

734

4199

1.75

43.60

1.4

1.3

253.10

250.16

u/ml

0.11

434

2613

Gastro-oesophageal reflux disease

1042

5526

1.60

43.46

1.3

276.04

256.74

u/ml

1.29

632

3501

Caries of enamel

1661

7486

1.46

43.31

1.4

1.3

250.63

258.34

u/ml

0.54

1103

4722

Arthropathies

1715

5952

1.47

43.21

1.3

258.12

245.07

u/ml

1.08

1072

3799

Symptoms and signs involving the urinary system

1170

5689

1.56

43.00

1.4

1.3

250.51

264.77

u/ml

1.07

740

3579

Viral hepatitis

206

733

2.94

42.74

1.3

264.30

245.44

u/ml

0.39

148

467

Immunodeficiencies

144

415

3.67

42.71

1.6

1.4

247.74

239.87

u/ml

0.09

241

Exposure to unspecified factor

1754

8339

1.44

42.56

1.3

244.37

255.04

u/ml

0.95

1182

5196

Viral and other specified intestinal infections, including avohilmo

672

3677

1.79

42.44

1.7

1.3

230.13

234.83

u/ml

0.17

444

2255

Chronic gastritis

358

1647

2.21

42.01

1.3

1.2

310.44

273.88

u/ml

1.03

231

1020

Chronic periodontitis, including avohilmo

1530

6652

1.48

41.95

1.4

1.3

279.79

260.65

u/ml

1.65

1022

4275

Cholelithiasis

1184

5233

1.56

41.86

1.3

274.27

267.22

u/ml

0.33

730

3396

Diseases of spleen

128

6.35

41.84

1.4

1.2

299.59

279.03

u/ml

0.17

Periodontitis

1532

6660

1.48

41.78

1.4

1.3

279.63

260.74

u/ml

1.62

1020

4282

Early onset COPD, excluding more controls

271

1109

2.48

41.68

1.2

1.3

311.45

273.00

u/ml

1.02

168

717

Charcot foot

112

6.72

41.50

1.8

1.2

313.76

252.64

u/ml

0.81

Diaphragmatic hernia

495

2578

1.95

41.41

1.3

1.2

287.08

280.22

u/ml

0.20

312

1608

Volume depletion

172

560

3.15

41.34

1.8

1.2

269.21

268.57

u/ml

0.01

114

319

Other acute viral hepatitis

117

6.80

41.33

1.3

1.2

206.11

242.14

u/ml

0.40

Other embolism and thrombosis

231

883

2.68

41.30

1.4

1.2

303.27

266.50

u/ml

1.06

159

549

Chronic hepatitis NAS

7.79

41.23

1.3

1.2

275.41

216.23

u/ml

0.56

Solid cancers, including Hilmo

1272

4866

1.54

41.04

1.3

281.63

263.79

u/ml

1.27

813

3189

Renal tubulo-interstitial disorders in diseases classified elsewhere

9.73

40.99

1.8

1.2

244.23

321.94

u/ml

0.62

Molar incisor enamel hypoplasia

199

685

3.02

40.93

3.3

1.5

192.45

181.77

u/ml

0.19

125

337

Other diseases of hard tissues of teeth

760

2255

1.76

40.90

1.4

1.2

262.98

255.44

u/ml

0.31

488

1408

Urticaria and erythema

695

4038

1.75

40.81

1.4

1.3

258.12

255.04

u/ml

0.10

432

2540

SLE, ICD10

225

4.67

40.76

1.2

1.3

330.56

252.77

u/ml

0.76

134

SLE, strict definition

225

4.67

40.76

1.2

1.3

330.56

252.77

u/ml

0.76

134

Other metabolic disorders

267

1103

2.48

40.63

1.4

1.2

291.04

268.44

u/ml

0.53

172

682

Chronic periodontitis, complicated

826

4901

1.66

40.29

1.4

1.3

280.45

272.76

u/ml

0.32

551

3112

Hepatomegaly and splenomegaly, not elsewhere classified

9.03

40.23

1.6

1.1

266.06

260.88

u/ml

0.03

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1439

6173

1.48

40.19

1.4

1.3

282.48

260.41

u/ml

2.08

914

3986

Other antidepressants

1694

6010

1.45

40.16

1.3

258.42

253.98

u/ml

0.26

1046

3882

Sequelae of external causes of morbidity and mortality

433

2183

2.02

40.01

1.4

1.3

257.35

267.85

u/ml

0.32

281

1377

Any mental disorder

1749

6128

1.44

39.85

1.3

272.79

249.17

u/ml

2.57

1119

3859

Diagnoses used for exclusion with ILD

388

1886

2.09

39.60

1.3

282.23

273.95

u/ml

0.22

249

1184

ILD medications: pirfenidone

12.66

39.33

1.1

424.03

265.67

u/ml

1.32

Solid cancers

1210

4657

1.53

39.12

1.3

288.19

265.41

u/ml

1.67

766

3056

Mantle cell lymphoma, including Hilmo

8.62

39.00

1.3

1.1

342.22

256.45

u/ml

0.44

Hypoplasia of dental enamel , including avohilmo

187

650

3.01

38.28

3.4

1.5

189.06

179.67

u/ml

0.16

121

321

Mantle cell lymphoma

11.79

38.25

1.4

1.0

358.75

286.11

u/ml

0.25

Haemorrhage, not elsewhere classified

171

5.05

38.23

1.5

1.2

274.12

280.91

u/ml

0.05

Pleural effusion

220

855

2.62

37.95

1.2

305.85

284.94

u/ml

0.46

146

518

Diseases of oral cavity, salivary glands and jaws

751

2261

1.73

37.70

1.3

1.2

271.65

255.35

u/ml

0.76

472

1411

Sequelae with surgical and medical care as external cause

335

1571

2.17

37.70

1.5

1.3

258.62

271.53

u/ml

0.34

220

977

Any operation in hilmo

6.70

37.61

1.3

1.2

215.32

170.88

u/ml

0.69

Viral warts

249

1037

2.48

37.52

2.2

1.3

264.98

249.74

u/ml

0.33

164

632

Migraine

994

4973

1.57

37.47

1.3

240.83

245.39

u/ml

0.19

633

3180

L01XX Other antineoplastic agents

113

301

3.90

37.37

1.2

341.93

274.49

u/ml

0.81

167

L04AC Interleukin inhibitors

188

686

2.86

37.30

1.2

1.3

264.39

251.80

u/ml

0.24

125

424

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1432

5840

1.46

37.11

1.5

1.3

288.13

251.97

u/ml

4.38

914

3749

Hodgkin lymphoma, hilmo

102

257

4.27

36.95

1.4

1.2

254.80

257.27

u/ml

0.03

152

Respiratory insufficiency

113

302

3.81

36.77

1.4

1.2

289.30

279.95

u/ml

0.12

177

Visual disturbances and blindness

837

5245

1.61

36.43

1.3

270.09

261.09

u/ml

0.35

521

3274

Candidiasis, including avohilmo

547

3070

1.81

36.34

1.3

262.25

259.84

u/ml

0.06

355

1950

Benign neoplasm: Colon

690

3861

1.69

36.28

1.3

297.19

274.52

u/ml

1.01

444

2396

Episodal and paroxysmal disorders

1869

6830

1.40

36.27

1.3

258.96

247.62

u/ml

0.95

1165

4346

Other diseases of anus and rectum

443

2317

1.93

36.24

1.4

1.3

288.79

268.56

u/ml

0.67

265

1449

Sarcoidosis

241

1003

2.46

36.17

1.3

1.2

284.49

271.18

u/ml

0.30

157

629

Cellulitis

421

2183

1.96

36.01

1.5

1.3

262.91

256.40

u/ml

0.18

276

1357

Herpesviral [herpes simplex] infections

248

1051

2.42

35.82

1.4

1.2

265.01

264.67

u/ml

0.01

161

646

Dipeptidyl peptidase 4 (DPP-4) inhibitors

706

3310

1.69

35.68

1.4

1.3

308.73

276.13

u/ml

2.13

439

2105

Benign neoplasm of colon, rectum, anus and anal canal

811

4260

1.62

35.65

1.3

296.81

273.32

u/ml

1.26

529

2665

Secondary thrombocytopenia

7.63

35.51

1.2

1.3

275.67

238.49

u/ml

0.28

Undetermined asthma, excluding more controls

211

830

2.59

35.48

1.4

1.2

255.48

265.91

u/ml

0.21

128

504

Amiodarone users

169

596

2.91

35.41

1.2

284.46

282.52

u/ml

0.03

123

351

Gastroduodenal ulcer

329

1565

2.12

35.22

1.4

1.2

304.68

271.33

u/ml

1.26

222

968

Other functional intestinal disorders

704

3861

1.67

35.20

1.4

277.91

255.23

u/ml

0.99

427

2382

Other disorders of lacrimal gland

567

3246

1.77

35.11

1.3

250.69

272.36

u/ml

0.99

365

2040

Other pleural conditions

159

545

2.99

35.00

1.3

1.2

315.03

282.36

u/ml

0.63

101

321

Viral and other specified intestinal infections

519

2838

1.82

34.75

1.9

1.3

237.51

231.27

u/ml

0.19

346

1700

Disorders of skin appendages

936

6064

1.55

34.66

1.4

1.3

258.91

249.38

u/ml

0.48

604

3827

Hypokalaemia

200

777

2.63

34.65

1.6

1.2

255.79

273.99

u/ml

0.36

117

459

Hydronephrosis

182

675

2.76

34.58

1.8

1.2

263.36

274.04

u/ml

0.19

123

397

Seborrhoeic keratosis

343

1676

2.08

34.57

1.4

1.2

284.40

284.11

u/ml

0.01

227

1031

Chronic apical periodontitis

1802

7322

1.39

34.48

1.3

264.09

253.08

u/ml

0.82

1148

4707

Cystic disease of liver

11.58

34.45

1.7

1.1

284.84

295.56

u/ml

0.04

Total colectomy operation

122

364

3.53

34.38

1.2

1.3

254.77

255.24

u/ml

0.01

219

Total colectomy

122

364

3.53

34.38

1.2

1.3

254.77

255.24

u/ml

0.01

219

Idiopathic gout

154

525

3.01

34.29

1.5

1.2

277.84

277.81

u/ml

0.00

110

314

Abnormal findings on diagnostic imaging of other body structures

243

1043

2.38

33.99

1.3

287.98

269.06

u/ml

0.40

149

648

Non-allergic asthma (mode), excluding more controls

278

1248

2.24

33.98

1.4

1.2

274.29

255.20

u/ml

0.42

189

764

Candidiasis

282

1291

2.24

33.92

1.4

1.3

276.97

262.75

u/ml

0.35

182

798

Paralytic ileus and intestinal obstruction

347

1713

2.05

33.88

1.3

277.85

272.61

u/ml

0.10

224

1065

Intestinal stricture

431

2299

1.90

33.68

1.4

1.3

280.25

274.14

u/ml

0.14

272

1421

Major coronary heart disease event excluding revascularizations

690

2724

1.68

33.67

1.3

1.2

293.85

274.52

u/ml

0.73

441

1663

Systemic lupus erythematosus, unspecified

200

4.51

33.56

1.2

1.3

341.73

256.56

u/ml

0.71

118

Undetermined asthma

211

853

2.52

33.54

1.4

1.2

255.48

266.07

u/ml

0.22

128

522

Iron deficiency anaemia secondary to blood loss (chronic)

242

1042

2.36

33.53

1.5

1.2

296.64

273.18

u/ml

0.57

153

648

Myocardial infarction

564

2241

1.77

33.43

1.3

1.2

295.04

275.42

u/ml

0.65

362

1360

Amputation of ankle bones

123

5.63

33.23

1.7

1.2

276.90

258.50

u/ml

0.18

Other diseases of blood and blood-forming organs

136

442

3.18

33.04

1.3

240.20

259.03

u/ml

0.33

272

Visual disturbances

777

4905

1.60

33.04

1.3

269.67

261.70

u/ml

0.29

485

3080

Depression or dysthymia

1055

3804

1.53

32.93

1.3

268.98

255.35

u/ml

0.76

659

2428

Chronic pancreatitis

207

840

2.52

32.82

1.4

1.3

280.93

281.59

u/ml

0.01

133

517

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

188

731

2.65

32.72

1.3

320.91

268.67

u/ml

0.85

111

442

Disorders of sclera, cornea, iris and ciliary body

892

5823

1.55

32.70

1.3

246.18

265.08

u/ml

1.29

586

3713

Other respiratory disorders and diseases

283

1314

2.19

32.66

1.4

1.3

288.42

271.47

u/ml

0.42

190

798

Other diseases of the respiratory system

283

1314

2.19

32.66

1.4

1.3

288.42

271.47

u/ml

0.42

190

798

Eosinophilic disease (BM)

6.92

32.48

1.1

1.2

234.57

262.79

u/ml

0.29

Viral pneumonia (known virus, not influenza)

223

4.24

32.41

1.8

1.5

279.96

251.01

u/ml

0.30

117

Dental operations

784

2484

1.64

32.40

1.3

1.2

264.13

255.88

u/ml

0.35

494

1569

Isolated proteinuria

255

4.03

32.34

1.9

1.2

223.70

262.83

u/ml

0.67

151

Osteonecrosis

128

407

3.26

32.31

1.4

1.2

210.93

264.90

u/ml

1.39

235

Non-allergic asthma (mode)

278

1277

2.19

32.13

1.4

1.3

274.29

257.75

u/ml

0.35

189

782

Abnormalities of heart beat

546

3072

1.74

32.07

1.3

281.13

254.14

u/ml

1.03

344

1935

Hypertensive Heart Disease

269

914

2.26

31.94

1.5

1.2

251.59

280.10

u/ml

0.91

172

538

Follow-up examination after treatment for conditions other than malignant neoplasms

623

2453

1.71

31.91

1.3

1.2

275.23

248.13

u/ml

1.52

402

1587

Herpesviral [herpes simplex] infections, including avohilmo

487

2750

1.80

31.83

1.3

252.60

256.01

u/ml

0.09

320

1745

Psychiatric diseases

1540

5499

1.41

31.78

1.3

267.42

250.95

u/ml

1.41

972

3484

Chronic ulcer of skin, not elsewhere classified

125

396

3.25

31.66

1.5

1.2

318.82

261.35

u/ml

1.12

226

Disorders of thyroid, IBD co-morbidities

298

949

2.18

31.63

1.3

1.2

279.22

244.97

u/ml

0.93

205

654

COPD-related respiratory insufficiency

166

615

2.75

31.63

1.3

1.2

300.74

286.37

u/ml

0.19

105

371

Hypothyroidism, drug reimbursement

215

606

2.52

31.60

1.4

1.2

279.79

241.26

u/ml

0.98

129

394

Diabetes, insulin treatment (Kela reimbursement)

1496

6360

1.41

31.53

1.4

1.3

290.99

255.87

u/ml

4.34

960

4075

Other general symptoms and signs

124

390

3.26

31.32

1.3

225.47

252.39

u/ml

0.63

219

Asthma (diagnoses ohter than nonallergic)

1435

8313

1.40

31.16

1.3

269.83

250.32

u/ml

1.62

894

5259

Recurrent or chronic depression

713

3061

1.63

31.04

1.2

1.3

269.74

257.01

u/ml

0.53

453

1999

Other renal tubulo-interstitial diseases

147

4.97

30.80

1.8

1.2

215.58

246.26

u/ml

0.37

Ulcerative enterocolitis

228

4.07

30.55

1.2

1.3

341.64

248.63

u/ml

0.94

146

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

594

3543

1.68

30.52

1.9

1.3

222.08

246.63

u/ml

1.51

385

2210

Diabetic neuropathy

210

885

2.43

30.45

1.6

1.4

258.57

300.96

u/ml

1.37

143

564

Disorders of vitreous body and globe

661

3861

1.63

30.44

1.4

1.2

270.79

279.78

u/ml

0.30

435

2408

Marginal zone B-cell lymphoma, including Hilmo

6.72

30.43

1.1

1.2

241.97

250.34

u/ml

0.06

Other and unspecified diseases of blood and blood-forming organs

173

4.60

30.40

1.4

1.3

209.91

275.06

u/ml

0.98

Missing teeth due to accident, extraction or parodontitis

836

4866

1.55

30.30

1.3

311.24

266.53

u/ml

3.71

529

3069

Functional dyspepsia

420

2302

1.85

30.24

1.3

285.15

257.31

u/ml

1.14

279

1456

Peripheral arterial reconstruction

204

853

2.43

30.19

1.6

1.2

299.63

290.51

u/ml

0.16

142

506

Disorders of vitreous body

645

3777

1.64

30.16

1.4

1.2

271.74

279.75

u/ml

0.25

427

2355

Sulfasalazine

394

2119

1.88

30.08

1.2

1.3

292.63

249.56

u/ml

2.23

238

1356

Cholecystectomy

951

5417

1.50

29.83

1.3

273.76

274.03

u/ml

0.01

580

3502

Amputation of foot

147

4.89

29.82

1.7

1.2

251.25

282.81

u/ml

0.36

Spondyloarthritis

291

1420

2.08

29.59

1.3

287.81

259.03

u/ml

0.88

183

901

Low back pain

1286

6136

1.42

29.58

1.3

269.48

252.07

u/ml

1.20

839

3947

Disorders of lacrimal system

647

3953

1.63

29.39

1.3

253.51

270.40

u/ml

0.76

404

2488

Other or unspecified ileus, impaction or obstruction

244

1114

2.22

29.37

1.3

263.47

281.79

u/ml

0.37

152

680

Vocal cord dysfunction

203

747

2.43

29.29

1.3

286.65

232.06

u/ml

1.50

115

471

Injuries to the ankle and foot

1299

7925

1.41

29.25

1.4

1.3

233.57

253.61

u/ml

2.08

832

5049

Other diseases of pancreas

145

523

2.85

29.23

1.5

1.2

241.59

278.32

u/ml

0.93

311

Abnormal findings on examination of urine, without diagnosis

116

372

3.26

29.09

1.8

1.2

231.65

253.38

u/ml

0.37

214

Unspecified haematuria

573

2798

1.68

29.01

1.5

1.3

251.55

268.40

u/ml

0.82

375

1739

Persons with potential health hazards related to communicable diseases

803

5222

1.54

28.96

1.5

1.3

249.12

239.61

u/ml

0.46

521

3281

Postprocedural endocrine and metabolic disorders, not elsewhere classified

223

990

2.30

28.95

1.4

1.2

286.30

268.77

u/ml

0.38

145

618

Use of hypnotics and sedatives

1599

6693

1.37

28.87

1.3

273.10

260.74

u/ml

0.97

1057

4283

Dysphagia

325

1664

1.98

28.80

1.3

1.2

270.10

267.93

u/ml

0.05

196

1046

Mature T/NK-cell lymphomas, hilmo

6.42

28.80

1.4

1.2

351.80

266.50

u/ml

0.63

Hypercalcemia

265

3.69

28.79

1.7

1.3

284.38

267.99

u/ml

0.16

141

Irritable bowel syndrome

452

2581

1.77

28.41

1.2

1.3

246.78

264.04

u/ml

0.74

276

1636

Conjunctivitis (acute, non atopic), including avohilmo

1629

7258

1.36

28.38

1.3

248.63

256.44

u/ml

0.50

1043

4580

Other and unspecified drugs and medicaments

175

708

2.54

28.15

1.3

316.36

254.25

u/ml

1.10

102

433

Other specific joint derangements/joint disorders

1293

5744

1.41

28.02

1.3

264.04

246.47

u/ml

1.24

790

3696

Need for other prophylactic measures

142

521

2.83

27.97

1.6

1.3

245.46

238.57

u/ml

0.09

303

Diseases of pulp and periapical tissues and dental caries

900

3045

1.53

27.87

1.3

1.2

261.94

249.92

u/ml

0.61

556

1909

Diabetes medication

1610

6941

1.36

27.82

1.4

1.3

288.20

250.29

u/ml

4.96

1020

4486

Acute lymphocytic leukaemia, including Hilmo

113

6.04

27.73

1.5

2.0

110.12

174.30

u/ml

1.93

Acute lymphocytic leukaemia

113

6.04

27.73

1.5

2.0

110.12

174.30

u/ml

1.93

Acute lymphocytic leukaemia, helper endpoint

113

6.04

27.73

1.5

2.0

110.12

174.30

u/ml

1.93

Other and unspecified acquired haemolytic anaemias

7.91

27.71

1.4

1.2

267.50

220.31

u/ml

0.41

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

129

443

2.92

27.66

1.3

1.2

283.76

288.33

u/ml

0.06

264

Other nutritional deficiencies

1114

7163

1.43

27.55

1.3

268.60

257.53

u/ml

0.67

670

4628

Acute nephritic syndrome

166

4.52

27.54

1.9

1.3

279.13

262.05

u/ml

0.15

Obesity related asthma

539

3259

1.67

27.47

1.2

1.3

252.45

267.06

u/ml

0.65

331

2079

Diseases of middle ear and mastoid

1070

6098

1.45

27.42

1.4

1.3

244.68

244.61

u/ml

0.00

690

3881

Disorders of tooth development and eruption

302

1234

2.02

27.40

1.6

1.2

245.79

246.91

u/ml

0.02

194

763

Disease of hard tissues of teeth, NOS

681

2219

1.62

27.26

1.3

1.2

291.18

255.68

u/ml

2.27

420

1395

Myeloproliferative diseases

136

494

2.82

27.09

1.2

302.31

270.70

u/ml

0.51

289

Gastric ulcer

221

1003

2.23

27.07

1.5

1.2

320.01

275.19

u/ml

1.40

153

618

Thrombotic microangiopathy

9.96

26.97

1.5

1.2

228.12

217.75

u/ml

0.04

Invasive ventilation

146

554

2.72

26.82

1.8

1.4

313.07

258.15

u/ml

1.22

107

318

Enteropathic arthropathies

169

4.39

26.81

1.3

319.98

224.83

u/ml

1.72

103

External causes of morbidity and mortality

1091

3786

1.45

26.59

1.3

254.07

250.58

u/ml

0.14

664

2370

Isolated proteinuria with specified morphological lesion

6.31

26.46

1.9

1.2

219.90

255.11

u/ml

0.30

Other CVD

241

1143

2.14

26.41

1.4

1.2

280.31

288.77

u/ml

0.16

151

688

Hypoplasia of dental enamel, prenatal

13.60

26.39

5.8

2.4

132.45

89.25

u/ml

0.56

Viral warts, including avohilmo

446

2606

1.74

26.05

1.8

1.3

254.88

252.94

u/ml

0.05

283

1601

Unspecified acute lower respiratory infection

282

1432

2.01

25.85

1.6

1.3

243.99

257.83

u/ml

0.39

187

893

Cardiac arrest

238

3.46

25.79

1.7

1.3

321.58

253.14

u/ml

1.05

137

Continuous positive airway pressure

254

1021

2.10

25.75

1.5

1.3

269.91

250.15

u/ml

0.51

162

627

Tubulo-interstitial nephritis, not specified as acute or chronic

114

389

3.00

25.47

1.7

1.2

251.31

261.59

u/ml

0.13

220

Sleep disorders (combined)

1739

6855

1.33

25.45

1.2

1.3

261.20

253.37

u/ml

0.51

1081

4383

Disorders of oesophagus in diseases classified elsewhere

118

5.01

25.36

1.3

1.2

304.71

244.94

u/ml

0.74

Nonorganic sleeping disorders, excluding more controls

387

2188

1.80

25.32

1.2

1.3

263.24

241.12

u/ml

0.89

247

1401

Melanocytic naevi

535

3300

1.64

25.31

1.6

1.3

254.23

261.52

u/ml

0.25

365

2085

Special screening examination for infectious and parasitic diseases

458

1952

1.73

25.20

1.2

244.98

240.87

u/ml

0.10

287

1295

Covid-19 suspected case

411

2370

1.76

25.16

1.4

1.3

249.09

256.42

u/ml

0.22

270

1498

Dental caries, including avohilmo

993

3497

1.46

25.14

1.3

1.2

260.30

250.93

u/ml

0.49

626

2180

Other/unspecified dorsalgia

578

3594

1.60

24.95

1.3

282.14

264.51

u/ml

0.59

369

2328

Erythema nodosum

188

4.01

24.74

1.3

266.37

242.06

u/ml

0.28

110

Myocardial infarction, strict

493

2086

1.69

24.68

1.3

1.2

292.22

273.06

u/ml

0.59

321

1252

Complications of cardiac and vascular prosthetic devices, implants and grafts

117

4.97

24.64

1.6

1.2

271.32

278.40

u/ml

0.05

Asthma, including avohilmo

1898

8033

1.31

24.62

1.3

265.04

250.46

u/ml

1.32

1192

5098

Childhood asthma (age<16), excluding more controls

327

1371

1.90

24.41

1.3

1.2

235.98

220.66

u/ml

0.40

200

849

Other headache syndromes

657

4274

1.55

24.26

1.3

262.74

261.66

u/ml

0.03

414

2778

Asthma, hospital admissions , main diagnosis only

1309

8403

1.36

24.25

1.3

266.85

250.62

u/ml

1.14

814

5330

Hernia

1368

6713

1.36

24.20

1.4

1.3

267.43

259.72

u/ml

0.45

877

4281

Hernia of abdominal wall

641

4171

1.55

24.04

1.5

1.3

277.31

267.26

u/ml

0.39

412

2665

Secondary right heart disease

224

3.65

24.00

1.4

1.2

361.77

280.52

u/ml

0.94

112

Fibrosis of liver

7.65

23.96

1.6

1.2

320.06

225.11

u/ml

0.64

Dorsalgia

1619

6469

1.33

23.95

1.3

256.04

248.90

u/ml

0.42

1045

4133

L01XE Protein kinase inhibitors

101

335

3.12

23.89

1.2

308.51

260.76

u/ml

0.79

189

Microscopic polyangiitis

9.52

23.72

1.7

1.4

222.95

335.18

u/ml

0.49

COPD (mode)

299

1222

1.92

23.68

1.2

1.3

310.59

272.98

u/ml

1.08

186

757

Chronic lower respiratory diseases

1945

7934

1.30

23.63

1.3

270.62

248.73

u/ml

2.46

1216

5037

Colectomy operation

232

1136

2.07

23.52

1.2

286.96

278.03

u/ml

0.15

128

700

Other disorders of skin and subcutaneous tissue, not elsewhere classified

220

1057

2.12

23.49

1.4

1.2

284.61

266.57

u/ml

0.38

124

641

Mycoses, including avohilmo

1474

8447

1.34

23.49

1.3

253.72

254.33

u/ml

0.03

931

5367

Rheumatoid arthritis

418

2171

1.72

23.44

1.2

305.54

274.46

u/ml

1.31

230

1393

Childhood asthma (age<16)

328

1396

1.87

23.40

1.3

1.2

235.65

220.92

u/ml

0.38

201

868

Exposure to other specified factors

1337

8554

1.35

23.24

1.3

243.21

254.27

u/ml

0.74

855

5407

DVT of lower extremities

250

1263

2.01

23.20

1.4

1.2

277.95

277.44

u/ml

0.01

165

785

Hypotension

201

936

2.17

23.17

1.4

1.2

280.52

288.03

u/ml

0.12

126

563

Subjective visual disturbances

404

2373

1.73

23.12

1.3

267.48

264.14

u/ml

0.07

262

1492

Accidents

1297

4757

1.37

23.08

1.3

259.22

255.26

u/ml

0.18

810

3009

Heart failure and hypertrophic cardiomyopathy

112

4.94

23.03

1.6

1.2

336.42

278.71

u/ml

0.51

Acquired absence of organs, not elsewhere classified

6.33

22.99

1.9

1.1

296.42

287.40

u/ml

0.04

Injury, poisoning and certain other consequences of external causes

884

3035

1.47

22.92

1.3

259.72

247.41

u/ml

0.58

547

1868

Benign neoplasms

1633

6762

1.32

22.84

1.4

1.3

265.65

247.49

u/ml

1.77

1067

4273

Actinic keratosis

372

1937

1.76

22.82

1.3

1.2

297.47

291.93

u/ml

0.12

219

1143

Arterial embolism and thrombosis

276

3.26

22.72

1.5

1.2

314.20

261.98

u/ml

0.80

151

Other problems related to primary support group, including family circumstances

291

1521

1.91

22.71

2.6

1.3

208.38

232.34

u/ml

0.75

174

897

Other pulmonary heart/vessel disease

263

3.34

22.56

1.3

353.89

260.83

u/ml

1.24

133

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

7.66

22.46

1.4

1.1

237.05

343.48

u/ml

0.59

Localized swelling, mass and lump of skin and subcutaneous tissue

478

2955

1.64

22.43

1.3

251.80

263.33

u/ml

0.39

306

1839

Other complications of surgical and medical care, not elsewhere classified

172

766

2.29

22.33

1.4

1.2

261.15

273.41

u/ml

0.24

469

415

2218

1.70

22.23

1.3

1.2

298.64

287.58

u/ml

0.31

248

1335

Skin changes due to chronic exposure to nonionizing radiation

382

2012

1.73

22.12

1.3

1.2

302.75

291.20

u/ml

0.29

224

1190

Drug-induced adrenocortical insufficiency

129

4.54

21.96

1.7

1.4

287.95

252.74

u/ml

0.26

Other arrhythmias

894

4685

1.43

21.93

1.3

269.87

258.68

u/ml

0.51

574

2976

Squamous cell neoplasms and carcinomas of the skin

103

361

2.89

21.85

1.2

289.61

290.04

u/ml

0.00

212

Other disorders of adrenal gland

108

392

2.86

21.82

1.6

1.4

252.98

242.05

u/ml

0.13

215

Other specified/unspecified systemic involvement of connective tissue

105

375

2.88

21.75

1.3

293.73

273.82

u/ml

0.15

229

Encephalopathy

6.50

21.65

1.2

1.1

341.96

304.03

u/ml

0.19

Use of pramipexole

282

1521

1.88

21.57

1.4

1.2

284.12

280.73

u/ml

0.07

188

939

Eosinophilia

123

4.62

21.51

1.3

1.5

231.39

248.50

u/ml

0.16

Other external causes of accidental injury

1284

4757

1.36

21.49

1.3

259.54

255.26

u/ml

0.20

796

3009

Polyarteritis nodosa and related conditions

107

4.94

21.46

1.4

294.80

271.30

u/ml

0.15

Malignant neoplasm of skin, including Hilmo

566

2425

1.57

21.41

1.4

1.3

298.11

278.39

u/ml

0.82

357

1562

Diseases of pulp and periapical tissues, including avohilmo

1641

6516

1.31

21.32

1.3

247.76

250.92

u/ml

0.19

1035

4101

Hypoplasia of dental enamel, prenatal , including avohilmo

105

5.75

21.13

4.5

2.2

219.19

114.69

u/ml

1.00

Rheumatoid arthritis, including avohilmo

483

3041

1.60

21.01

1.2

1.3

295.73

273.85

u/ml

0.89

270

1907

Adverse effects, not elsewhere classified

372

2199

1.72

20.95

1.5

1.3

282.80

249.96

u/ml

0.96

230

1375

Myalgia

390

2332

1.69

20.94

1.3

253.44

258.88

u/ml

0.14

241

1483

Liver disorders in diseases classified elsewhere

20.99

20.83

1.1

1.3

499.83

164.08

u/ml

1.60

Adrenocortical insufficiency

267

3.23

20.79

1.7

1.4

275.72

240.88

u/ml

0.40

151

Disturbances of skin sensation

457

2851

1.62

20.76

1.2

1.3

245.70

264.15

u/ml

0.76

293

1830

Other juvenile arthritis

128

523

2.56

20.56

1.4

1.5

236.78

197.38

u/ml

0.71

299

Nonsuppurative otitis media, including avohilmo

664

3883

1.50

20.51

1.5

1.3

240.50

234.35

u/ml

0.23

418

2423

Constipation

1263

6411

1.34

20.49

1.3

284.92

258.35

u/ml

2.19

787

4040

Carcinoma in situ of skin

113

432

2.67

20.46

1.4

1.2

252.16

290.87

u/ml

0.86

247

Behavioural syndromes associated with physiological disturbances and physical factors

1500

7795

1.31

20.43

1.3

244.05

257.56

u/ml

1.19

960

4959

Congenital malformation of biliary tract

8.58

20.36

3.3

2.3

245.87

110.74

u/ml

1.80

Caries of dentine, including avohilmo

1100

4098

1.38

20.28

1.3

259.43

247.02

u/ml

0.76

700

2555

Other and unspecified local infections of skin and subcutaneous tissue

181

857

2.16

20.26

1.6

1.3

274.94

252.77

u/ml

0.47

126

523

Migraine with aura

465

2932

1.61

20.20

1.3

229.64

245.83

u/ml

0.55

304

1890

Other symptoms and signs involving the digestive system and abdomen

232

1200

1.96

20.19

1.4

1.3

251.40

266.96

u/ml

0.29

129

709

Sleep apnoea

1325

6307

1.33

20.14

1.3

285.64

262.92

u/ml

1.88

801

4121

Other and unspecified effects of external causes

513

3315

1.57

20.09

1.4

1.3

276.65

250.45

u/ml

0.98

319

2081

Special screening examination for other diseases and disorders

192

932

2.09

19.97

1.5

1.3

238.57

239.81

u/ml

0.02

100

589

Atopic dermatitis

1043

6097

1.37

19.96

1.3

227.83

249.75

u/ml

2.02

632

3908

ILD medications: nintedanib

19.47

19.93

1.1

1.0

350.75

256.09

u/ml

0.56

Other joint disorders

1480

5902

1.31

19.92

1.3

253.13

245.09

u/ml

0.52

924

3778

Dorsopathies

1682

6620

1.29

19.91

1.3

255.52

247.30

u/ml

0.55

1072

4196

Osteoporosis with pathological fracture (FG)

288

3.04

19.91

1.3

1.2

254.59

255.15

u/ml

0.01

161

Benign neoplasm of other and ill-defined parts of digestive system

232

1207

1.95

19.89

1.2

289.68

279.20

u/ml

0.22

149

747

Pruritus

195

956

2.08

19.86

1.4

1.2

245.04

274.34

u/ml

0.79

115

605

Cerebrovascular diseases

871

4288

1.42

19.84

1.4

1.3

281.07

274.81

u/ml

0.26

557

2704

Chronic myeloproliferative disease

5.71

19.79

1.4

1.2

261.89

294.11

u/ml

0.15

Marginal zone B-cell lymphoma

7.59

19.79

1.1

283.40

307.36

u/ml

0.11

Lower back pain or/and sciatica

1631

7892

1.29

19.75

1.3

266.09

254.67

u/ml

0.80

1060

5038

Angina pectoris

576

2501

1.54

19.70

1.4

1.2

318.79

275.37

u/ml

1.99

368

1512

Malignant neoplasm of digestive organs, including Hilmo

438

1988

1.63

19.62

1.3

307.01

280.63

u/ml

0.91

277

1260

Hypocalcemia

182

3.71

19.60

1.7

1.3

286.36

262.46

u/ml

0.25

103

Other coagulation defects

142

618

2.36

19.58

1.4

1.3

261.88

256.98

u/ml

0.05

371

Urticaria

523

3413

1.55

19.57

1.4

1.3

254.47

255.14

u/ml

0.02

328

2145

Disorders of conjunctiva

1357

8038

1.32

19.56

1.3

253.44

252.48

u/ml

0.04

866

5085

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

478

2028

1.60

19.54

1.4

1.3

312.25

284.46

u/ml

1.11

295

1281

Other abnormal findings of blood chemistry

347

2.86

19.53

1.3

1.2

301.00

251.95

u/ml

0.38

212

Other local infections of skin and subcutaneous tissue

187

911

2.10

19.43

1.6

1.3

279.71

253.95

u/ml

0.58

128

551

Shock, not elsewhere classified

7.99

19.33

1.8

1.3

231.00

315.00

u/ml

0.43

Other diseases of stomach and duodenum

101

376

2.75

19.33

1.5

1.2

322.70

263.08

u/ml

1.01

224

Obesity and other hyperalimentation

1004

6948

1.37

19.31

1.3

271.80

257.58

u/ml

0.86

600

4517

Giant cell arteritis

202

3.47

19.29

1.2

281.11

288.22

u/ml

0.05

106

Dermatitis due to substances taken internally

117

471

2.56

19.23

1.6

1.3

315.46

254.91

u/ml

0.97

292

Fissure and fistula of anal and rectal regions

346

2051

1.71

19.22

1.3

255.52

264.72

u/ml

0.19

205

1317

Suppurative and unspecified otitis media

733

4535

1.45

19.21

1.5

1.3

234.50

237.18

u/ml

0.10

460

2869

Obesity

1000

6933

1.37

19.20

1.3

271.23

257.47

u/ml

0.82

598

4508

Other dorsopathies, not elsewhere classified

1613

6515

1.29

19.13

1.3

245.61

248.27

u/ml

0.14

1046

4152

Umbilical hernia

408

2529

1.63

19.07

1.5

1.3

266.14

271.36

u/ml

0.15

260

1622

Chronic rhinitis, nasopharyngitis and pharyngitis

517

3383

1.54

19.07

1.3

269.75

263.26

u/ml

0.20

318

2165

Elevated blood glucose level

151

682

2.27

19.06

1.7

1.3

253.77

263.31

u/ml

0.14

411

Personal history of other diseases and conditions

249

1347

1.88

18.83

1.6

1.2

269.16

238.55

u/ml

0.82

162

757

Other obstetric conditions, not elsewhere classified

630

2680

1.50

18.81

1.2

232.00

245.71

u/ml

0.75

436

1747

Other arterial embolism and thrombosis

141

3.97

18.57

1.5

1.2

323.38

243.94

u/ml

1.10

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

620

2632

1.50

18.54

1.2

230.72

244.18

u/ml

0.73

428

1721

Migraine without aura

408

2552

1.62

18.46

1.3

259.83

242.86

u/ml

0.46

270

1623

Other and unspecified coagulation defects

110

439

2.59

18.45

1.4

1.3

272.26

255.64

u/ml

0.14

262

Iridocyclitis

341

2038

1.69

18.44

1.3

269.61

268.80

u/ml

0.02

210

1274

Personality disorders, excluding more controls

449

2865

1.58

18.42

1.2

1.3

277.28

243.39

u/ml

1.65

275

1862

Juvenile arthritis (FINNGEN)

133

581

2.38

18.41

1.4

1.5

244.46

210.60

u/ml

0.55

333

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

576

3382

1.51

18.41

1.5

1.4

233.26

219.02

u/ml

0.64

341

2086

Acute generalized exanthematous pustulosis

370

2.74

18.41

1.7

1.3

323.31

229.78

u/ml

1.53

209

Fall on same level

1845

7821

1.26

18.36

1.3

257.23

251.58

u/ml

0.34

1187

4930

Other maternal disorders predominantly related to pregnancy

825

3676

1.41

18.29

1.2

245.76

265.22

u/ml

1.35

553

2310

Other and unspecified immunodeficiencies with predominantly antibody defects

110

4.53

18.09

2.0

1.4

212.17

228.94

u/ml

0.09

Other diseases of lip and oral mucosa

612

4192

1.47

18.09

1.3

253.60

266.93

u/ml

0.60

372

2638

Type 2 diabetes, definitions combined

1250

5524

1.32

18.04

1.3

1.2

293.30

257.50

u/ml

3.71

757

3615

Other diseases of upper respiratory tract

1637

6696

1.28

18.03

1.3

256.37

251.18

u/ml

0.30

1002

4284

Other specified disorders of kidney and ureter

212

3.33

17.97

1.7

1.2

232.01

262.48

u/ml

0.42

123

Sleep apnoea, including avohilmo

1418

6640

1.30

17.88

1.3

280.65

260.30

u/ml

1.74

873

4329

Special screening examination for neoplasms

340

2.76

17.85

1.3

1.2

237.55

253.56

u/ml

0.28

227

Chronic sinusitis

624

4295

1.46

17.83

1.2

1.3

276.48

263.25

u/ml

0.43

372

2825

Other neurological diseases

902

5108

1.38

17.76

1.3

286.30

266.43

u/ml

1.03

584

3223

Other congenital malformations of the digestive system

136

607

2.32

17.67

2.3

1.7

231.22

203.71

u/ml

0.61

310

Hyperkinetic disorders, excluding more controls

337

1896

1.69

17.62

1.5

1.3

234.09

213.10

u/ml

0.72

194

1174

AV-block

195

843

2.00

17.60

1.4

1.3

298.69

262.10

u/ml

0.98

124

520

Nerve, nerve root and plexus disorders

1499

7039

1.28

17.51

1.3

269.86

261.29

u/ml

0.51

950

4562

Benzodiazepine use

1485

7848

1.28

17.49

1.2

1.3

264.45

256.96

u/ml

0.47

918

5085

Disorders of the thyroid gland

1376

6920

1.30

17.42

1.3

268.26

256.25

u/ml

0.76

854

4456

Abnormality of white blood cells, not elsewhere classified

5.70

17.41

1.4

1.3

304.84

222.47

u/ml

0.62

Generalized skin eruption due to drugs and medicaments

336

2.78

17.33

1.7

1.4

332.17

232.90

u/ml

1.47

191

Allergic asthma (mode), excluding more controls

355

2123

1.65

17.32

1.2

245.78

239.34

u/ml

0.16

209

1350

Type 2 diabetes, strict (exclude DM1)

1256

5588

1.31

17.31

1.3

1.2

292.95

258.73

u/ml

3.42

759

3658

Carcinoma in situ of skin of other and unspecified parts of face

351

2.69

17.31

1.3

1.1

269.10

312.49

u/ml

0.75

192

Cardiodefibrillation

378

2349

1.62

17.25

1.3

1.2

302.96

276.85

u/ml

0.92

254

1430

Wegener granulomatosis

105

4.45

17.24

1.4

302.72

281.47

u/ml

0.13

Disorder of lipoprotein metabolism, unspecified

150

703

2.16

17.19

1.3

1.2

258.34

284.26

u/ml

0.66

100

418

Nonhereditary hypogammaglobulinemia

5.18

17.19

1.4

1.3

225.91

245.01

u/ml

0.14

Diseases of the ear and mastoid process

1804

7220

1.26

17.15

1.3

258.31

253.82

u/ml

0.25

1122

4638

Portal vein thrombosis

114

4.27

17.15

1.4

315.17

263.85

u/ml

0.44

Symptoms and signs involving the nervous and musculoskeletal systems

813

5911

1.38

17.10

1.3

262.05

263.92

u/ml

0.07

508

3714

Conjunctivitis

1236

7663

1.31

17.08

1.3

250.34

251.17

u/ml

0.04

786

4843

Type 2 diabetes, definitions combined, including avohilmo

1267

5618

1.31

17.07

1.3

1.2

291.50

258.86

u/ml

3.23

773

3686

UC patients in KELA-register (code 208), prior to 1994

272

2.96

17.01

1.3

1.2

340.93

282.00

u/ml

0.73

160

Fluid overload

17.00

17.01

2.2

1.3

258.75

234.22

u/ml

—

Other disorders of glucose regulation and pancreatic internal secretion

158

762

2.12

16.96

1.6

1.4

247.41

250.96

u/ml

0.06

110

445

Myocardial infarction, without ST-elevation

402

2294

1.59

16.96

1.3

1.2

296.75

282.31

u/ml

0.33

246

1400

Recurrent aphthous stomatitis , including avohilmo

255

1445

1.79

16.83

1.5

1.3

235.36

257.50

u/ml

0.42

153

863

Melanocytic naevi of trunk

217

1172

1.89

16.78

1.8

1.3

279.72

262.47

u/ml

0.33

145

737

Acute lymphadenitis

132

597

2.28

16.77

1.5

1.3

236.49

231.94

u/ml

0.06

354

Renal agenesis and other reduction defects of kidney, including avohilmo

6.23

16.76

1.6

1.5

216.41

167.86

u/ml

0.52

Acute suppurative otitis media

581

3728

1.47

16.74

1.6

1.3

227.46

229.61

u/ml

0.07

363

2354

Disorders of eyelid, lacrimal system and orbit

1210

6813

1.31

16.73

1.3

261.62

263.88

u/ml

0.10

782

4326

Myeloproliferative diseases (CML excluded)

108

447

2.47

16.69

1.2

285.09

272.21

u/ml

0.15

260

Malignant neoplasm of digestive organs

382

1821

1.61

16.67

1.3

312.73

280.53

u/ml

1.10

248

1154

Fibromyalgia

160

783

2.08

16.49

1.2

318.10

259.40

u/ml

0.90

502

Selective serotonin reuptake inhibitors

1499

6123

1.28

16.48

1.2

1.3

253.65

252.74

u/ml

0.04

926

3922

Abscess of anal and rectal regions

156

757

2.10

16.47

1.3

269.90

247.56

u/ml

0.42

479

Benign neoplasm: Colon, unspecified

285

1674

1.72

16.45

1.3

1.2

335.21

284.47

u/ml

1.30

176

1031

Other congenital malformations of the digestive system, including avohilmo

145

683

2.19

16.44

2.3

1.7

230.85

205.26

u/ml

0.58

361

Nonsuppurative otitis media

520

3049

1.50

16.33

1.6

1.3

230.30

223.71

u/ml

0.22

327

1839

Transport accidents

751

4507

1.40

16.27

1.3

242.04

255.09

u/ml

0.59

492

2861

Conjunctivitis (acute, non atopic)

488

3256

1.51

16.22

1.5

1.4

257.14

251.61

u/ml

0.16

312

2012

Retinal detachments and breaks

400

2565

1.57

16.22

1.4

1.2

256.78

279.34

u/ml

1.00

270

1590

Alcohol use disorder, Swedish definition

788

5220

1.38

16.18

1.3

285.97

258.50

u/ml

1.97

503

3359

Hypertrophic cardiomyopathy

308

2.79

16.17

1.6

1.3

324.94

263.93

u/ml

0.93

174

Dermatophytosis

207

1115

1.89

16.12

1.4

1.3

268.58

268.05

u/ml

0.01

124

679

Other congenital malformations of urinary system

5.30

16.12

3.6

1.4

176.59

262.52

u/ml

0.91

Intestinal malabsorption

360

2.63

16.11

1.4

1.3

259.05

242.36

u/ml

0.23

213

Misadventures to patients during surgical and medical care

200

1065

1.90

16.11

1.4

1.2

286.42

278.74

u/ml

0.10

128

655

Methotrexate

171

864

2.00

16.06

1.2

271.35

249.24

u/ml

0.46

102

520

Falls/tendency to fall

1707

6840

1.26

16.05

1.3

258.07

251.63

u/ml

0.40

1063

4320

In situ neoplasms

478

3194

1.51

16.03

1.3

1.2

286.14

277.33

u/ml

0.28

316

1995

Seropositive rheumatoid arthritis

280

1639

1.71

16.01

1.2

312.05

277.09

u/ml

1.17

148

1032

899

5822

1.35

16.00

1.3

284.49

255.93

u/ml

2.34

578

3734

857

5661

1.36

15.99

1.3

287.82

255.82

u/ml

2.71

556

3624

Neuromuscular dysfunction of bladder

136

633

2.19

15.98

1.4

1.2

244.06

266.18

u/ml

0.47

377

Atopic dermatitis, strict definition with reimbursement

594

3983

1.45

15.95

1.4

1.3

223.19

241.27

u/ml

1.05

352

2521

Symptoms and signs involving cognition, perception, emotional state and behaviour

1406

7393

1.28

15.95

1.3

266.11

259.23

u/ml

0.37

885

4724

Sleep disorders

1396

7567

1.28

15.91

1.2

1.3

246.90

257.90

u/ml

0.83

880

4855

Malignant neoplasm of skin

498

2246

1.51

15.85

1.3

301.04

280.86

u/ml

0.76

314

1434

Stomatitis and related lesions

339

2107

1.63

15.84

1.5

1.3

235.24

257.19

u/ml

0.54

205

1308

Allergic asthma (mode)

355

2173

1.61

15.82

1.2

245.78

241.12

u/ml

0.11

209

1389

Calcific aortic valvular stenosis, including rheumatic fever

272

1534

1.72

15.64

1.3

1.2

275.17

277.50

u/ml

0.05

164

928

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

754

5301

1.38

15.59

1.3

270.84

259.11

u/ml

0.45

464

3462

Background retinopathy and retinal vascular changes

136

3.76

15.56

1.6

1.2

328.93

268.74

u/ml

0.57

Phobic anxiety disorders

299

1808

1.68

15.52

1.5

1.3

236.34

235.83

u/ml

0.01

187

1127

Vasculitis limited to skin, not elsewhere classified

175

3.39

15.51

1.2

1.3

278.79

246.80

u/ml

0.29

Calcific aortic valvular stenosis, diagnosis (helper)

271

1533

1.71

15.48

1.3

1.2

275.82

277.39

u/ml

0.03

163

928

Operations 2 for CAVS

271

1533

1.71

15.48

1.3

1.2

275.82

277.39

u/ml

0.03

163

928

Other abnormalities of plasma proteins

4.54

15.43

1.7

1.3

215.21

251.37

u/ml

0.29

Calcific aortic valvular stenosis, operated

273

1549

1.71

15.43

1.3

1.2

274.50

275.47

u/ml

0.02

164

938

Calcific aortic valvular stenosis

273

1549

1.71

15.43

1.3

1.2

274.50

275.47

u/ml

0.02

164

938

Keratitis

531

3655

1.47

15.41

1.4

1.3

243.10

262.00

u/ml

0.83

351

2330

Irregular menses

767

4205

1.38

15.27

1.3

1.2

245.76

254.59

u/ml

0.43

472

2741

Renal agenesis and other reduction defects of kidney

6.10

15.24

1.6

1.5

211.00

166.94

u/ml

0.43

Inflammatory diseases of female pelvic organs

895

4573

1.35

15.13

1.2

255.21

258.57

u/ml

0.12

577

2914

Arthropathy in ulcerative colitis

4.30

15.00

1.3

1.4

316.90

245.55

u/ml

0.65

Infections with a predominantly sexual mode of transmission, including avohilmo

758

5094

1.37

14.98

1.3

253.10

240.04

u/ml

0.70

504

3261

Polymyalgia rheumatica

134

636

2.13

14.93

1.2

270.74

292.25

u/ml

0.32

372

Cholecystitis

159

804

2.00

14.92

1.3

1.2

292.62

281.66

u/ml

0.15

491

Drug-induced osteoporosis with pathological fracture

4.32

14.86

1.3

274.43

291.05

u/ml

0.11

Other specified/unspecified bacterial intestinal infections

108

472

2.34

14.86

1.3

259.36

253.74

u/ml

0.07

273

Lupus nephritis

15.65

14.83

1.4

2.3

278.00

164.70

u/ml

—

Erectile dysfunction

109

479

2.32

14.78

1.5

1.3

254.30

280.25

u/ml

0.46

284

Chronic myeloid leukaemia, including Hilmo

5.77

14.73

1.1

1.2

358.25

225.86

u/ml

1.18

Obesity due to excess calories

743

5472

1.37

14.61

1.3

269.43

257.18

u/ml

0.56

429

3571

Sicca syndrome [Sjögren]

120

553

2.21

14.51

1.2

286.22

283.27

u/ml

0.04

335

Other malignant neoplasms of skin (=non-melanoma skin cancer)

428

1913

1.53

14.47

1.3

315.12

284.33

u/ml

1.14

258

1205

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

110

489

2.28

14.46

1.4

1.3

284.28

273.43

u/ml

0.14

290

Ventral hernia

293

1798

1.65

14.39

1.4

1.3

291.87

279.92

u/ml

0.26

190

1127

Somatoform disorder

251

1482

1.72

14.36

1.2

1.3

261.52

270.31

u/ml

0.21

151

934

Cardiomyopathy, Hypertrophic obstructive

102

4.09

14.32

1.8

1.2

360.84

243.20

u/ml

1.36

Viral infections of the central nervous system, including avohilmo

141

696

2.07

14.32

1.2

1.3

277.80

254.47

u/ml

0.33

419

Acute posthaemorrhagic anaemia

179

3.21

14.22

1.4

1.2

304.17

286.77

u/ml

0.14

Post-traumatic stress disorder

196

1085

1.84

14.16

1.2

216.58

243.55

u/ml

0.81

121

681

Kela reimbursement Agammaglobulinemia (D80-84)

4.85

14.12

2.1

1.3

168.93

218.97

u/ml

0.50

Paracetamol or NSAID medication

328

1017

1.64

14.12

1.3

1.5

216.51

242.68

u/ml

0.82

178

604

Decubitus ulcer and pressure area

335

2.55

14.11

1.6

1.2

295.65

259.61

u/ml

0.47

185

Hypersplenism

12.63

14.10

1.6

1.2

272.50

175.36

u/ml

0.53

Diseases of salivary glands

470

3218

1.47

14.09

1.3

258.72

263.98

u/ml

0.14

295

2030

Dentofacial anomalies [including malocclusion]

1134

6935

1.29

14.06

1.4

1.3

249.87

253.36

u/ml

0.14

698

4477

Erosion of teeth , including avohilmo

483

3330

1.47

14.03

1.7

1.3

263.52

252.06

u/ml

0.36

326

2102

Artificial opening status

313

2.61

14.01

1.8

1.1

292.11

247.95

u/ml

0.47

173

Cytomegaloviral hepatitis

15.42

14.00

1.1

452.20

175.18

u/ml

—

Generalized anxiety disorder

332

2115

1.59

14.00

1.2

1.3

268.46

240.43

u/ml

0.98

213

1337

Seborrhoeic dermatitis

158

818

1.96

13.98

1.4

1.2

255.46

269.73

u/ml

0.22

523

Insomnia

1366

7585

1.26

13.95

1.2

1.3

246.79

257.28

u/ml

0.77

872

4888

Haemorrhoids and perianal venous thrombosis

395

2597

1.52

13.89

1.2

1.3

250.95

274.42

u/ml

0.90

228

1644

Vascular disorders of the intestines

302

2.62

13.88

1.3

1.2

291.06

286.36

u/ml

0.05

170

Injuries to the abdomen, lower back, lumbar spine and pelvis

574

4027

1.41

13.85

1.3

259.95

260.41

u/ml

0.01

365

2523

Asthma and allergy, excluding more controls

225

1285

1.75

13.85

1.2

231.76

241.15

u/ml

0.18

133

794

Osteonecrosis due to drugs

4.18

13.85

1.6

1.2

229.92

268.28

u/ml

0.29

Malignant immunoproliferative diseases

5.09

13.80

1.8

1.2

269.94

300.77

u/ml

0.13

Late syphilis

101

4.10

13.77

1.6

1.2

318.24

282.15

u/ml

0.22

Other diseases of oesophagus

121

571

2.15

13.76

1.4

1.2

283.92

263.53

u/ml

0.36

343

Substance abuse, excluding more controls

791

4943

1.34

13.69

1.2

1.3

280.10

250.82

u/ml

2.18

512

3147

Reactive arthropathies

137

680

2.05

13.67

1.3

263.87

253.79

u/ml

0.16

432

Neovascular glaucoma

254

2.79

13.66

1.5

1.2

264.17

269.75

u/ml

0.06

142

Nonorganic sleeping disorders

387

2571

1.52

13.57

1.2

1.3

263.24

252.66

u/ml

0.33

247

1627

Malignant neoplasm of urinary organs, including Hilmo

119

561

2.15

13.55

1.4

1.3

280.11

276.73

u/ml

0.04

335

Hypersensitivity angiitis

10.62

13.51

1.7

1.2

344.06

257.88

u/ml

0.29

Crohn's disease (strict) with PSC

23.46

13.49

1.5

518.71

150.00

u/ml

—

Unspecified privation

171

921

1.89

13.45

1.4

1.3

303.05

263.56

u/ml

0.77

119

570

Other obstructive and reflux uropathy

332

2.54

13.44

1.6

1.2

279.65

244.93

u/ml

0.46

191

Asthma and allergy

225

1297

1.73

13.40

1.2

231.76

241.07

u/ml

0.18

133

804

Weight loss

158

831

1.93

13.37

1.4

1.3

282.00

253.86

u/ml

0.33

479

Dermatopolymyositis (FG)

4.41

13.35

1.2

299.35

231.74

u/ml

0.51

Other sleep disorders

186

1031

1.83

13.33

1.2

1.3

243.00

253.02

u/ml

0.22

128

642

Rash and other nonspecific skin eruption

148

763

1.97

13.28

1.4

1.3

275.24

268.42

u/ml

0.07

443

Abnormal weight loss

144

736

1.99

13.26

1.3

297.75

253.81

u/ml

0.51

416

Unspecified contracted kidney

6.68

13.21

2.0

1.1

233.91

222.52

u/ml

0.04

Glaucoma secondary to other eye disorders

259

2.73

13.18

1.5

1.2

264.17

271.04

u/ml

0.07

138

Excessive attrition of teeth

954

7315

1.30

13.13

1.6

1.3

254.50

255.53

u/ml

0.04

611

4689

Chorioretinal inflammation

221

2.91

13.13

1.3

282.55

247.11

u/ml

0.44

137

Psoriatic and enteropathic arthropathies

173

942

1.86

13.13

1.3

312.73

264.85

u/ml

1.23

110

603

Basal cell carcinoma, including Hilmo

426

1939

1.50

13.12

1.4

1.3

308.83

285.12

u/ml

0.83

264

1222

Retention of urine

376

2005

1.53

13.11

1.4

1.2

284.86

272.19

u/ml

0.37

241

1263

Cyst of kidney

404

2.34

13.00

1.5

1.2

237.77

287.19

u/ml

1.00

227

Retinal haemorrhage

138

3.44

13.00

1.7

1.2

237.37

285.17

u/ml

0.48

Left ventricular outflow tract obstruction (LVOTO), broad definition

184

1028

1.82

12.93

1.7

1.4

250.40

249.19

u/ml

0.02

133

625

Spondylopathies (FG)

221

1300

1.72

12.90

1.2

1.3

276.64

248.33

u/ml

0.72

138

837

Speech and linguistic disorders, excluding more controls

214

1171

1.75

12.89

1.9

1.4

194.18

203.16

u/ml

0.22

127

678

Delirium, not induced by alcohol and other psychoactive substances

133

665

2.02

12.87

1.3

1.2

309.75

288.91

u/ml

0.33

401

Panic disorder

287

1808

1.61

12.83

1.3

229.76

245.40

u/ml

0.53

194

1153

Acquired absence of limb

5.04

12.81

1.6

1.2

251.05

286.06

u/ml

0.21

Inflammatory diseases of the central nervous system

142

732

1.98

12.80

1.3

278.60

262.38

u/ml

0.21

447

Other and unspecified vasculitis limited to skin

155

3.28

12.76

1.3

1.2

275.24

259.81

u/ml

0.11

Excessive, frequent and irregular menstruation

599

2289

1.41

12.75

1.4

1.2

256.89

252.73

u/ml

0.13

361

1444

Haemolytic-uraemic syndrome

12.46

12.69

2.4

1.6

183.61

163.17

u/ml

0.14

Malignant neoplasm of kidney, except renal pelvis

446

2.25

12.67

1.5

1.3

271.81

269.94

u/ml

0.02

265

Emphysema

396

2.33

12.66

1.2

365.38

276.83

u/ml

1.19

230

Osteopathy in diseases classified elsewhere

6.02

12.64

2.0

1.4

346.60

271.58

u/ml

0.22

Viral infections of the central nervous system

127

633

2.05

12.62

1.2

1.3

280.67

256.85

u/ml

0.31

381

Nonalcoholic steatohepatitis

4.85

12.60

1.2

336.44

243.97

u/ml

0.61

Adult-onset Still disease

10.66

12.52

1.3

1.4

270.67

173.85

u/ml

0.85

Discitis, unspecified

3.90

12.43

1.5

1.2

316.92

296.77

u/ml

0.14

Bacterial, viral and other infectious agents, including avohilmo

167

918

1.85

12.39

1.6

1.4

254.71

259.14

u/ml

0.08

123

585

Hypothyroidism, other/unspecified

1231

6470

1.26

12.34

1.3

275.32

258.13

u/ml

1.10

741

4172

Problems related to lifestyle

182

1027

1.80

12.34

1.2

296.98

254.40

u/ml

1.21

121

641

Early onset COPD

271

1698

1.61

12.33

1.2

1.3

311.45

282.06

u/ml

0.70

168

1055

Carrier of infectious disease

219

2.85

12.22

1.4

1.2

258.91

236.21

u/ml

0.26

130

Diseases of male genital organs

795

3013

1.34

12.22

1.4

251.11

245.49

u/ml

0.21

497

1902

Injuries to the wrist and hand

1536

8349

1.22

12.21

1.3

247.05

254.96

u/ml

0.53

946

5302

Thyroiditis, ILD-related definition

169

936

1.83

12.18

1.4

1.3

306.75

259.09

u/ml

0.80

119

575

Other epidermal thickening

342

2.43

12.17

1.6

1.4

273.00

245.26

u/ml

0.39

196

Malignant neoplasm of urinary organs

103

480

2.17

12.14

1.5

1.3

272.14

272.44

u/ml

0.00

288

Hypothyreosis and Thyroxine purchase for inclusion criteria

1270

6687

1.25

12.13

1.3

273.42

258.46

u/ml

0.93

762

4321

Recurrent and persistent haematuria

4.84

12.13

1.6

1.2

277.59

226.00

u/ml

0.30

Hypertension, portal

13.09

12.10

1.4

442.69

245.60

u/ml

—

Dermatopolymyositis

3.99

12.09

1.2

1.4

290.45

255.72

u/ml

0.21

Benign neoplasm: Transverse colon

135

697

1.97

12.09

1.4

1.2

304.42

291.33

u/ml

0.17

421

Systemic sclerosis (FG)

115

3.59

12.07

1.3

1.4

307.50

226.22

u/ml

1.05

Rosacea

196

1137

1.75

12.07

1.4

1.2

282.09

267.75

u/ml

0.23

122

701

Erythema multiforme

166

3.13

12.05

1.3

297.32

268.88

u/ml

0.21

Stroke, including SAH

673

3585

1.35

12.01

1.3

276.76

276.58

u/ml

0.01

428

2243

Encephalitis

267

2.64

12.00

1.2

1.4

316.68

232.51

u/ml

0.74

158

Temporal arteritis

171

3.06

12.00

1.2

300.43

296.95

u/ml

0.02

Stroke, excluding SAH

625

3314

1.37

11.94

1.3

281.62

276.08

u/ml

0.19

398

2079

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

3.98

11.92

1.1

324.88

263.97

u/ml

0.33

Bacterial, viral and other infectious agents

154

839

1.87

11.79

1.6

1.4

253.01

256.35

u/ml

0.05

113

539

Lichen simplex chronicus and prurigo

435

2.23

11.78

1.6

1.2

279.62

270.46

u/ml

0.11

272

Chronic diseases of tonsils and adenoids

1227

6217

1.25

11.78

1.4

1.3

253.02

249.67

u/ml

0.14

751

4006

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

103

491

2.17

11.73

2.0

1.5

301.18

210.95

u/ml

1.69

260

Other follicular disorders

146

784

1.90

11.72

1.4

1.3

242.58

251.86

u/ml

0.19

492

Heartburn

154

839

1.86

11.70

1.3

1.2

258.77

268.49

u/ml

0.15

508

Aspergillosis

4.69

11.69

1.6

1.1

294.43

301.61

u/ml

0.03

Hypoglycaemia, other or unspecified

125

638

2.00

11.66

1.6

1.4

246.82

249.49

u/ml

0.04

372

Acute and subacute iridocyclitis

267

1692

1.60

11.64

1.3

277.87

266.67

u/ml

0.25

163

1056

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

10.10

11.63

1.6

2.2

272.15

126.42

u/ml

1.24

Unspecified misadventure during surgical and medical care

393

2.29

11.62

1.4

1.2

252.98

256.66

u/ml

0.04

236

Other and unspecified follicular disorders

369

2.34

11.59

1.3

246.59

242.33

u/ml

0.05

224

Syphilis, including avohilmo

215

2.80

11.48

1.4

1.2

294.66

257.75

u/ml

0.41

135

Syphilis

215

2.80

11.48

1.4

1.2

294.66

257.75

u/ml

0.41

135

Carcinoma in situ of skin of upper limb, including shoulder

119

3.46

11.47

1.3

1.1

333.78

321.64

u/ml

0.07

Aspergillosis, including avohilmo

4.61

11.46

1.6

1.1

294.43

301.61

u/ml

0.03

Colonic or urogenital fistula

363

2466

1.49

11.45

1.3

261.55

268.48

u/ml

0.14

217

1567

Giant cell arteritis with polymyalgia rheumatica

176

2.97

11.42

1.2

300.43

297.67

u/ml

0.02

Late syphilis, including avohilmo

125

3.44

11.42

1.6

1.2

309.23

271.17

u/ml

0.26

Other encephalitis

251

2.64

11.35

1.2

1.4

319.22

235.48

u/ml

0.71

154

Pain and other conditions associated with female genital organs and menstrual cycle

366

2076

1.49

11.35

1.3

1.2

238.02

247.54

u/ml

0.31

226

1326

Carcinoma in situ of skin of scalp and neck

125

3.37

11.31

1.4

1.1

287.19

344.54

u/ml

0.48

KRA_PSY_EATING, excluding more controls

181

1038

1.76

11.31

1.4

1.3

208.36

230.90

u/ml

0.67

112

646

Rare circulating lymphoid malignancy

10.95

11.29

1.3

1.5

150.50

233.73

u/ml

—

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

265

2.62

11.29

2.4

1.5

220.83

221.32

u/ml

0.00

138

Melanocytic naevi, other sites/unspecified

145

787

1.88

11.25

1.6

1.2

269.66

253.96

u/ml

0.24

107

478

Procreative management

612

3747

1.36

11.22

1.5

1.4

236.11

251.27

u/ml

0.76

423

2303

Corns and callosities

444

2.18

11.21

1.7

1.2

347.03

270.28

u/ml

1.50

263

Symptoms and signs involving speech and voice

401

2788

1.45

11.19

1.3

275.19

271.56

u/ml

0.08

252

1743

Small fibre neuropathy

212

2.78

11.19

1.4

1.2

242.01

268.70

u/ml

0.27

124

Malignant neoplasm of other and unspecified parts of biliary tract

4.30

11.19

1.1

362.35

249.63

u/ml

0.60

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

184

1057

1.75

11.18

1.6

1.5

293.85

218.96

u/ml

2.45

110

608

Other (seronegative) rheumatoid arthritis, wide

217

1323

1.66

11.09

1.2

299.68

280.20

u/ml

0.41

122

824

Injuries to the thorax

592

4397

1.35

11.08

1.3

294.63

262.03

u/ml

1.51

384

2813

Other and unspecified urticaria

317

2113

1.52

11.05

1.4

1.3

246.96

257.93

u/ml

0.29

190

1304

Open wound of lower leg

241

1512

1.61

11.02

1.4

1.3

293.31

251.02

u/ml

1.30

160

920

Aortic valve malfunction, age under 60 years

160

903

1.80

10.95

1.6

1.4

243.38

257.58

u/ml

0.31

119

565

Benign neoplasm: Stomach

116

590

1.99

10.90

1.2

308.78

291.61

u/ml

0.28

346

Pre-eclampsia or eclampsia

302

1998

1.53

10.90

1.3

1.2

263.51

266.72

u/ml

0.08

224

1289

Other mycoses, not elsewhere classified/unspecified

8.88

10.89

1.9

1.1

221.56

302.07

u/ml

0.29

Acne, including avohilmo

527

3116

1.38

10.86

1.3

212.53

222.97

u/ml

0.43

335

1928

Anterior Iridocyclitis

279

1816

1.55

10.85

1.3

278.23

263.14

u/ml

0.36

167

1137

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

616

4000

1.34

10.79

1.3

1.2

258.21

261.50

u/ml

0.11

419

2605

Lung diseases due to external agents

151

839

1.82

10.78

1.3

1.2

290.88

269.89

u/ml

0.35

507

Juvenile rheumatoid arthirtis

200

2.80

10.74

1.4

273.51

209.65

u/ml

0.66

118

Pre-eclampsia or poor fetal growth

451

3218

1.41

10.67

1.3

1.2

263.22

258.02

u/ml

0.16

326

2093

Other inflammation of eyelid, including avohilmo

703

5394

1.31

10.60

1.3

269.74

251.77

u/ml

0.88

460

3403

Disorders of plasma-protein metabolism, not elsewhere classified

4.62

10.56

1.1

1.2

386.47

238.50

u/ml

0.71

Dizziness and giddiness

970

6006

1.26

10.45

1.3

266.52

265.52

u/ml

0.03

618

3841

Injuries to the knee and lower leg

1772

8060

1.19

10.43

1.3

255.13

253.11

u/ml

0.11

1171

5042

Coeliac disease

196

1187

1.67

10.39

1.4

1.3

240.11

247.33

u/ml

0.13

118

700

Ovarian cyst

498

2055

1.40

10.37

1.3

1.2

263.91

259.80

u/ml

0.11

300

1333

Injuries to the head

1663

8277

1.20

10.29

1.3

253.00

253.54

u/ml

0.03

1020

5262

Drug-induced hypoglycaemia without coma

113

3.41

10.28

1.5

1.2

263.26

259.95

u/ml

0.02

Reactive arthropathies, FINNGEN

113

583

1.97

10.26

1.3

260.36

252.86

u/ml

0.10

356

Migraine without aura and triptan purchases

312

2108

1.50

10.25

1.3

252.26

249.50

u/ml

0.06

209

1352

Drug-induced osteoporosis

3.93

10.19

1.5

1.2

261.55

290.59

u/ml

0.18

Other diseases of gallbladder

246

2.53

10.15

1.3

1.2

280.40

277.42

u/ml

0.03

138

Diseases of external ear

488

3575

1.37

10.13

1.4

1.3

224.23

260.89

u/ml

2.55

295

2231

Open wound of ankle and foot

177

1052

1.71

10.10

1.4

1.3

243.53

249.40

u/ml

0.12

116

654

Temporomandibular joint disorders, including avohilmo

725

5443

1.30

10.10

1.2

1.3

247.90

251.06

u/ml

0.10

441

3506

Sequelae of other external causes

437

2.12

10.09

1.3

240.42

254.36

u/ml

0.17

255

Arthropathy in Crohn disease

3.92

10.07

1.5

1.2

342.50

243.30

u/ml

0.79

Fracture of rib(s), sternum and thoracic spine

362

2522

1.45

10.06

1.2

1.3

308.69

269.11

u/ml

1.13

230

1610

Fracture of lumbar spine and pelvis

246

1580

1.57

10.04

1.3

285.00

273.54

u/ml

0.22

158

959

Soft tissue disorders related to use, overuse and pressure

332

2277

1.47

10.02

1.4

1.3

279.06

269.07

u/ml

0.19

213

1448

Polyarthritis, unspecified

236

2.56

10.02

1.4

1.2

312.97

252.44

u/ml

0.83

143

Pulmonary oedema

3.93

10.02

1.8

1.1

283.43

298.84

u/ml

0.07

Pyogenic arthritis

445

2.10

9.98

1.4

1.2

263.36

269.80

u/ml

0.07

277

Other specified/unspecified necrotizing vasculopathies

3.93

9.90

1.5

1.2

224.00

270.73

u/ml

0.44

Other symptoms and signs involving the nervous and musculoskeletal systems

562

4222

1.34

9.87

1.4

1.3

263.00

263.04

u/ml

0.00

348

2651

Unknown and unspecified causes of morbidity

394

2.16

9.85

1.2

237.90

261.88

u/ml

0.33

251

Infection of intervertebral disc (pyogenic)

3.72

9.80

1.3

1.2

265.47

349.29

u/ml

0.68

Disorders of adult personality and behaviour

490

3617

1.37

9.76

1.2

1.3

266.11

249.72

u/ml

0.64

302

2334

Migraine with aura and triptan purchases

295

1992

1.50

9.75

1.3

234.57

249.59

u/ml

0.47

183

1270

Mixed connective tissue disease

107

3.39

9.70

1.1

1.4

292.57

256.03

u/ml

0.25

Speech therapy

309

2108

1.48

9.63

1.4

1.3

256.79

273.65

u/ml

0.48

215

1312

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

276

1841

1.51

9.60

1.2

311.19

276.22

u/ml

1.15

146

1147

Acne

267

1767

1.53

9.56

1.4

1.3

240.51

222.70

u/ml

0.47

169

1068

Other disorders of eye and adnexa

227

1455

1.58

9.56

1.3

274.50

259.33

u/ml

0.24

150

892

Injuries to unspecified part of trunk, limb or body region

160

940

1.73

9.55

1.4

1.3

232.21

258.63

u/ml

0.77

118

564

Pregnancy hypertension

563

3793

1.33

9.54

1.3

1.2

257.90

261.11

u/ml

0.11

389

2461

Nail disorders

141

800

1.79

9.53

1.4

1.3

221.39

248.49

u/ml

0.75

488

Other/unspecified seropositive rheumatoid arthritis

278

1861

1.50

9.51

1.2

312.27

275.87

u/ml

1.23

147

1155

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

229

1472

1.57

9.49

1.3

1.4

236.94

266.59

u/ml

1.20

164

897

Shoulder lesions

913

4361

1.26

9.41

1.3

271.61

267.77

u/ml

0.14

574

2833

Seropositive rheumatoid arthritis, wide

280

1882

1.50

9.40

1.2

312.05

275.79

u/ml

1.24

148

1168

Atopic dermatitis, strict definition

568

4217

1.33

9.35

1.4

220.82

240.63

u/ml

1.18

334

2641

Pre-eclampsia

282

1904

1.50

9.31

1.3

1.2

262.87

265.72

u/ml

0.06

208

1230

Voice disturbances

323

2238

1.45

9.30

1.2

1.3

275.38

270.26

u/ml

0.10

199

1402

Degenerative macular diseases

114

610

1.89

9.25

1.3

1.2

261.12

276.85

u/ml

0.25

362

Concussion

763

4651

1.28

9.24

1.3

245.81

242.07

u/ml

0.15

472

2978

Conduction disorders

310

1698

1.47

9.23

1.4

1.3

301.75

259.93

u/ml

1.71

193

1025

Diplopia

175

1063

1.67

9.20

1.2

1.3

259.28

268.21

u/ml

0.15

104

661

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

426

3066

1.38

9.17

1.2

1.3

249.75

240.00

u/ml

0.34

277

1983

Hyphaema and other vascular disorders of iris and ciliary body

143

2.96

9.13

1.3

1.2

265.93

249.65

u/ml

0.15

Basal cell carcinoma

381

1840

1.42

9.12

1.3

304.77

285.03

u/ml

0.59

232

1152

Membranous nephropathy

9.57

9.10

2.4

1.1

353.36

244.33

u/ml

—

Other shoulder lesions

142

819

1.76

9.06

1.4

1.2

285.25

255.18

u/ml

0.60

514

Systemic sclerosis

138

2.98

9.06

1.3

307.50

253.17

u/ml

0.54

Emotional disorders starting during childhood or adolecense, excluding more controls

134

739

1.80

9.06

1.6

1.4

258.72

195.11

u/ml

1.61

420

Retinal vascular disorders

116

629

1.86

9.04

1.4

1.2

267.68

286.16

u/ml

0.30

380

Chronic myeloid leukaemia

9.38

9.04

1.1

1.0

238.00

186.56

u/ml

—

Other disorders starting during childhood or adolecense, excluding more controls

140

770

1.78

9.03

2.3

1.5

178.03

198.63

u/ml

0.52

438

Tick-borne viral encephalitis, including avohilmo

5.24

9.02

1.0

1.3

260.42

246.00

u/ml

0.08

Dermatographic urticaria

116

632

1.87

9.00

1.4

1.2

264.77

259.58

u/ml

0.07

396

Chronic viral hepatitis

105

556

1.93

8.95

1.3

300.69

238.37

u/ml

1.24

362

Diabetes mellitus in pregnancy

527

2509

1.34

8.93

1.2

1.3

255.28

253.90

u/ml

0.04

362

1620

Other and unspecified rosacea

127

714

1.80

8.87

1.3

1.2

306.59

264.52

u/ml

0.59

445

Polyarteritis nodosa

7.04

8.86

1.4

1.2

271.67

198.80

u/ml

0.43

Congenital malformations of the circulatory system

266

1743

1.50

8.86

1.8

1.5

247.95

238.50

u/ml

0.22

180

1022

Benign neoplasm: Ascending colon

150

885

1.71

8.81

1.2

290.40

284.96

u/ml

0.08

535

Polyuria

246

1634

1.52

8.79

1.2

256.08

270.66

u/ml

0.41

144

1038

Amputation of thigh

124

3.04

8.78

1.4

1.1

356.40

329.58

u/ml

0.15

Complications of internal orthopaedic prosthetic devices, implants and grafts

208

1332

1.57

8.76

1.3

1.2

299.03

282.90

u/ml

0.32

122

805

Obesity, other/unspecified

492

3695

1.34

8.76

1.2

1.3

265.76

260.63

u/ml

0.15

299

2432

Tonsillectomy and adenotomy

1015

5765

1.23

8.75

1.4

1.3

248.42

242.04

u/ml

0.30

620

3702

Adenocarcinoma and Papillary adenocarcinoma of kidney

4.11

8.72

1.7

1.1

319.50

271.14

u/ml

0.27

Retinal vascular occlusion

114

623

1.85

8.69

1.4

1.2

267.68

285.69

u/ml

0.29

378

Vasomotor and allergic rhinitis

608

4603

1.30

8.61

1.2

1.4

235.24

247.94

u/ml

0.59

345

2928

Other surgical follow-up care

254

2.38

8.61

1.3

1.2

224.35

229.21

u/ml

0.06

147

Allergic purpura

280

2.32

8.59

1.4

1.3

241.15

243.95

u/ml

0.02

164

Disturbance of activity and attention

335

2321

1.43

8.59

1.5

1.4

228.20

218.10

u/ml

0.28

195

1417

Personality disorders

449

3342

1.35

8.55

1.2

1.3

277.28

251.55

u/ml

1.10

275

2177

Adult respiratory distress syndrome

3.70

8.52

1.6

1.2

192.24

297.97

u/ml

0.99

Aortic aneurysm

212

1348

1.55

8.43

1.4

1.2

285.18

279.27

u/ml

0.10

136

836

Acquired pure red cell aplasia [erythroblastopenia]

8.30

8.43

1.3

1.4

214.38

363.73

u/ml

—

Other disorders of optic [2nd] nerve and visual pathways

106

574

1.88

8.43

1.4

239.47

250.87

u/ml

0.20

329

Intracranial trauma

870

4734

1.25

8.42

1.3

253.46

241.19

u/ml

0.74

542

3040

Specific development disorders of scholastic skills

141

818

1.74

8.40

1.9

1.6

199.90

193.45

u/ml

0.12

473

Injuries to the hip and thigh

576

3978

1.30

8.40

1.3

268.00

262.14

u/ml

0.21

350

2479

Dental pulpitis, including avohilmo

1418

7668

1.19

8.40

1.3

251.01

255.18

u/ml

0.23

909

4937

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

248

1668

1.50

8.39

1.3

1.4

238.02

266.11

u/ml

1.19

178

1016

Attention to artificial openings

196

2.54

8.35

1.9

1.3

233.52

256.19

u/ml

0.26

104

Fentanyl

516

1.91

8.34

1.2

251.85

277.28

u/ml

0.48

299

Biliary cirrhosis, NAS

11.36

8.33

1.9

1.7

221.75

200.00

u/ml

—

Other and unspecified vascular occlusions

455

1.98

8.33

1.5

1.2

266.14

280.35

u/ml

0.20

267

Valvular operations

147

876

1.69

8.32

1.4

1.3

287.84

263.38

u/ml

0.46

105

544

Ischaemic Stroke, excluding all haemorrhages

549

3084

1.32

8.32

1.3

280.78

278.75

u/ml

0.06

342

1936

Prurigo nodularis

145

2.83

8.31

1.6

1.2

331.60

261.33

u/ml

0.62

Traction detachment of retina

4.12

8.30

1.9

1.2

207.61

252.40

u/ml

0.33

Acute laryngitis and tracheitis

233

1528

1.52

8.30

1.5

1.3

223.02

227.69

u/ml

0.09

146

929

Viral agents as the cause of diseases classified to other chapters

198

2.56

8.29

1.9

1.4

201.18

264.49

u/ml

1.03

109

Lack of expected normal physiological development

293

2.21

8.28

2.7

1.5

180.42

181.72

u/ml

0.01

145

Acidosis

140

2.87

8.27

1.9

1.2

262.14

281.88

u/ml

0.14

Injury of unspecified body region

116

650

1.81

8.24

1.5

1.3

237.78

247.27

u/ml

0.18

377

Viral haemorrhagic fevers, not elsewhere classified/unspecified

111

615

1.83

8.19

1.4

1.2

272.85

275.47

u/ml

0.04

377

Unspecific neurodegenerative disorder

139

1581

0.60

8.17

1.1

1.2

261.21

286.60

u/ml

0.55

916

Spondylopathies in diseases classified elsewhere

3.89

8.17

1.3

1.2

295.50

341.65

u/ml

0.20

Exclusions for E4_PCOS_BROAD

285

1981

1.45

8.16

1.6

1.4

246.54

248.57

u/ml

0.04

195

1197

conjunctival haemorrhage

487

1.94

8.16

1.4

1.2

337.90

282.47

u/ml

0.87

287

Otitis externa, unspecified

188

1201

1.59

8.13

1.6

1.3

223.48

255.06

u/ml

1.02

111

740

Malnutrition

206

2.52

8.13

2.6

1.8

204.93

231.22

u/ml

0.21

100

Systemic sclerosis, icd10

147

2.80

8.12

1.3

307.50

247.02

u/ml

0.64

Mental and behavioural disorders due to psychoactive substance use

840

6231

1.24

8.10

1.2

1.3

285.44

254.04

u/ml

2.58

546

4004

Cardiac murmurs and other cardiac sounds

178

1111

1.61

8.09

1.4

261.73

213.87

u/ml

1.07

105

605

Urolithiasis

369

2686

1.38

8.08

1.4

1.3

271.68

273.06

u/ml

0.03

222

1711

Hordeolum and other deep inflammation of eyelid

104

568

1.86

8.07

1.4

1.3

267.84

244.61

u/ml

0.39

328

Anosmia

3.62

8.04

1.3

1.2

229.42

239.26

u/ml

0.06

Otitis externa

334

2396

1.41

8.03

1.5

1.3

225.61

261.47

u/ml

1.88

205

1484

Myositis

183

2.58

8.00

1.2

244.24

241.57

u/ml

0.02

105

Drug-induced polyneuropathy

3.59

7.99

1.4

1.9

185.55

223.56

u/ml

0.24

Intestinal adhesions without obstruction

512

1.90

7.96

1.3

352.54

280.91

u/ml

1.25

309

Ocular pain

139

829

1.70

7.95

1.4

1.3

281.63

251.37

u/ml

0.37

499

Viral agents as the cause of diseases classified to other chapters, including avohilmo

239

2.38

7.95

1.8

1.4

219.89

256.04

u/ml

0.54

134

Triptan medication for migraine, single purchase ok

1178

6673

1.20

7.89

1.2

1.3

259.61

252.81

u/ml

0.36

756

4257

Migraine, single triptan purchase ok & required. ICD-code if available is included

1178

6673

1.20

7.89

1.2

1.3

259.61

252.81

u/ml

0.36

756

4257

Otitis media, unspecified

253

1595

1.48

7.87

1.9

1.3

232.72

210.09

u/ml

0.64

141

900

Other symptoms and signs involving cognitive functions and awareness

512

3475

1.31

7.83

1.2

1.3

279.67

274.23

u/ml

0.15

298

2177

Visual impairment including blindness (binocular or monocular)

459

1.94

7.83

1.4

1.3

251.72

259.51

u/ml

0.08

258

Unspecified fall

705

5529

1.26

7.78

1.4

1.3

253.03

256.46

u/ml

0.13

440

3391

Specific personality disorders

390

2887

1.36

7.76

1.2

1.3

269.35

252.77

u/ml

0.54

245

1877

Granulomatous disorders of skin and subcutaneous tissue

192

2.51

7.75

1.7

1.4

248.34

224.62

u/ml

0.26

115

Disorders of psychological development

301

1981

1.43

7.74

1.8

1.4

198.23

205.93

u/ml

0.23

166

1143

Infections with a predominantly sexual mode of transmission

497

3801

1.31

7.74

1.3

265.08

246.74

u/ml

0.85

337

2456

COPD, hospital admission 2, with asthma infections

300

1822

1.42

7.73

1.2

1.3

305.16

278.03

u/ml

0.72

184

1122

Other (not insulin) diabetes medications

1199

5892

1.20

7.72

1.3

1.2

291.86

259.88

u/ml

3.03

712

3869

Right hemicolectomy

292

2.19

7.72

1.3

1.2

358.93

274.95

u/ml

0.95

164

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

445

3361

1.33

7.69

1.4

1.3

258.89

261.87

u/ml

0.09

288

2099

Other aneurysm

299

2.17

7.69

1.5

1.2

320.71

268.95

u/ml

0.71

163

Malignant neoplasm, without specification of site, including Hilmo

186

2.50

7.66

1.2

342.00

259.99

u/ml

0.68

100

Other peripheral vascular diseases

107

599

1.81

7.64

1.1

1.2

258.41

262.71

u/ml

0.06

352

Noninflammatory disorders of female genital tract

594

2311

1.30

7.61

1.3

1.2

245.89

251.35

u/ml

0.18

358

1457

Disorders of muscles

146

892

1.66

7.60

1.2

1.3

297.10

262.73

u/ml

0.63

559

Hyperkinetic disorders

348

2480

1.39

7.57

1.5

1.4

230.68

218.97

u/ml

0.35

199

1515

Other disorders of conjunctiva

158

985

1.62

7.57

1.3

1.2

309.99

277.37

u/ml

0.70

104

607

Hyperhidrosis

206

2.43

7.57

1.2

1.3

223.12

233.36

u/ml

0.12

130

Other forms of systemic lupus erythematosus

4.09

7.56

1.2

1.5

354.23

266.25

u/ml

0.36

Sequelae of cerebrovascular disease

328

2016

1.40

7.54

1.2

284.85

276.51

u/ml

0.21

205

1236

Other disorders of iris and ciliary body

201

2.45

7.51

1.3

1.2

257.03

270.15

u/ml

0.13

119

Polymyositis

4.21

7.47

1.4

1.2

215.00

245.85

u/ml

0.16

Other/unspecified reactive arthropathies

103

576

1.82

7.43

1.2

1.3

242.00

257.66

u/ml

0.24

351

Autonomic disorders

190

2.49

7.43

1.3

1.2

254.14

226.88

u/ml

0.29

105

Duodenal ulcer

101

560

1.82

7.42

1.5

1.2

249.60

272.45

u/ml

0.48

344

Abnormalities of gait and mobility

142

867

1.66

7.41

1.3

1.4

267.37

270.15

u/ml

0.04

501

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

289

2053

1.42

7.41

1.2

243.33

253.65

u/ml

0.29

178

1320

Arthropod-borne viral fevers and viral haemorrhagic fevers

125

739

1.71

7.40

1.4

1.2

273.95

263.96

u/ml

0.17

461

Amyloidosis

126

2.85

7.40

1.5

1.2

201.91

308.74

u/ml

1.23

Unstable angina pectoris

303

1692

1.41

7.39

1.2

326.52

276.33

u/ml

1.33

192

1015

Malignant neoplasm of head and neck

412

1.96

7.38

1.2

297.33

274.39

u/ml

0.31

253

Other eating disorders

122

719

1.73

7.38

1.4

183.52

230.94

u/ml

1.65

428

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

374

2775

1.36

7.37

1.3

275.53

242.55

u/ml

1.47

244

1784

Seronegative rheumatoid arthritis

123

724

1.72

7.37

1.2

296.54

273.46

u/ml

0.38

445

Carcinoma in situ of skin of trunk

149

2.67

7.34

1.3

1.1

237.68

327.09

u/ml

1.21

Calculus of kidney and ureter

342

2501

1.38

7.34

1.4

1.3

273.64

270.68

u/ml

0.05

206

1598

Polycythaemia vera

155

2.63

7.32

1.2

350.95

256.73

u/ml

0.74

Thyrotoxicosis, other and/or unspecified

256

1784

1.45

7.29

1.3

1.2

266.47

269.01

u/ml

0.05

172

1124

Sacroiliitis, not elsewhere classified

515

1.86

7.28

1.3

1.2

293.67

255.55

u/ml

0.50

322

Other specified and unspecified retinal disorders

229

2.32

7.26

1.5

1.2

305.45

252.67

u/ml

0.68

130

Essential (haemorrhagic) thrombocythaemia

198

2.42

7.24

1.2

266.21

255.31

u/ml

0.10

109

Etanercept

112

648

1.76

7.22

1.3

1.4

284.13

251.14

u/ml

0.48

394

Malignant neoplasm, without specification of site

122

2.83

7.19

1.2

327.17

274.08

u/ml

0.28

Viral meningitis, including avohilmo

370

2.02

7.17

1.2

1.3

259.90

244.00

u/ml

0.17

231

N06DA Anticholinesterases

102

1360

0.58

7.15

1.1

1.2

268.13

285.76

u/ml

0.27

791

Use of anticholinesterases

102

1360

0.58

7.15

1.1

1.2

268.13

285.76

u/ml

0.27

791

Hydrocele

140

860

1.64

7.15

1.6

1.4

242.13

250.35

u/ml

0.15

548

Fitting and adjustment of other devices

281

1753

1.42

7.12

1.4

1.1

267.94

266.67

u/ml

0.02

159

1012

Disorders of optic nerve and visual pathways

147

917

1.62

7.10

1.3

259.50

255.27

u/ml

0.07

103

547

Trigger finger

176

1143

1.55

7.10

1.3

1.2

270.47

271.61

u/ml

0.02

117

723

Disorders of continuity of bone

151

948

1.61

7.09

1.4

1.3

252.99

255.76

u/ml

0.04

576

Other postsurgical states

426

1.93

7.07

2.0

1.2

281.92

246.45

u/ml

0.50

247

Other disorders of bone

281

2004

1.41

7.06

1.3

264.94

257.19

u/ml

0.13

167

1246

Acute bronchiolitis

182

1081

1.55

7.00

2.1

1.6

222.44

176.66

u/ml

1.17

110

542

Fracture of foot, except ankle

380

2849

1.34

6.99

1.4

1.3

244.68

259.71

u/ml

0.50

253

1789

Mixed hyperlipidaemia

246

2.23

6.96

1.5

1.2

249.63

282.05

u/ml

0.40

141

Amenorrhoea

132

807

1.66

6.95

1.3

266.53

246.95

u/ml

0.34

527

Bipolar affective disorders

291

2095

1.40

6.94

1.2

1.3

258.58

257.06

u/ml

0.03

186

1356

Primary hyperparathyroidism

115

677

1.72

6.92

1.3

1.2

271.13

286.48

u/ml

0.21

395

Embedded and impacted teeth

581

3735

1.27

6.91

1.5

1.3

216.63

227.33

u/ml

0.45

350

2348

Fall on same level involving ice and snow

766

6264

1.23

6.87

1.3

261.71

262.52

u/ml

0.03

511

3960

COPD

425

2622

1.32

6.87

1.2

1.3

309.44

278.20

u/ml

1.11

263

1623

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

222

2.30

6.86

1.3

1.2

242.12

229.68

u/ml

0.15

126

Other symptoms and signs involving the circulatory and respiratory systems

524

1.82

6.86

1.4

1.3

327.42

243.68

u/ml

0.84

311

Other specified/unspecified soft tissue disorders

287

2.12

6.84

1.3

1.2

276.61

279.05

u/ml

0.02

170

Abnormal involuntary movements

180

1186

1.53

6.84

1.3

256.88

267.87

u/ml

0.23

120

725

COPD, hospital admissions 3, with asthma pneumonia sepsis

233

1378

1.46

6.82

1.2

319.98

283.46

u/ml

0.85

143

839

Intracerebral haemorrhage

112

657

1.72

6.81

1.4

1.2

286.67

287.23

u/ml

0.01

390

Persistent mood disorders

249

1751

1.43

6.78

1.3

277.15

263.57

u/ml

0.30

140

1122

Nonspecific lymphadenitis

512

1.83

6.78

1.3

255.60

262.94

u/ml

0.10

318

Infection due to other mycobacteria

3.47

6.75

1.3

1.2

383.81

267.86

u/ml

0.54

Emotionally unstable personality disorder

232

1616

1.45

6.73

1.2

1.3

243.73

245.27

u/ml

0.03

149

1028

Helminthiases

145

2.64

6.72

1.5

1.4

172.77

222.69

u/ml

0.92

Spondylopathies

923

4526

1.21

6.69

1.2

1.3

281.22

266.14

u/ml

0.74

557

2940

Social phobias

178

1178

1.53

6.68

1.4

1.3

230.94

237.61

u/ml

0.14

110

729

Acute gastritis

449

1.87

6.67

1.3

1.2

323.38

257.26

u/ml

1.08

274

Acne vulgaris

203

1380

1.49

6.67

1.5

1.3

233.45

216.40

u/ml

0.41

127

840

Speech and linguistic disorders

228

1521

1.46

6.66

2.0

1.5

197.34

198.98

u/ml

0.04

133

873

Polycystic ovarian syndrome, consortium definition

953

4549

1.21

6.66

1.3

1.2

253.03

257.77

u/ml

0.19

572

2931

Tick-borne viral encephalitis

6.14

6.64

1.0

1.3

232.36

247.45

u/ml

0.08

Pyoderma gangrenosum

3.99

6.64

1.4

1.3

220.91

196.25

u/ml

0.17

Benign neoplasm: Rectum

180

1193

1.52

6.64

1.3

1.2

344.53

282.93

u/ml

1.16

120

734

Other and unspecified iridocyclitis

394

1.94

6.64

1.2

1.3

242.38

241.65

u/ml

0.01

246

Vitamin deficiency

366

1.97

6.63

1.3

251.82

241.29

u/ml

0.15

214

Vitamin deficiency, wide

366

1.97

6.63

1.3

251.82

241.29

u/ml

0.15

214

Other mycoses, not elsewhere classified/unspecified, including avohilmo

152

2.58

6.62

1.6

1.3

228.00

227.25

u/ml

0.01

Sciatica+with lumbago

651

4650

1.24

6.59

1.2

1.3

259.99

263.50

u/ml

0.11

424

3027

Congenital malformations of heart and great arteries

232

1573

1.45

6.59

1.9

1.5

248.22

235.27

u/ml

0.29

152

905

Vitamin B12 deficiency anaemia

523

1.79

6.57

1.4

1.2

289.36

275.78

u/ml

0.17

316

Disorder of the sleep-wake schedule

215

2.32

6.57

1.2

1.5

250.36

218.39

u/ml

0.39

117

Other salmonella infections

246

2.20

6.56

1.2

1.3

184.67

254.80

u/ml

1.55

151

Certolizumab pegol

165

2.50

6.54

1.1

1.2

367.53

245.53

u/ml

0.92

Superficial injury of lower leg

386

2930

1.33

6.54

1.3

270.79

255.70

u/ml

0.51

257

1809

Presence of other devices

198

1320

1.48

6.52

1.4

1.1

269.58

269.97

u/ml

0.01

101

791

Other salmonella infections, including avohilmo

314

2.04

6.48

1.2

1.3

186.76

247.02

u/ml

1.49

190

Scleritis and episcleritis

520

1.80

6.46

1.4

1.2

217.97

257.81

u/ml

1.13

317

Hypothyroidism, strict autoimmune, 3 medication purchases required

1079

6131

1.19

6.45

1.3

281.36

259.17

u/ml

1.40

650

3971

Anuria and oliguria

5.78

6.42

2.3

1.4

210.60

246.67

u/ml

—

Triptan medication for migraine, min. 3 purchases

878

5462

1.21

6.41

1.2

1.3

254.17

252.05

u/ml

0.08

563

3548

Other nutritional anaemias

4.18

6.40

1.5

1.3

183.75

287.63

u/ml

0.49

Pain in thoracic spine

209

1440

1.46

6.39

1.3

248.63

264.85

u/ml

0.24

137

921

Disorders of synovium and tendon

687

4745

1.23

6.36

1.3

261.57

259.39

u/ml

0.07

432

3087

Other keratitis

170

1126

1.53

6.35

1.3

1.2

219.02

259.06

u/ml

1.12

115

709

Allergic rhinitis

536

4207

1.27

6.35

1.2

1.4

237.20

240.55

u/ml

0.11

306

2635

Amyloidosis, other/unspecified

114

2.80

6.35

1.4

1.1

210.55

325.03

u/ml

1.19

Benign neoplasm: Rectum, anus and anal canal

198

1352

1.47

6.33

1.3

1.2

337.11

283.43

u/ml

1.04

130

836

Respiratory conditions due to other external agents

103

2.89

6.32

1.2

257.05

315.42

u/ml

0.37

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

764

4882

1.22

6.32

1.3

1.2

281.54

260.91

u/ml

1.13

521

3139

Respiratory disorders in diseases classified elsewhere

3.09

6.32

1.2

1.3

267.89

259.12

u/ml

0.05

Abnormal findings in nipple discharge synovial fluid wound secretions

121

2.74

6.26

1.6

1.4

326.12

227.28

u/ml

0.62

Postprocedural disorders of digestive system, not elsewhere classified

225

2.22

6.25

1.6

1.3

320.58

254.90

u/ml

0.58

132

Folate deficiency anaemia

3.64

6.24

1.3

1.2

345.40

260.04

u/ml

—

Scleritis

2.93

6.20

1.5

1.2

274.07

216.11

u/ml

0.52

Other and unspecified acne

170

2.45

6.19

1.6

1.3

240.50

218.26

u/ml

0.20

103

Tooth eruption problems

342

2488

1.34

6.19

1.6

1.4

222.16

220.77

u/ml

0.03

201

1472

Corneal ulcer

255

1833

1.40

6.19

1.4

1.3

269.27

257.88

u/ml

0.22

167

1155

Other and unspecified epidermal thickening

220

2.24

6.18

1.9

1.4

229.85

237.29

u/ml

0.07

130

Impetigo

551

1.76

6.17

2.0

1.5

218.38

230.59

u/ml

0.13

328

Other disorders of pigmentation

320

2.00

6.17

1.5

1.3

297.98

234.84

u/ml

0.78

182

Other endocrine disorders

125

747

1.64

6.15

2.7

1.6

243.90

191.64

u/ml

1.17

378

Bronchiectasis

440

1.84

6.13

1.4

1.2

319.76

261.37

u/ml

0.77

255

Iron deficiency

385

1.92

6.12

1.2

1.4

265.10

215.23

u/ml

0.85

237

Absence of one kidney, including avohilmo

4.47

6.12

1.4

1.5

220.80

139.92

u/ml

—

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

5.41

6.12

1.4

1.1

313.00

187.82

u/ml

—

Certain conditions originating in the perinatal period

231

1453

1.43

6.11

2.0

1.5

195.73

193.67

u/ml

0.04

129

784

Use of memantine

1010

0.54

6.11

1.1

1.2

256.39

283.68

u/ml

0.34

577

Use of other anti-dementia drugs

1010

0.54

6.11

1.1

1.2

256.39

283.68

u/ml

0.34

577

Malignant melanoma, including Hilmo

149

966

1.55

6.11

1.4

1.2

236.72

276.76

u/ml

1.25

604

Malignant neoplasm of head and neck, including Hilmo

513

1.77

6.11

1.2

1.3

283.13

273.05

u/ml

0.13

325

Disorders in reading

304

2.07

6.10

2.2

1.7

266.87

173.91

u/ml

1.85

158

Tuberculosis of other organs, strict, including avohilmo

105

2.82

6.10

1.6

1.2

277.56

308.23

u/ml

0.22

Postprocedural disorders of nervous system

120

742

1.64

6.09

1.2

1.3

227.10

260.88

u/ml

0.87

480

Infection due to other mycobacteria, including avohilmo

3.15

6.09

1.3

1.2

383.81

250.63

u/ml

0.66

Familial hypercholesterolemia

127

794

1.61

6.09

1.5

1.2

258.73

277.45

u/ml

0.28

471

Visual field defects

574

1.73

6.08

1.4

1.3

318.02

274.74

u/ml

0.67

344

Unspecified/other endometriosis

149

949

1.56

6.07

1.2

244.26

264.52

u/ml

0.57

100

633

Other and unspecified visual disturbances

140

898

1.58

6.07

1.2

1.3

278.71

266.13

u/ml

0.20

542

Oesophagitis

364

1.92

6.05

1.4

1.3

221.10

255.94

u/ml

0.45

220

Other noninflammatory disorders of vulva and perineum

135

860

1.59

6.03

1.2

1.3

244.12

271.09

u/ml

0.65

556

Childhood allergy (age < 16)

392

2486

1.32

6.03

1.4

195.38

206.27

u/ml

0.39

223

1494

Disorders of ocular muscles, binocular movement, accommodation and refraction

727

5953

1.22

6.01

1.5

1.3

258.02

249.40

u/ml

0.31

448

3746

Cluster headache, wide

352

1.94

5.98

1.2

1.3

216.89

248.70

u/ml

0.60

219

Degenerative diseases of the nervous system

122

1387

0.63

5.97

1.1

1.2

258.59

283.61

u/ml

0.47

804

Ingrowing nail

520

1.76

5.92

1.4

1.3

201.03

243.57

u/ml

1.27

320

Livedoid vasculitis

7.39

5.88

1.2

1.4

240.88

441.67

u/ml

—

Fracture of lower leg, including ankle

716

5808

1.21

5.88

1.3

251.15

263.09

u/ml

0.52

481

3652

Pneumonia derived septicemia

292

2.03

5.86

1.7

1.4

223.70

229.92

u/ml

0.06

162

Diseases of tongue

382

1.88

5.85

1.5

1.1

245.02

265.23

u/ml

0.20

221

Henoch-Schönlein purpura nephritis (HSPN)

5.22

5.84

1.8

1.2

158.33

194.56

u/ml

0.64

Adhesive capsulitis of shoulder

176

1195

1.48

5.83

1.4

1.2

229.28

280.62

u/ml

2.11

108

753

Drug-induced acute pancreatitis

9.86

5.82

1.0

1.4

150.00

289.80

u/ml

—

Other prurigo

3.34

5.80

1.5

1.2

208.73

248.55

u/ml

0.22

Pollen allergy

382

2909

1.31

5.80

1.2

1.4

240.88

231.01

u/ml

0.30

212

1783

COPD related to multimorbidity

346

2218

1.32

5.78

1.2

301.32

280.20

u/ml

0.58

210

1350

Benign neoplasm: Caecum

106

644

1.66

5.75

1.2

272.48

291.28

u/ml

0.25

376

Retinal detachment with retinal break

131

838

1.58

5.75

1.5

1.2

268.40

278.30

u/ml

0.15

516

Cluster headache, strict

336

1.94

5.74

1.3

212.40

234.57

u/ml

0.39

207

Alzheimer disease, including avohilmo

118

1289

0.63

5.74

1.1

1.2

244.61

285.96

u/ml

0.98

743

Volvulus

138

2.51

5.73

1.4

1.3

271.17

258.34

u/ml

0.09

Other protozoal intestinal diseases

115

2.70

5.73

1.4

1.3

254.45

229.95

u/ml

0.16

Other/unspecified rheumatoid arthritis

119

745

1.61

5.72

1.2

294.45

275.80

u/ml

0.26

443

Congenital vesicoureteral reflux

117

2.78

5.72

2.7

1.7

197.69

165.49

u/ml

0.20

Cervicalgia

244

1766

1.39

5.70

1.3

238.93

274.22

u/ml

1.36

156

1123

Superficial injury of wrist and hand

352

2695

1.32

5.70

1.3

245.35

251.07

u/ml

0.14

205

1683

Tuberculosis of other organs, strict

2.81

5.67

1.6

1.2

281.50

309.53

u/ml

0.17

Substance abuse

791

6150

1.20

5.65

1.2

1.3

280.10

255.49

u/ml

1.68

512

3958

Thoracic aortic aneurysm

141

921

1.54

5.64

1.5

1.2

275.77

279.73

u/ml

0.05

570

Acute appendicitis

946

7462

1.18

5.64

1.3

254.21

258.89

u/ml

0.23

619

4823

Varicella [chickenpox], including avohilmo

103

627

1.67

5.61

1.8

1.5

304.84

221.23

u/ml

1.37

355

Personal history of malignant neoplasm

580

1.69

5.61

1.3

1.1

245.20

267.60

u/ml

0.30

329

Diseases of appendix

1004

7670

1.17

5.58

1.3

255.58

258.69

u/ml

0.15

653

4949

Carcinoma in situ of skin of lower limb, including hip

3.04

5.56

1.4

1.1

237.88

339.31

u/ml

0.73

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

7.47

5.53

1.5

1.1

236.17

194.43

u/ml

—

Impotence

419

1.82

5.53

1.6

1.3

213.92

261.23

u/ml

1.04

263

Supplementary factors related to causes of morbidity and mortality classified elsewhere

440

3479

1.27

5.53

1.5

1.3

249.54

257.20

u/ml

0.24

292

2166

Injuries to the shoulder and upper arm

1145

7622

1.16

5.51

1.3

251.25

260.53

u/ml

0.55

734

4793

Rotator cuff syndrome

670

3798

1.22

5.48

1.3

274.00

270.58

u/ml

0.10

428

2456

Appendicitis, broad definition

996

7645

1.17

5.47

1.3

254.30

258.58

u/ml

0.22

649

4936

Disorders of phosphorus metabolism and phosphatases

3.65

5.46

2.1

1.4

214.46

221.07

u/ml

0.04

Intracranial and intraspinal abscess and granuloma

2.96

5.44

1.4

1.2

223.19

286.60

u/ml

0.47

Menorrhagia

408

1767

1.29

5.42

1.3

1.2

266.65

270.92

u/ml

0.11

248

1140

Nontraumatic intracranial haemmorrhage

171

1172

1.47

5.41

1.4

1.2

267.45

282.10

u/ml

0.31

115

720

Alzheimer’s disease, strict definition

933

0.55

5.40

1.1

1.2

253.84

287.66

u/ml

0.43

537

Diseases of the myoneural junction and muscle

139

915

1.53

5.40

1.3

296.51

270.00

u/ml

0.44

550

Viral meningitis

351

1.89

5.39

1.2

1.3

267.02

245.84

u/ml

0.22

217

Excessive vomiting in pregnancy

123

790

1.58

5.37

1.3

1.2

221.03

267.20

u/ml

1.41

488

Campylobacter enteritis

220

2.14

5.37

1.3

258.12

241.72

u/ml

0.12

133

Allergic bronchopulmonary aspergillosis (ABPA)

7.12

5.37

1.5

1.2

311.00

215.70

u/ml

—

Bullous disorders

365

1.86

5.36

1.3

1.2

242.26

253.41

u/ml

0.10

210

Other specified/unspecified inflammatory spondylopathies

431

1.79

5.36

1.1

1.2

243.93

270.36

u/ml

0.46

273

Malignant melanoma

132

860

1.54

5.36

1.3

239.58

278.40

u/ml

1.07

542

Perioral dermatitis

194

2.22

5.35

1.9

1.3

224.50

223.27

u/ml

0.01

124

Other immunodeficiencies

102

2.76

5.35

1.8

1.6

227.06

209.40

u/ml

0.10

Postmenopausal osteoporosis with pathological fracture

253

2.04

5.34

1.2

1.1

240.60

309.44

u/ml

1.09

140

All dysplastic lesions of the vulva

295

1.96

5.34

1.4

1.2

305.76

266.33

u/ml

0.51

187

Familial hypercholesterolemia, with ischemic heart disease

423

1.79

5.34

1.5

1.2

304.70

294.99

u/ml

0.08

257

Alzheimer disease

1114

0.61

5.33

1.1

1.2

252.40

284.50

u/ml

0.57

645

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

780

6284

1.19

5.32

1.2

1.3

250.06

252.70

u/ml

0.10

487

3976

Mouth breathing

514

4150

1.24

5.32

1.5

1.4

258.02

261.26

u/ml

0.08

304

2616

Complications following infusion, transfusion and therapeutic injection

102

2.73

5.31

1.9

1.3

248.94

264.98

u/ml

0.11

Substance use, excluding alcohol

304

2306

1.33

5.30

1.2

1.3

292.96

248.78

u/ml

1.77

204

1464

Obsessive-compulsive disorder

139

921

1.53

5.29

1.2

1.3

251.62

227.13

u/ml

0.44

573

Retinal breaks without detachment

170

1171

1.46

5.29

1.3

1.2

241.48

285.62

u/ml

1.47

107

734

Superficial injury of ankle and foot

223

1615

1.39

5.28

1.4

1.3

214.31

249.46

u/ml

1.57

145

990

Other and unspecified disorders of vitreous body

398

3056

1.28

5.26

1.3

1.2

277.71

284.47

u/ml

0.14

259

1894

Benign neoplasm: Pancreas

163

2.32

5.26

1.2

321.15

304.83

u/ml

0.08

Other nonthrombocytopenic purpura

3.34

5.25

1.3

1.4

311.40

257.09

u/ml

—

Fracture of femur

230

1505

1.38

5.22

1.3

1.2

286.92

270.86

u/ml

0.41

137

881

Tuberculosis of other organs

2.85

5.18

1.6

1.2

250.85

324.79

u/ml

0.61

Agoraphobia

371

1.84

5.16

1.2

1.3

216.14

238.45

u/ml

0.37

233

Other disorders of optic disc

116

2.58

5.13

1.3

1.4

254.26

245.27

u/ml

0.06

Rheumatism, unspecified

134

886

1.52

5.11

1.2

311.46

271.19

u/ml

0.80

537

Autoimmune hyperthyroidism

400

1.80

5.11

1.2

270.72

238.94

u/ml

0.47

251

Use of antiglaucoma preparations and miotics

378

1.81

5.10

1.4

1.2

326.11

293.63

u/ml

0.37

212

Dysplasia of cervi uteri

320

1717

1.32

5.09

1.3

1.2

268.30

260.92

u/ml

0.20

228

1140

Type of accident

399

3153

1.27

5.08

1.5

1.3

249.55

255.24

u/ml

0.16

261

1954

Emotional disorders and disorders of social functioning with onset specific to childhood

149

992

1.50

5.08

1.5

248.16

191.62

u/ml

1.60

550

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

206

2.16

5.08

2.1

1.6

217.19

230.29

u/ml

0.12

106

Other noninfective disorders of lymphatic vessels and lymph nodes

245

2.03

5.08

1.4

1.2

223.26

245.16

u/ml

0.28

138

Superficial injury of hip and thigh

175

1223

1.44

5.05

1.4

1.3

264.99

260.04

u/ml

0.09

106

743

Neuralgia and neuritis, unspecified

395

1.80

5.03

1.2

278.91

259.66

u/ml

0.23

258

Varicella [chickenpox]

516

1.70

5.02

1.7

1.4

314.21

231.41

u/ml

1.14

297

Eating disorders

203

1460

1.40

5.00

1.4

1.3

209.49

240.02

u/ml

1.19

127

893

Corticotropin deficiency

3.25

5.00

1.4

1.3

292.00

233.87

u/ml

0.28

Psoriasis vulgaris

231

1698

1.37

4.99

1.3

286.71

266.89

u/ml

0.51

158

1068

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

152

1038

1.47

4.96

1.1

1.2

295.16

277.80

u/ml

0.30

103

651

Psoriasis

349

2723

1.29

4.94

1.3

283.69

265.67

u/ml

0.55

226

1739

Bell's palsy

143

967

1.49

4.93

1.3

1.2

241.85

270.19

u/ml

0.61

592

Other specified and unspecified disorders of eye and adnexa

276

1.95

4.92

1.3

1.2

282.61

257.54

u/ml

0.20

161

Other chronic obstructive pulmonary disease

390

2516

1.27

4.91

1.2

1.3

300.93

278.71

u/ml

0.66

239

1555

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

150

1008

1.49

4.90

2.2

1.6

184.83

196.62

u/ml

0.27

101

569

Other inflammation of eyelid

177

1248

1.43

4.90

1.4

1.3

252.32

267.66

u/ml

0.34

116

747

Trochanteric bursitis

145

984

1.48

4.90

1.3

1.2

293.29

271.03

u/ml

0.23

605

Thyrotoxicosis

289

2203

1.32

4.88

1.3

1.2

264.11

271.93

u/ml

0.20

190

1372

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

641

5280

1.20

4.88

1.3

227.60

247.89

u/ml

1.28

402

3346

Somnolence, stupor and coma

312

1.89

4.87

1.3

266.34

263.03

u/ml

0.03

177

Other and unspecified nail disorders

182

2.19

4.87

1.2

1.3

219.22

232.75

u/ml

0.13

110

Disorders of optic nerve, not elsewhere classified

131

2.42

4.87

1.2

1.3

309.44

310.48

u/ml

0.01

Hypersensitivity pneumonitis due to organic dust

101

2.65

4.86

1.4

1.2

291.82

284.38

u/ml

0.04

Dementia

186

1773

0.71

4.82

1.1

1.2

274.08

278.91

u/ml

0.08

1059

Other disorders of eyelid

403

3025

1.26

4.80

1.2

1.3

268.65

285.34

u/ml

0.60

256

1875

Clear cell adenocarcinoma of kidney

237

2.01

4.77

1.3

1.2

241.44

269.28

u/ml

0.32

135

Abnormal findings in secretions and smears from cervix uteri vagina vulva

645

3957

1.20

4.76

1.3

1.2

282.38

255.80

u/ml

1.53

455

2565

Streptococcus and staphylococcus as the cause of diseases classified to other chapters, including avohilmo

3.15

4.76

2.1

1.4

243.50

253.22

u/ml

—

Injuries to the neck

336

2625

1.29

4.74

1.2

1.3

218.80

255.94

u/ml

2.55

218

1670

Coronary artery bypass grafting

192

1016

1.41

4.73

1.3

1.2

297.66

281.74

u/ml

0.34

121

605

Other orthopaedic follow-up care

344

1.82

4.72

1.2

284.27

264.70

u/ml

0.18

207

Streptococcus and staphylococcus as the cause of diseases classified to other chapters

3.67

4.70

2.3

1.1

260.56

259.00

u/ml

—

161

1127

1.44

4.70

1.1

1.2

227.26

249.96

u/ml

0.71

122

766

Other arthrosis

551

3031

1.22

4.69

1.3

278.82

274.49

u/ml

0.11

345

1994

Other and unspecified haemorrhagic conditions

109

2.54

4.69

1.6

1.4

218.60

241.59

u/ml

0.18

Necrosis of pulp, including avohilmo

819

6922

1.17

4.66

1.3

244.22

260.46

u/ml

0.99

520

4498

Eating disorder

183

1312

1.41

4.64

1.4

1.3

207.85

235.34

u/ml

0.92

113

799

Malignant neoplasm of other connective and soft tissue

134

2.36

4.63

1.3

1.4

282.53

232.01

u/ml

0.36

213

2.06

4.63

1.7

1.2

267.16

247.86

u/ml

0.19

129

Other symptoms and signs involving the urinary system

117

770

1.53

4.62

1.4

1.3

230.83

257.58

u/ml

0.54

468

Malignant neoplasm of pancreas, including Hilmo

383

1.76

4.61

1.1

1.2

273.24

281.41

u/ml

0.08

230

Allergic conjunctivitis

820

6755

1.17

4.59

1.2

1.3

249.23

252.92

u/ml

0.15

514

4287

Malignant neoplasm of tonsil and base of tongue

110

2.51

4.59

1.1

1.2

280.87

275.87

u/ml

0.03

Spondylosis

560

3616

1.21

4.58

1.2

1.3

287.37

272.95

u/ml

0.45

322

2346

Dissociative [conversion] disorders

363

1.79

4.58

1.3

237.93

242.68

u/ml

0.05

222

Malignant neoplasm of small intestine, including Hilmo

154

2.24

4.56

1.7

1.3

329.94

231.24

u/ml

0.86

Follow-up examination after treatment for malignant neoplasms

444

1.70

4.56

1.2

276.49

259.10

u/ml

0.20

285

Superficial injury of head

307

2381

1.29

4.55

1.2

1.4

230.02

259.42

u/ml

1.17

193

1469

Acute appendicitis, no complications

764

6475

1.18

4.54

1.3

250.54

259.15

u/ml

0.47

504

4215

Malignant neoplasm of other connective and soft tissue, including Hilmo

228

2.00

4.52

1.2

1.4

242.76

233.39

u/ml

0.08

127

Hypermobility syndrome

562

1.63

4.52

1.2

1.3

251.94

246.54

u/ml

0.07

358

Ulcer of vagina/vulva

208

2.06

4.52

1.4

241.85

238.63

u/ml

0.03

123

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

190

1333

1.39

4.51

1.1

1.3

281.93

278.19

u/ml

0.07

125

837

Other disorders of nervous system

439

1.70

4.50

1.3

1.2

287.57

264.86

u/ml

0.25

261

Other protozoal intestinal diseases, including avohilmo

202

2.08

4.49

1.3

237.76

239.42

u/ml

0.01

117

Schizophrenia

116

1723

0.67

4.49

1.2

1.3

249.40

251.95

u/ml

0.04

1117

Vulvovaginal ulceration/inflammation in other diseases

110

721

1.54

4.47

1.3

1.2

230.47

250.89

u/ml

0.42

459

Papulosquamous disorders

459

3744

1.23

4.46

1.3

287.43

269.49

u/ml

0.63

289

2379

Other and unspecified mood [affective] disorders

126

851

1.50

4.45

1.3

243.93

240.52

u/ml

0.05

539

Epilepsy

383

3054

1.26

4.45

1.3

1.4

265.34

254.60

u/ml

0.30

230

1905

Intracranial injury

790

6301

1.17

4.44

1.3

248.92

254.67

u/ml

0.27

484

3941

Status post-ami

195

1072

1.38

4.43

1.3

1.2

315.03

282.77

u/ml

0.60

116

635

Gestational diabetes (for exclusion)

556

3167

1.21

4.43

1.2

246.87

249.85

u/ml

0.11

387

2091

Xerosis cutis

106

2.51

4.43

1.2

1.3

329.00

269.75

u/ml

0.45

Malignant neoplasm of small intestine

112

2.46

4.42

1.8

1.3

335.56

256.44

u/ml

0.52

Other and unspecified diseases of spleen

5.31

4.41

1.5

1.3

409.40

142.36

u/ml

—

Morphin

106

2.49

4.41

1.2

350.06

298.81

u/ml

0.32

Redundant prepuce, phimosis and paraphimosis

299

2288

1.29

4.40

1.3

1.4

234.25

246.84

u/ml

0.36

181

1474

Car occupant injured in other and unspecified transport accidents

281

2170

1.30

4.39

1.3

241.28

254.36

u/ml

0.36

182

1381

Dementia, including avohilmo

212

1943

0.74

4.38

1.1

1.2

271.64

285.07

u/ml

0.30

118

1164

Any dementia

154

1505

0.71

4.38

1.1

1.2

276.51

280.35

u/ml

0.06

885

Myocardial infarction, with ST-elevation

140

966

1.46

4.38

1.4

1.2

273.14

293.82

u/ml

0.36

599

Pneumonia due to Haemophilus influenzae

6.60

4.37

1.5

1.1

227.00

202.11

u/ml

—

Persons encountering health services in circumstances related to reproduction

890

5146

1.16

4.37

1.4

236.89

252.12

u/ml

1.01

577

3176

Hidradenitis suppurativa

384

1.75

4.35

1.5

1.3

238.98

227.21

u/ml

0.18

253

Fracture of shoulder and upper arm

441

3588

1.23

4.34

1.3

252.15

259.27

u/ml

0.22

286

2200

Implicit parasitic Sepsis, including avohilmo

4.31

4.29

1.8

1.2

438.57

305.91

u/ml

—

Myocardial infarction, unclassifiable

151

945

1.43

4.29

1.5

1.2

260.06

297.70

u/ml

0.85

571

Other primary thrombocytopenia

5.12

4.29

1.2

1.6

142.00

216.54

u/ml

—

Other/unspecified synovitis and tenosynovitis

137

947

1.46

4.28

1.4

1.2

283.11

264.15

u/ml

0.29

592

Panniculitis, unspecified

2.92

4.28

1.2

153.77

251.55

u/ml

1.53

Vascular diseases of the intestine

178

2.10

4.28

1.1

1.2

278.61

267.35

u/ml

0.08

Malignant neoplasm of oropharynx

2.61

4.26

1.1

1.2

315.86

264.27

u/ml

0.31

Melanocytic naevi of lower limb, including hip

387

1.73

4.23

1.6

1.3

297.47

247.91

u/ml

0.51

227

Episcleritis

440

1.68

4.22

1.4

1.2

202.69

248.01

u/ml

1.39

274

Malignant melanoma of skin, including Hilmo

118

794

1.49

4.21

1.3

1.2

234.75

283.26

u/ml

1.47

494

Absence of one kidney

4.37

4.20

1.3

1.6

208.67

129.91

u/ml

—

Suggestive for eosinophilic asthma

103

675

1.54

4.19

1.1

1.2

245.39

277.68

u/ml

0.53

416

Ulcer of oesophagus

365

1.74

4.19

1.2

295.97

263.98

u/ml

0.37

216

Alcoholic gastritis

2.59

4.18

1.3

1.2

333.25

258.88

u/ml

0.43

Tuberculosis, IBD comorbidity

328

1.78

4.18

1.4

1.2

280.24

276.61

u/ml

0.03

189

Benign neoplasm: Sigmoid colon

175

1269

1.39

4.17

1.3

1.2

284.39

290.54

u/ml

0.09

115

785

Alzheimer’s disease (Late onset)

819

0.58

4.17

1.1

261.65

295.78

u/ml

0.38

461

Inflammatory disease of uterus

190

1399

1.37

4.15

1.3

1.2

233.76

263.16

u/ml

1.10

128

899

Implicit parasitic Sepsis

4.85

4.13

1.8

1.1

438.57

320.78

u/ml

—

LSIL lesion of the vulva

188

2.06

4.12

1.4

1.2

337.85

274.76

u/ml

0.64

119

Malignant neoplasm of tonsil

2.69

4.11

1.1

1.2

271.69

274.02

u/ml

0.01

Single delivery by forceps and vacuum extractor

159

1317

0.71

4.10

1.2

1.3

281.55

248.77

u/ml

0.96

104

836

Allergic colitis

385

1.74

4.09

2.1

1.9

157.54

164.18

u/ml

0.10

214

Nummular dermatitis

608

1.56

4.07

1.5

1.3

270.03

265.65

u/ml

0.05

388

Other condition

201

1499

1.35

4.05

1.5

1.3

230.04

253.55

u/ml

0.64

140

935

Complications of other internal prosthetic devices, implants and grafts

231

1.93

4.03

1.5

1.2

247.70

254.37

u/ml

0.06

132

Other nonscarring hair loss

2.67

4.03

1.3

357.93

213.42

u/ml

1.22

Degeneration of macula and posterior pole

382

2377

1.24

4.01

1.3

1.2

267.83

285.59

u/ml

0.64

248

1431

Use of donepezil

839

0.57

4.01

1.1

256.83

294.06

u/ml

0.58

474

Prolonged pregnancy

145

1728

0.71

4.00

1.2

1.3

249.16

248.44

u/ml

0.01

101

1120

Poisoning by drugs, medicaments and biological substances

354

2848

1.25

3.98

1.3

261.90

252.04

u/ml

0.27

223

1816

Chronic iridocyclitis

394

1.70

3.98

1.3

239.36

247.54

u/ml

0.10

231

Pneumococcal septicemia

298

1.81

3.96

1.7

1.4

208.73

241.37

u/ml

0.44

154

Other factor of the environment

100

2.47

3.95

1.7

1.2

205.00

273.30

u/ml

0.67

Malignant melanoma of skin

644

1.53

3.95

1.3

240.66

275.96

u/ml

0.78

406

Barrett oesophagus

320

1.77

3.94

1.2

347.00

268.44

u/ml

0.87

191

Anomalies of dental arch relationship, including avohilmo

348

2528

1.25

3.94

1.7

1.3

230.61

238.42

u/ml

0.19

189

1538

Papilloedema, unspecified

227

1.94

3.93

1.6

1.4

188.03

233.97

u/ml

0.93

128

Benign paroxysmal vertigo

284

2229

1.28

3.93

1.3

292.08

278.31

u/ml

0.24

180

1385

Alcohol-induced chronic pancreatitis

504

1.61

3.91

1.4

1.3

322.06

278.56

u/ml

0.60

324

Superficial injury of abdomen, lower back and pelvis

221

1681

1.32

3.91

1.2

1.3

246.43

251.86

u/ml

0.12

147

1051

Ovarian dysfunction

134

942

1.44

3.90

1.2

228.62

242.48

u/ml

0.27

621

Other congenital malformations

160

1160

1.39

3.90

1.6

1.5

238.10

231.50

u/ml

0.11

662

Postpartum haemorrhage due to retained placenta

1410

0.66

3.89

1.2

257.92

248.26

u/ml

0.10

972

Inflammatory disorders of male genital organs, not elsewhere classified

107

2.40

3.89

1.4

1.2

349.67

207.64

u/ml

0.89

Separation of retinal layers (serosa)

322

1.76

3.87

1.6

1.2

278.12

265.26

u/ml

0.13

199

Coxarthrosis [arthrosis of hip](FG)

494

2822

1.21

3.86

1.2

1.3

285.89

279.19

u/ml

0.19

294

1779

Secondary polycythaemia

166

2.09

3.85

1.3

1.2

312.38

285.08

u/ml

0.20

Hyperplasia of prostate

366

1656

1.25

3.82

1.3

261.28

269.37

u/ml

0.22

235

1069

Arterial embolism and thrombosis of lower extremity artery

166

2.07

3.82

1.3

294.93

268.70

u/ml

0.18

Cerebral aneurysm, nonruptured

587

1.55

3.78

1.6

1.2

280.67

282.14

u/ml

0.02

355

All dysplastic lesions of the cervix uteri, vagina or vulva

390

3110

1.23

3.77

1.3

1.2

282.79

252.32

u/ml

1.55

278

2050

Small kidney of unknown cause

7.23

3.77

1.5

1.3

296.88

176.57

u/ml

—

Other and unspecified psoriasis

517

1.58

3.76

1.3

1.2

234.91

260.09

u/ml

0.43

325

Other erythematous conditions

252

1.85

3.74

1.7

1.2

251.00

268.49

u/ml

0.16

148

Viral encephalitis, not elsewhere classified/unspecified

148

2.14

3.73

1.3

368.70

261.45

u/ml

0.53

Non-selective monoamine reuptake inhibitors

358

2785

1.24

3.73

1.2

1.3

263.61

280.46

u/ml

0.61

213

1796

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

662

1.51

3.72

1.3

1.2

243.89

272.82

u/ml

0.52

419

Chronic laryngitis and laryngotracheitis

144

1033

1.40

3.72

1.3

1.2

328.91

289.89

u/ml

0.80

644

Other hereditary haemolytic anaemias

3.24

3.71

1.2

1.7

164.22

148.95

u/ml

—

Other or unspecified immunodeficiency

3.98

3.70

1.6

1.9

286.29

141.60

u/ml

—

Seminoma of testis, including Hilmo

2.62

3.69

1.3

1.2

303.75

293.71

u/ml

0.05

COPD, hospital admissions

388

2670

1.23

3.69

1.2

300.97

279.54

u/ml

0.63

238

1630

Tuberculosis, wide, including avohilmo

364

1.69

3.69

1.4

1.2

291.51

283.68

u/ml

0.06

204

Acute nasopharyngitis (common cold)

157

1136

1.38

3.68

1.3

287.28

254.93

u/ml

0.59

759

Mental and behavioural disorders due to alcohol

658

5380

1.17

3.67

1.2

1.3

278.84

255.75

u/ml

1.43

429

3427

Tuberculosis, wide

357

1.69

3.67

1.4

1.2

290.76

278.86

u/ml

0.10

201

Urethritis and urethral syndrome

149

2.12

3.66

1.5

1.2

242.45

204.24

u/ml

0.33

Anogenital herpesviral [herpes simplex] infection, including avohilmo

191

1439

1.34

3.66

1.2

244.07

245.81

u/ml

0.03

134

909

Malignant neoplasm of endocrine gland, including Hilmo

592

1.53

3.66

1.4

1.3

286.68

257.61

u/ml

0.46

346

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

350

1.70

3.65

1.3

275.59

252.47

u/ml

0.26

204

Emotional disorders starting during childhood or adolescence

137

973

1.42

3.65

1.6

254.98

191.31

u/ml

1.73

534

Helminthiases, including avohilmo

467

1.61

3.64

1.4

1.5

234.25

229.00

u/ml

0.06

277

Pneumonitis due to solids and liquids

489

1.59

3.64

1.3

303.36

262.91

u/ml

0.48

285

Algoneurodystrophy

262

1.82

3.63

1.1

1.2

253.67

231.40

u/ml

0.28

158

Lifestyle-related condition

2.46

3.62

1.7

1.2

198.67

275.02

u/ml

0.70

Hypoparathyroidism

198

1.94

3.60

1.4

1.3

328.78

246.57

u/ml

0.93

105

Perineal laceration during delivery

174

1873

0.74

3.59

1.2

240.37

244.74

u/ml

0.08

120

1213

Striking against or struck by other objects

522

4406

1.19

3.58

1.3

1.4

242.31

251.12

u/ml

0.34

327

2746

Malignant neoplasm of eye and adnexa, including Hilmo

2.62

3.58

1.2

1.4

248.11

253.39

u/ml

—

Atypical facial pain

368

1.68

3.57

1.3

1.2

201.22

261.12

u/ml

1.76

221

Disorders of adrenal gland, other and/or unspecified

3.79

3.57

1.2

1.4

122.38

315.41

u/ml

—

Toxoplasmosis, including avohilmo

3.78

3.56

1.5

1.3

277.80

243.82

u/ml

—

COPD, early/later onset

391

2694

1.22

3.56

1.2

300.75

280.12

u/ml

0.60

240

1645

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

152

2.08

3.50

1.3

368.70

259.46

u/ml

0.54

Dislocation, sprain and strain of joints and ligaments at neck level

233

1816

1.29

3.49

1.2

1.3

217.95

251.34

u/ml

1.63

147

1151

Malignant neoplasm of adrenal gland

3.72

3.49

1.7

2.1

176.25

281.78

u/ml

—

Appendectomy

861

7200

1.14

3.49

1.3

249.78

258.57

u/ml

0.48

565

4680

L02BA Anti-estrogens

1150

0.65

3.49

1.1

1.2

262.61

281.90

u/ml

0.28

716

Schistosomiasis [bilharziasis], including avohilmo

4.35

3.48

1.4

1.5

359.00

188.00

u/ml

—

Enthesopathies of lower limb, excluding foot

271

2151

1.27

3.48

1.3

266.83

265.66

u/ml

0.02

177

1380

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

544

1.54

3.45

1.4

1.2

333.80

261.40

u/ml

0.63

339

Other and unspecified myopathies

584

1.52

3.45

1.3

311.23

267.97

u/ml

0.61

351

Other and unspecified bullous disorders

2.64

3.43

1.3

1.2

202.67

231.39

u/ml

—

Carcinoma in situ of skin of ear and external auricular canal

2.70

3.42

1.6

1.1

225.70

283.55

u/ml

—

Medicines for HER+ breast cancer

208

2502

0.77

3.42

1.1

1.2

271.72

283.73

u/ml

0.21

124

1560

Disorders of refraction and accommodation

434

3614

1.20

3.40

1.7

1.4

275.78

248.29

u/ml

0.82

264

2213

Osteomyelitis of vertebra

4.63

3.39

1.0

1.2

284.00

399.00

u/ml

—

Other bullous disorders

203

1.90

3.38

1.3

203.66

247.88

u/ml

0.53

116

Certain zoonotic bacterial diseases

134

2.13

3.38

1.1

1.3

322.36

268.30

u/ml

0.37

Radiculopathy

146

1069

1.37

3.37

1.2

1.3

250.92

285.75

u/ml

0.80

676

Left ventricular outflow tract obstruction, narrow definition

573

1.52

3.36

2.1

1.6

264.95

236.98

u/ml

0.37

311

Scabies

501

1.56

3.35

1.3

231.83

242.25

u/ml

0.12

295

Other meningitis

128

2.16

3.34

1.6

1.4

214.67

241.70

u/ml

0.30

Other superficial mycoses

226

1.85

3.33

1.6

1.3

265.31

218.97

u/ml

0.36

139

Traumatic subdural haemorrhage

108

702

1.45

3.33

1.3

270.65

268.07

u/ml

0.04

445

Cervicobrachial syndrome

246

1942

1.27

3.32

1.2

1.3

247.22

272.51

u/ml

0.97

169

1247

Assault

222

1733

1.29

3.32

1.3

239.00

242.87

u/ml

0.08

157

1108

Short stature, not elsewhere classified

498

1.56

3.31

3.0

1.8

233.49

165.43

u/ml

1.16

242

Endometriosis of pelvic peritoneum

200

1397

1.31

3.31

1.1

1.2

290.21

270.16

u/ml

0.30

124

917

Malignant neoplasm of endocrine gland

518

1.54

3.30

1.4

1.3

288.65

255.56

u/ml

0.46

307

Other and unspecified disease of Bartholin gland

149

2.04

3.28

1.2

282.85

249.83

u/ml

0.29

Other intracranial haemorrhages

149

2.04

3.27

1.0

1.2

238.74

306.14

u/ml

0.80

Injuries to the elbow and forearm

979

7460

1.13

3.27

1.3

247.93

255.85

u/ml

0.44

637

4684

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

192

1.92

3.26

1.5

1.4

237.60

193.95

u/ml

0.42

115

Status epilepticus

279

1.74

3.25

1.3

209.44

245.47

u/ml

0.42

157

Disorders of porphyrin and bilirubin metabolism

110

2.25

3.25

1.5

1.4

226.54

252.47

u/ml

0.19

Other enthesopathies

330

2699

1.23

3.24

1.3

272.87

269.83

u/ml

0.07

204

1750

Kela-code for severe mental illness

337

4093

0.82

3.24

1.2

1.3

266.35

257.15

u/ml

0.26

188

2665

Other female pelvic inflammatory diseases

164

1232

1.34

3.23

1.2

319.51

272.60

u/ml

0.64

101

780

Routine general health check-up of defined subpopulation

157

2.01

3.22

1.5

1.2

202.75

200.42

u/ml

0.03

Poisoning by medicine

318

2596

1.23

3.22

1.3

261.85

251.95

u/ml

0.25

203

1656

Ehlers-Danlos syndrome, including avohilmo

117

2.20

3.21

1.2

1.3

267.14

193.64

u/ml

0.56

Other disorders starting during childhood or adolescence

140

1021

1.38

3.21

2.3

1.7

178.03

191.31

u/ml

0.31

552

Seropositive rheumatoid arthritis, strict definition

145

1072

1.36

3.18

1.1

1.2

309.55

284.54

u/ml

0.45

659

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

2.39

3.17

1.3

1.1

200.85

313.34

u/ml

1.05

Dementia in Alzheimer disease

626

0.59

3.17

1.1

319.32

293.29

u/ml

0.22

355

Outcome of delivery

255

1240

1.27

3.16

1.2

1.3

205.52

261.97

u/ml

4.39

187

767

Peritonsillar abscess

289

2340

1.24

3.16

1.3

238.92

259.01

u/ml

0.73

198

1534

Postzoster neuralgia

2.45

3.16

1.3

1.1

416.33

300.93

u/ml

0.41

Other congenital malformations, including avohilmo

208

1621

1.29

3.16

1.5

1.4

232.40

240.25

u/ml

0.17

130

956

Other and unspecified erythematous conditions

230

1.81

3.15

1.8

1.2

253.55

262.58

u/ml

0.07

136

Abnormal blood-pressure reading, without diagnosis

366

1.63

3.14

1.6

1.3

285.97

245.86

u/ml

0.40

220

Malignant neoplasm of mesothelium and soft tissue

208

1.85

3.14

1.3

303.67

232.91

u/ml

0.68

114

Malignant neoplasm of tonsil, including Hilmo

2.33

3.13

1.1

1.2

271.69

259.76

u/ml

0.07

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

461

1.55

3.11

1.4

256.49

255.17

u/ml

0.01

275

Smoking dependency

108

764

1.43

3.11

1.3

299.88

265.73

u/ml

0.48

489

Later onset COPD, excluding more controls

114

615

1.42

3.11

1.2

275.71

279.00

u/ml

0.04

371

Other disorders of veins

403

3322

1.20

3.10

1.3

1.2

271.84

273.05

u/ml

0.03

258

2134

Medical abortion

768

3640

1.14

3.09

1.2

266.91

258.70

u/ml

0.32

508

2276

Pure hyperglyceridaemia

181

1.91

3.09

1.4

1.3

224.29

263.93

u/ml

0.50

106

Orchitis and epididymitis

109

773

1.42

3.09

1.5

1.3

288.96

244.18

u/ml

0.71

494

Cluster headache, wide,, including avohilmo

511

1.52

3.09

1.3

274.42

245.94

u/ml

0.19

324

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

2.32

3.08

1.4

1.3

200.31

226.23

u/ml

0.28

Benign neoplasm: Duodenum

146

2.02

3.07

1.2

295.33

299.86

u/ml

0.03

Cutaneous lupus erythematosus

153

1.99

3.07

1.3

269.15

216.93

u/ml

0.50

Toxoplasmosis

3.47

3.07

1.4

1.3

277.80

243.82

u/ml

—

Exposure to other and unspecified inanimate mechanical forces

117

842

1.40

3.07

1.4

1.3

226.75

247.21

u/ml

0.42

510

Other benign neoplasms of skin

379

3163

1.20

3.06

1.4

1.3

286.90

272.35

u/ml

0.43

228

1994

Any dementia, excluding more controls

147

1348

0.75

3.06

1.1

1.2

273.69

279.29

u/ml

0.08

777

Disorders of iron metabolism

133

2.08

3.05

1.3

1.2

221.83

269.35

u/ml

0.30

Vitamin D deficiency

182

1.91

3.05

1.2

1.4

221.38

234.84

u/ml

0.14

109

Seronegative juvenile rheumatoid arthritis

256

1.76

3.05

1.3

1.5

270.25

187.24

u/ml

0.75

140

Tularaemia

100

2.25

3.04

1.1

1.3

306.08

283.12

u/ml

0.11

Glaucoma

506

3671

1.17

3.03

1.4

1.2

281.35

282.00

u/ml

0.02

324

2264

525

1.53

3.03

3.0

2.0

186.48

159.02

u/ml

0.26

245

Mental and behavioural disorders due to tobacco

108

768

1.42

3.03

1.3

299.88

267.28

u/ml

0.45

490

Anankastic personality disorder

386

1.60

3.03

1.2

1.3

364.23

245.14

u/ml

1.52

249

Other disorders of bladder

107

759

1.42

3.03

1.5

1.2

255.83

264.35

u/ml

0.14

461

Trigeminal neuralgia

402

1.58

3.00

1.2

269.52

258.50

u/ml

0.13

240

Hereditary deficiency of other clotting factors

2.61

3.00

1.6

1.3

294.70

171.60

u/ml

—

Arthrosis

773

3719

1.14

2.99

1.2

1.3

265.05

268.78

u/ml

0.13

463

2449

Lung cancer and mesothelioma

117

713

1.40

2.99

1.2

279.90

278.29

u/ml

0.02

431

Use of rotigotine

2.60

2.99

1.3

1.2

348.55

293.78

u/ml

0.22

Bruxism

162

1.95

2.99

1.3

310.95

220.35

u/ml

1.01

102

Atrophic disorders of skin

171

1310

1.31

2.97

1.4

1.2

260.71

262.70

u/ml

0.03

792

Unspecified visual impairment (binocular)

121

2.11

2.96

1.4

1.6

215.92

271.94

u/ml

0.35

Other melanin hyperpigmentation

114

2.14

2.96

1.7

1.2

287.27

258.47

u/ml

0.16

Traumatic subarachnoid haemorrhage

205

1.82

2.96

1.2

206.08

265.97

u/ml

1.29

123

Impacted teeth

426

3094

1.19

2.94

1.5

1.3

206.91

223.37

u/ml

0.78

262

1900

Congenital obstruction of the pelviureteric junction

2.51

2.93

2.1

1.3

184.55

209.45

u/ml

0.15

Other predominantly sexually transmitted diseases, not elsewhere classified

256

2067

1.25

2.92

1.3

1.2

284.05

244.23

u/ml

1.50

173

1352

Other congenital malformations of skin

406

1.57

2.91

1.4

1.5

231.97

234.30

u/ml

0.02

241

Gastrojejunal ulcer

2.48

2.91

1.9

1.2

363.40

245.05

u/ml

—

Benign neoplasm of other and unspecified endocrine glands

141

1055

1.34

2.90

1.2

248.66

276.90

u/ml

0.53

653

Mixed disorders of conduct and emotions, excluding more controls

368

1.61

2.90

1.5

197.78

192.73

u/ml

0.08

223

Disorders of eyelid in diseases classified elsewhere

229

1.77

2.89

1.3

1.2

227.67

248.84

u/ml

0.24

127

Asthma and opportunity respiratory infection

259

1.72

2.88

1.5

1.2

258.00

271.80

u/ml

0.13

146

Pregnancy examination and test

256

1274

1.25

2.88

1.2

1.3

228.06

253.54

u/ml

0.98

176

778

Congenital varicose veins

2.68

2.87

1.0

1.6

157.60

168.68

u/ml

—

Malignant neoplasm of bladder, including Hilmo

472

1.51

2.85

1.3

1.2

269.39

280.48

u/ml

0.10

290

Ankylosing spondylitis

108

777

1.40

2.85

1.2

1.3

261.42

269.85

u/ml

0.11

497

Malignant neoplasm of oropharynx, including Hilmo

116

2.10

2.85

1.1

1.2

315.86

264.81

u/ml

0.33

Fall on and from stairs and steps

306

2524

1.22

2.84

1.2

1.3

260.91

263.39

u/ml

0.06

192

1580

Cluster headache, strict, including avohilmo

497

1.51

2.83

1.3

272.88

245.20

u/ml

0.18

314

Benign neoplasm of mouth and pharynx

111

803

1.39

2.83

1.3

1.2

302.13

271.63

u/ml

0.28

489

Cervical disc disorders

361

3025

1.20

2.82

1.2

1.3

268.33

273.47

u/ml

0.10

211

1965

Combined immunodeficiencies

2.52

2.82

1.4

1.3

323.20

198.09

u/ml

—

Disturbances of smell and taste

276

1.68

2.82

1.3

1.2

316.87

270.80

u/ml

0.18

159

Pediculosis, acariasis and other infestations

629

1.45

2.82

1.3

262.32

255.80

u/ml

0.06

379

Asthma/COPD (KELA code 203)

1303

7918

1.10

2.82

1.3

267.94

248.97

u/ml

1.45

828

5027

Speech disturbances, not elsewhere classified

562

1.47

2.82

1.3

1.2

263.42

262.30

u/ml

0.01

328

Polyarthrosis

161

1108

1.31

2.81

1.2

1.3

291.88

292.37

u/ml

0.01

690

Aneurysms, operations, SAH

145

1095

1.33

2.80

1.5

1.2

265.78

282.64

u/ml

0.31

676

Abscess of Bartholin gland

217

1.78

2.79

1.2

245.70

246.57

u/ml

0.01

138

Flat foot [pes planus] (acquired)

696

1.42

2.79

1.2

286.65

269.96

u/ml

0.26

434

Psoriatic arthropathies

107

772

1.39

2.78

1.2

317.35

279.32

u/ml

0.57

492

Rheumatic fever incl heart disease

152

1.93

2.76

1.7

1.2

224.90

284.30

u/ml

0.60

582

1.47

2.76

2.9

1.9

179.67

156.98

u/ml

0.23

273

All dysplastic lesions of the vagina

181

1.85

2.76

1.6

1.2

305.28

248.65

u/ml

0.53

115

Parkinson's disease, including avohilmo

839

0.64

2.75

1.1

1.2

282.34

292.80

u/ml

0.09

505

Type 1 diabetes, definitions combined

175

1359

1.29

2.74

1.6

1.5

235.74

226.97

u/ml

0.17

123

815

Monoarthritis, not elsewhere classified

286

1.66

2.74

1.2

1.3

223.64

239.92

u/ml

0.21

176

Glaucoma suspect

320

2659

1.21

2.74

1.4

1.2

270.00

282.58

u/ml

0.36

208

1659

Mixed and other personality disorders

114

835

1.38

2.73

1.2

313.83

255.90

u/ml

1.14

559

Other abnormal immunological findings in serum

182

1.85

2.73

1.3

1.4

251.00

208.84

u/ml

0.27

109

Tobacco use

485

1.50

2.73

1.2

1.3

266.45

270.80

u/ml

0.05

305

Scar conditions and fibrosis of skin

365

1.58

2.72

1.4

1.3

237.54

228.89

u/ml

0.06

212

Congenital malformations of aortic and mitral valves

478

1.51

2.72

2.1

1.5

264.99

242.60

u/ml

0.26

264

Preterm labour and delivery

281

2310

1.22

2.71

1.3

1.2

252.00

271.05

u/ml

0.43

185

1502

Other congenital malformations of peripheral vascular system

154

1.93

2.71

1.2

1.5

203.00

215.59

u/ml

0.14

Other other unspecified disorders of the circulatory system

234

1.73

2.70

1.5

1.3

279.24

273.96

u/ml

0.03

125

Benign neoplasm: Descending colon

429

1.53

2.70

1.3

1.2

302.74

285.67

u/ml

0.15

250

Conotruncal defects

252

1.73

2.68

2.4

2.0

210.39

179.50

u/ml

0.33

122

Carpal tunnel syndrome

661

5041

1.14

2.68

1.2

1.3

286.69

273.05

u/ml

0.47

382

3294

Human immunodeficiency virus [HIV] disease

176

1.86

2.68

1.1

1.2

325.53

242.61

u/ml

0.54

113

Malignant neoplasm of thyroid gland, including Hilmo

511

1.48

2.68

1.3

1.2

294.43

258.11

u/ml

0.53

308

Pneumonia due to Streptococcus pneumoniae

265

1.68

2.67

1.6

1.3

273.55

256.66

u/ml

0.11

162

Benign neoplasm: Skin of other and unspecified parts of face

702

1.40

2.67

1.3

1.2

286.78

276.70

u/ml

0.12

418

Moderate visual impairment, binocular

147

1.92

2.66

1.5

1.3

200.00

322.34

u/ml

1.96

Coxarthrosis

455

2510

1.17

2.66

1.2

1.3

284.56

281.48

u/ml

0.08

271

1620

Hyperaldosteronism

176

1.84

2.66

1.6

1.2

327.35

277.22

u/ml

0.27

All dysplastic lesions of the cervix uteri

343

2835

1.20

2.65

1.3

1.2

277.93

250.64

u/ml

1.20

243

1881

Inguinal hernia, bilateral

703

1.40

2.65

1.6

1.3

278.22

288.67

u/ml

0.13

442

Metatarsalgia

108

788

1.38

2.65

1.2

245.91

263.80

u/ml

0.26

487

Corneal scars and opacities

206

1.77

2.64

1.7

1.2

212.75

258.77

u/ml

0.61

119

Malignant neoplasm of tonsil and base of tongue, including Hilmo

141

1.94

2.62

1.1

1.2

280.88

268.86

u/ml

0.09

Salpingitis and oophoritis

161

1247

1.30

2.62

1.2

265.43

279.57

u/ml

0.26

102

793

Raynaud syndrome

108

790

1.38

2.62

1.1

1.2

257.13

262.59

u/ml

0.07

485

Whooping cough, including avohilmo

163

1.88

2.61

1.4

170.42

211.41

u/ml

0.80

Overexertion and strenuous or repetitive movements

124

928

1.35

2.60

1.3

215.40

257.76

u/ml

1.28

585

Acute inflammation of orbit

2.51

2.59

1.5

1.7

204.78

174.65

u/ml

—

Convalescence

314

1.61

2.59

1.5

1.2

214.03

248.17

u/ml

0.55

187

Malignant neoplasm of bone and articular cartilage, including Hilmo

114

2.05

2.58

1.5

1.4

242.57

238.95

u/ml

0.02

Monoamine oxidase A inhibitors

118

877

1.35

2.58

1.2

1.3

276.51

275.69

u/ml

0.01

570

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

2.48

2.57

1.6

1.3

258.60

183.93

u/ml

—

Crossbite

160

1145

1.30

2.57

2.4

1.6

165.07

202.47

u/ml

1.23

596

Human immunodeficiency virus [HIV] disease, including avohilmo

179

1.82

2.55

1.1

1.2

325.53

246.53

u/ml

0.51

114

Inguinal or femoral hernia, bilateral

717

1.39

2.55

1.6

1.3

278.22

291.25

u/ml

0.17

452

Gestational [pregnancy-induced] hypertension

320

2677

1.20

2.55

1.3

1.2

258.67

257.81

u/ml

0.02

212

1758

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

426

3660

1.17

2.54

1.2

1.3

249.75

252.57

u/ml

0.08

277

2374

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

172

1.83

2.53

1.3

218.74

241.22

u/ml

0.29

118

Third [oculomotor] nerve palsy

129

1.97

2.53

1.4

240.47

278.17

u/ml

0.31

Enteritis due to Yersinia enterocolitica

3.08

2.53

1.3

1.2

177.50

264.40

u/ml

—

Exposure to other and unspecified animate mechanical forces

365

1.56

2.52

1.4

1.5

252.83

233.01

u/ml

0.21

215

Gluteal tendinitis

301

1.61

2.51

1.3

1.2

380.45

303.71

u/ml

0.33

180

Toxic colitis

4.56

2.51

1.3

1.4

305.43

246.67

u/ml

—

Fibroblastic disorders

209

1683

1.25

2.48

1.3

1.2

245.96

272.72

u/ml

0.82

131

1072

Open wound of head

676

5632

1.13

2.48

1.3

272.19

255.59

u/ml

0.78

408

3529

Open bite

112

834

1.36

2.48

2.3

1.6

178.12

217.53

u/ml

0.99

472

Hypertrophic disorders of skin

562

1.44

2.48

1.4

1.3

222.27

228.23

u/ml

0.07

346

LSIL lesion of the cervix uteri, vagina or vulva

179

1418

1.27

2.47

1.3

1.2

300.06

264.40

u/ml

0.89

127

922

Contusion of ankle

472

1.48

2.47

1.3

160.21

239.43

u/ml

3.35

283

Anogenital herpesviral [herpes simplex] infection

100

731

1.38

2.47

1.3

1.2

252.19

234.51

u/ml

0.27

472

Abdominal aortic aneurysm (AAA)

386

1.52

2.47

1.3

1.2

326.22

271.75

u/ml

0.67

215

Astigmatism

107

790

1.37

2.46

1.8

1.5

264.31

225.10

u/ml

0.63

445

Internal derangement of knee

420

3576

1.17

2.46

1.2

1.3

260.62

265.01

u/ml

0.12

254

2339

Malignant neoplasm of testis, including Hilmo

174

1.82

2.45

1.2

249.15

251.99

u/ml

0.02

101

Mental and behavioural disorders due to opioids

440

1.50

2.45

1.3

267.95

224.74

u/ml

0.59

289

COPD, hospital admissions 1, only main diagnosis

271

1925

1.21

2.45

1.2

294.71

282.33

u/ml

0.24

163

1181

Other and unspecified nonscarring hair loss

2.35

2.45

1.2

1.3

362.82

217.26

u/ml

1.03

Schizoaffective disorder

790

0.65

2.45

1.3

1.2

308.62

248.47

u/ml

0.75

521

Other enthesopathy of foot (+metatarsalgia)

114

851

1.35

2.44

1.3

1.2

240.55

260.61

u/ml

0.31

523

Hypertrophy of (infrapatellar) fat pad

2.34

2.44

1.3

1.4

379.90

223.52

u/ml

—

Sleep disorders, other/unspecified

416

1.51

2.44

1.4

1.3

198.11

235.97

u/ml

0.97

261

Single spontaneous delivery

354

2207

0.84

2.44

1.2

1.3

237.48

262.66

u/ml

1.19

229

1308

CR(E)ST syndrome

2.21

2.43

1.4

1.3

255.00

233.61

u/ml

0.10

Other bursitis of elbow

2.41

2.42

1.3

1.1

526.00

268.50

u/ml

—

Endovascular or surgical operations to intracerebral aneurysms

368

1.53

2.41

1.6

1.2

247.05

273.37

u/ml

0.30

216

Sulfonylureas

236

1530

1.23

2.41

1.3

1.2

289.28

283.70

u/ml

0.10

135

940

Ascorbic acid deficiency

5.51

2.40

1.2

2.5

414.33

145.13

u/ml

—

Polyhydramnios

516

1.45

2.40

1.3

1.2

243.74

258.69

u/ml

0.23

344

Herpesviral keratitis and keratoconjunctivitis

297

1.60

2.40

1.5

1.2

257.19

250.20

u/ml

0.06

174

Endometriosis

394

1953

1.18

2.40

1.2

260.88

263.64

u/ml

0.06

243

1278

Other and unspecified nonorganic psychotic disorders

200

2469

0.81

2.39

1.3

270.71

244.36

u/ml

0.69

122

1596

Type 1 diabetes, strict (exclude DM2)

173

1369

1.27

2.39

1.6

1.5

236.11

225.60

u/ml

0.21

122

822

Ptosis of eyelid

726

1.37

2.38

1.2

294.43

270.64

u/ml

0.30

425

Causalgia

125

1.96

2.38

1.6

1.3

246.43

222.91

u/ml

0.23

Disorders of vestibular function (Vertigo)

450

3798

1.16

2.38

1.2

1.3

283.08

274.14

u/ml

0.21

276

2385

Other conjunctival vascular disorders and cysts

161

1.83

2.37

1.3

1.2

231.65

256.24

u/ml

0.26

D07AA Corticosteroids, weak (group I)

237

1944

1.22

2.37

1.3

1.4

243.92

239.23

u/ml

0.08

137

1180

Mental and behavioural disorders due to alcohol, excluding acute intoxication

530

4608

1.14

2.37

1.2

1.3

272.85

263.18

u/ml

0.37

346

2976

Gonarthrosis [arthrosis of knee](FG)

708

3621

1.13

2.37

1.3

267.61

273.08

u/ml

0.19

430

2356

Other crystal arthropathies

2.17

2.36

1.6

1.2

208.00

265.36

u/ml

0.56

Pain associated with micturition

130

995

1.31

2.36

1.4

1.3

244.17

267.75

u/ml

0.49

596

Dermatophytosis, including avohilmo

837

7391

1.11

2.35

1.3

246.81

257.85

u/ml

0.61

522

4730

Alcohol abuse, main dg, excluding more controls

186

1490

1.25

2.35

1.2

1.3

244.69

255.23

u/ml

0.24

119

943

Other and unspecified syphilis, including avohilmo

3.35

2.35

1.1

1.4

219.00

230.64

u/ml

—

Benign neoplasm: Small intestine

229

1.68

2.34

1.2

255.67

270.86

u/ml

0.13

122

Benign neoplasm of urinary organs

291

1.59

2.34

1.1

1.2

279.97

263.81

u/ml

0.18

163

Bulimia nervosa (incl. atypical)

404

1.50

2.34

1.3

1.2

217.05

235.15

u/ml

0.26

255

Congenital malformations of the respiratory system

192

1.75

2.34

2.1

2.0

276.26

188.30

u/ml

0.37

Benign neoplasm of meninges

636

1.39

2.32

1.2

318.81

290.53

u/ml

0.34

363

Congenital malformations of the respiratory system, including avohilmo

200

1.73

2.31

2.1

1.9

267.58

188.29

u/ml

0.34

100

Other and unspecified disorders of skin and subcutaneous tissue

429

1.48

2.31

1.3

1.2

230.56

251.91

u/ml

0.24

257

Parkinson's disease

804

0.67

2.30

1.1

1.2

282.34

291.56

u/ml

0.08

486

Haemorrhage in early pregnancy

313

2569

1.19

2.30

1.2

249.53

267.99

u/ml

0.70

199

1644

Malignant neoplasm of parotid gland

2.81

2.29

1.4

1.2

279.00

154.17

u/ml

—

Fasciculation

2.07

2.29

1.4

1.3

226.31

231.90

u/ml

0.04

Other and specified injuries of hip and thigh

163

1.80

2.29

1.3

301.11

260.89

u/ml

0.30

Injury of eye and orbit

199

1613

1.24

2.28

1.3

252.31

256.86

u/ml

0.10

124

1022

Macular pucker

118

896

1.32

2.27

1.2

271.44

283.24

u/ml

0.20

542

Allergic urticaria

113

854

1.33

2.27

1.3

233.49

246.13

u/ml

0.18

515

Schizophrenia, schizotypal and delusional disorders

312

3675

0.85

2.27

1.3

273.85

255.01

u/ml

0.58

185

2389

Other and unspecified vaccines and biological substances

2.41

2.26

1.6

1.4

360.45

268.53

u/ml

—

Assault by bodily force

128

987

1.31

2.24

1.2

1.3

236.92

240.11

u/ml

0.05

628

Otalgia

115

873

1.33

2.24

1.3

1.4

281.72

243.04

u/ml

0.36

502

Transient ischemic attack

435

3005

1.15

2.24

1.2

306.61

280.55

u/ml

0.74

278

1877

Acne conglobata

2.33

2.23

1.1

1.2

387.29

230.35

u/ml

—

Monoplegia

107

2.00

2.23

1.5

1.3

279.57

245.54

u/ml

0.17

Contact with and exposure to communicable diseases

509

4458

1.14

2.22

1.5

1.3

256.35

236.96

u/ml

0.93

329

2791

Defects in the complement system

2.31

2.22

1.9

1.7

174.90

239.00

u/ml

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

368

3164

1.17

2.22

1.3

251.02

263.44

u/ml

0.42

243

2029

Dronedarone medication

121

1.92

2.22

1.0

1.1

323.31

251.80

u/ml

0.50

Maltreatment syndromes

652

1.38

2.21

1.3

260.63

232.49

u/ml

0.50

415

Paralytic ileus

195

1.71

2.20

1.2

1.3

360.78

258.22

u/ml

0.55

110

Gonarthrosis

617

3089

1.13

2.20

1.2

1.3

270.77

274.02

u/ml

0.10

374

2031

Infective dermatitis

120

919

1.31

2.20

1.4

1.2

255.10

277.02

u/ml

0.36

581

Memory loss

492

1.43

2.18

1.1

1.2

275.53

278.93

u/ml

0.04

291

Granuloma annulare

101

2.01

2.18

1.3

1.4

268.50

244.04

u/ml

—

Other disorders of bone density and structure

219

1.67

2.18

1.2

1.3

186.50

232.86

u/ml

0.63

122

Unspecified urinary incontinence

568

1.40

2.17

1.2

1.3

241.77

262.69

u/ml

0.26

330

Other and unspecified abdominal hernia

242

1.63

2.17

1.5

1.2

269.97

263.87

u/ml

0.04

142

Carcinoma in situ of other and unspecified genital organs

108

1.97

2.17

1.4

1.2

324.31

269.46

u/ml

0.38

Symptoms and signs involving emotional state

322

1.54

2.16

1.5

1.4

214.70

239.93

u/ml

0.30

188

Endometriosis of ovary

181

1375

1.24

2.16

1.2

274.32

280.25

u/ml

0.07

114

891

Pneumothorax

477

1.44

2.16

1.4

1.2

323.56

260.38

u/ml

0.68

280

Chondrocostal junction syndrome [Tietze]

282

1.58

2.15

1.1

1.2

160.08

233.71

u/ml

1.35

166

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

100

750

1.34

2.14

1.3

282.29

235.54

u/ml

0.82

449

Abrasion of teeth

398

3453

1.16

2.14

1.2

1.3

277.28

272.01

u/ml

0.15

260

2215

Other and unspecified acute skin changes due to ultraviolet radiation

130

1.87

2.14

1.3

1.2

271.74

317.67

u/ml

0.40

Human immunodeficiency virus [HIV] disease resulting in other conditions

160

1.78

2.13

1.0

1.2

338.22

239.61

u/ml

0.64

101

Human immunodeficiency virus [HIV] disease resulting in other conditions, including avohilmo

160

1.78

2.13

1.0

1.2

338.22

239.61

u/ml

0.64

101

Glucosamine medication

248

2367

0.83

2.13

1.2

299.44

294.72

u/ml

0.08

138

1437

Crystal arthropathies, rheuma endpoint

2.07

2.12

1.6

1.1

208.00

303.49

u/ml

1.03

Fracture of forearm

690

5563

1.12

2.12

1.3

254.28

260.05

u/ml

0.24

459

3445

Peptic ulcer

2.49

2.12

1.3

1.1

573.80

277.03

u/ml

—

Arteriovenous malformation of peripheral vessels

2.64

2.11

1.4

1.6

266.67

233.67

u/ml

—

Alcohol use disorder, ICD-based

489

4308

1.14

2.10

1.2

1.3

271.28

262.80

u/ml

0.30

318

2789

Necrotizing fasciitis

2.79

2.10

1.5

1.2

186.40

312.96

u/ml

—

Other extrapyramidal and movement disorders in other diseases

242

2019

1.20

2.10

1.2

1.3

306.20

274.18

u/ml

0.58

145

1253

Suppurative and necrotic conditions of lower respiratory tract

381

1.48

2.09

1.5

1.3

329.46

279.75

u/ml

0.61

218

Other otitis externa (chronic)

556

1.40

2.09

1.4

1.2

213.02

261.32

u/ml

1.02

332

Olecranon bursitis

447

1.44

2.09

1.6

1.2

249.49

274.24

u/ml

0.28

292

Striae atrophicae

2.07

2.08

1.4

1.3

274.50

196.36

u/ml

0.71

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

333

2857

1.17

2.08

1.3

300.70

268.75

u/ml

1.07

183

1886

Glucagon-like peptide-1 (GLP-1) analogues

333

2857

1.17

2.08

1.3

300.70

268.75

u/ml

1.07

183

1886

Malignant neoplasm of pancreas

316

1.53

2.08

1.1

1.2

284.81

273.36

u/ml

0.09

184

Hypertrophic scar

523

1.41

2.08

1.4

1.3

224.90

222.40

u/ml

0.03

317

Hypopituitarism

111

849

1.32

2.08

1.7

1.4

232.80

238.28

u/ml

0.09

498

Sequelae of infectious and parasitic diseases, including avohilmo

531

1.40

2.08

1.4

1.2

308.62

273.80

u/ml

0.37

333

Tic and related disorders

207

1.68

2.08

1.3

1.6

321.20

188.18

u/ml

1.04

106

Hypertrophy of tongue papillae

2.01

2.08

1.4

1.3

188.30

260.72

u/ml

—

Atopic conjunctivitis

490

1.42

2.08

1.4

248.10

234.15

u/ml

0.20

283

Deficiency of other B group vitamins

110

1.93

2.07

1.4

1.2

268.36

257.19

u/ml

0.08

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

153

999

1.26

2.07

1.2

1.3

265.34

279.62

u/ml

0.27

603

Iridocyclitis in diseases classified elsewhere

169

1.74

2.07

1.2

1.3

207.48

234.42

u/ml

0.26

Congenital malformations of cardiac septa

122

917

1.30

2.06

1.8

1.7

266.05

216.53

u/ml

1.03

480

Meningitis

407

1.46

2.06

1.4

1.3

243.03

250.02

u/ml

0.08

248

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

238

1.62

2.06

1.2

186.16

243.12

u/ml

1.27

153

Injury of muscle and tendon at hip and thigh level

124

964

1.29

2.06

1.4

1.3

275.40

265.22

u/ml

0.14

598

Follicular cysts of skin and subcutaneous tissue

203

1670

1.22

2.05

1.3

288.53

262.78

u/ml

0.76

142

1048

Other congenital malformations of upper alimentary tract

2.29

2.05

2.9

1.4

222.56

256.69

u/ml

—

Burn and corrosion confined to eye and adnexa

232

0.42

2.03

1.4

1.2

155.80

246.67

u/ml

—

140

Benign neoplasm: Adrenal gland

525

1.40

2.03

1.2

297.12

279.60

u/ml

0.17

309

Sequelae of infectious and parasitic diseases

525

1.40

2.03

1.4

1.2

308.62

275.55

u/ml

0.35

327

Other/unspecified soft tissue disorders related to use, overuse and pressure

239

1.61

2.03

1.3

231.70

238.99

u/ml

0.07

145

Lichen simplex chronicus

239

1.61

2.03

1.7

1.2

289.23

250.90

u/ml

0.30

146

Primary ovarian failure

170

1.73

2.03

1.2

1.4

269.94

231.82

u/ml

0.25

117

Embolic stroke

192

1.68

2.03

1.1

1.2

297.71

311.69

u/ml

0.06

Congenital malformations of cardiac chambers and connections

127

1.90

2.02

2.3

2.1

264.83

155.25

u/ml

0.92

Suppurative otitis media, unspecified

271

1.57

2.02

1.4

1.3

351.04

229.97

u/ml

1.54

151

Anti-inflammatory and antirheumatic products, non-steroids

457

2010

1.15

2.02

1.3

1.5

229.89

254.02

u/ml

0.95

259

1277

Panniculitis affecting regions of neck and back

263

1.57

2.02

1.2

271.48

259.19

u/ml

0.08

157

malignant neoplasm of female genital organs, including Hilmo

117

861

1.30

2.01

1.1

1.2

272.08

282.04

u/ml

0.13

534

Complications of genitourinary prosthetic devices, implants and grafts

148

1.78

2.00

1.8

1.2

240.65

254.73

u/ml

0.10

Haemorrhagic and haematological disorders of fetus and newborn

475

1.43

2.00

2.3

2.1

163.04

164.38

u/ml

0.01

214

Tooth agenesis EXCLUDE clefts and syndromes

639

1.36

1.99

1.8

1.6

250.70

193.98

u/ml

0.84

329

Dislocation of lens

2.31

1.99

1.3

1.2

161.88

275.84

u/ml

—

Alzheimer’s disease (Late onset), excluding more controls

447

0.67

1.99

1.1

1.2

273.48

256.42

u/ml

0.14

273

Schizophrenia or delusion

315

3661

0.86

1.98

1.3

272.90

255.57

u/ml

0.52

186

2380

Poor fetal growth

184

1506

1.23

1.98

1.3

1.2

256.45

246.29

u/ml

0.22

132

1011

Erythema intertrigo

156

1.75

1.98

1.9

1.2

355.19

294.08

u/ml

0.33

Asthma mixed form (mode), excluding more controls

296

1.53

1.98

1.3

1.2

229.17

242.53

u/ml

0.17

179

Parkinson's disease, strict definition

730

0.68

1.98

1.1

1.2

287.98

296.90

u/ml

0.07

434

Malignant neoplasm of testis

164

1.74

1.98

1.2

249.15

257.71

u/ml

0.06

Other disorders of amino-acid metabolism

2.65

1.97

2.0

1.5

169.20

286.21

u/ml

—

Supervision of high-risk pregnancy

290

1479

1.18

1.97

1.2

1.3

241.86

263.98

u/ml

0.84

198

920

Lesion of ulnar nerve

147

1175

1.26

1.96

1.4

1.3

299.55

273.63

u/ml

0.52

748

Certain zoonotic bacterial diseases, including avohilmo

234

1.60

1.95

1.1

1.3

279.67

267.08

u/ml

0.09

139

Strabismus

346

2989

1.16

1.94

1.4

228.00

251.59

u/ml

1.08

215

1826

Radial styloid tenosynovitis [de Quervain]

488

1.40

1.94

1.4

1.2

307.33

259.48

u/ml

0.71

300

Paraplegia, diplegia of upper limbs

165

1.72

1.93

1.4

1.3

316.31

253.36

u/ml

0.42

Bitten or struck by other mammals

164

1331

1.24

1.92

1.2

1.3

237.23

250.41

u/ml

0.23

106

831

Contusion of toe(s) without damage to nail

291

1.53

1.92

1.5

1.4

221.14

240.00

u/ml

0.23

170

Benign neoplasm: Skin of lip

2.03

1.92

1.5

1.3

317.20

280.86

u/ml

—

Other and unspecified mononeuropathies, also in other diseases

188

1.67

1.92

1.7

1.2

266.17

274.32

u/ml

0.06

109

Diseases of inner ear

529

4508

1.12

1.91

1.2

1.3

281.67

273.81

u/ml

0.21

326

2842

Use of levodopa decarboxylase inhibitor

712

0.69

1.90

1.1

1.2

314.12

296.23

u/ml

0.15

426

Carcinoma in situ of cervix uteri

142

1136

1.26

1.90

1.4

1.2

296.64

257.69

u/ml

0.91

107

742

Malignant neoplasm of corpus uteri, including Hilmo

381

1.45

1.89

1.1

1.2

287.23

286.22

u/ml

0.01

224

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

114

889

1.29

1.89

1.2

1.3

294.29

230.51

u/ml

1.76

570

Open wound of forearm

121

950

1.28

1.89

1.3

1.2

247.58

251.67

u/ml

0.06

578

100

1.94

1.89

1.4

1.3

343.62

225.33

u/ml

0.56

Other congenital malformations of intestine

2.03

1.88

2.0

1.6

257.88

188.77

u/ml

—

Other specified and unspecified personality disorders

119

933

1.28

1.88

1.3

1.2

296.29

255.69

u/ml

0.77

599

Right ventricular outflow tract obstruction

168

1.73

1.88

3.0

2.0

175.37

165.03

u/ml

0.09

Personal history of medical treatment

2.02

1.87

1.4

1.2

257.60

231.32

u/ml

—

Brain meningioma

252

1.56

1.87

1.3

1.2

274.33

269.17

u/ml

0.04

137

Thiazolidinediones

688

1.33

1.87

1.4

1.2

292.00

287.66

u/ml

0.04

428

Malignant neoplasm of adrenal gland, including Hilmo

2.26

1.87

1.7

1.9

176.25

277.18

u/ml

—

Blindness, monocular

2.43

1.87

1.4

1.3

134.60

264.95

u/ml

—

Exposure to excessive heat of man-made origin

2.25

1.86

1.2

1.4

242.40

279.47

u/ml

—

Patellar tendinitis

198

1.64

1.86

1.4

1.3

275.50

226.44

u/ml

0.34

122

severe traumatic brain injury, does not include concussion

191

1579

1.21

1.86

1.2

1.3

268.87

276.09

u/ml

0.16

120

993

Disorder of external ear, unspecified

261

1.55

1.85

1.2

1.3

175.24

250.67

u/ml

1.34

158

Bronchitis, not specified as acute or chronic

646

1.34

1.85

1.4

1.2

228.04

256.86

u/ml

0.51

419

Papillary adenocarcinoma of thyroid gland

334

1.48

1.85

1.4

1.2

321.87

232.92

u/ml

1.17

208

Malignant neoplasm of thyroid gland

468

1.40

1.83

1.4

1.2

305.35

252.95

u/ml

0.72

285

Other injuries of upper limb, level unspecified

101

1.92

1.83

1.1

1.4

162.79

227.34

u/ml

0.79

Other demyelinating diseases of the central nervous system

344

1.47

1.82

1.1

1.3

310.88

247.06

u/ml

0.52

220

Benign neoplasm: Liver/bile ducts

207

1.61

1.81

1.3

211.00

256.82

u/ml

0.59

128

Biomechanical lesions, not elsewhere classified

336

1.47

1.80

1.2

251.38

266.85

u/ml

0.17

192

Pregnancy with abortive outcome

782

3704

1.10

1.80

1.2

261.56

257.44

u/ml

0.16

525

2306

Malignant neoplasm of parotid gland, including Hilmo

2.38

1.79

1.4

1.2

279.00

186.71

u/ml

—

Benign neoplasm: salivary glands, exclude unknown (D119)

581

1.35

1.79

1.2

344.67

278.17

u/ml

0.86

347

Benign neoplasm: Cerebral meninges

581

1.35

1.79

1.2

328.36

298.36

u/ml

0.32

335

Male infertility

522

1.37

1.79

1.5

1.3

272.68

229.28

u/ml

0.61

342

Enterobiasis

2.32

1.79

1.5

1.8

180.86

157.62

u/ml

—

Asthma mixed form (mode)

304

1.49

1.78

1.3

1.2

229.17

239.92

u/ml

0.13

184

Cushing syndrome

2.13

1.78

1.4

292.22

247.49

u/ml

—

Faecal incontinence

479

1.38

1.77

1.3

1.2

317.18

278.90

u/ml

0.22

279

Other papulosquamous disorders

1.97

1.77

1.4

1.2

366.10

245.91

u/ml

—

Arthropathic psoriasis

122

968

1.27

1.77

1.2

306.67

275.17

u/ml

0.49

594

Delivery

371

2234

0.87

1.77

1.2

1.3

228.25

261.31

u/ml

1.86

237

1319

Thyroiditis

583

1.35

1.76

1.3

1.2

304.87

263.97

u/ml

0.31

356

Other disorders of breast

149

1210

1.24

1.76

1.2

261.45

267.54

u/ml

0.11

756

Pilonidal cyst

125

996

1.26

1.76

1.4

1.3

256.20

245.12

u/ml

0.16

643

Benign neoplasm: Skin of trunk

330

1.47

1.75

1.6

1.3

288.65

255.98

u/ml

0.30

200

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

2.25

1.75

1.1

304.57

351.68

u/ml

—

Embedded teeth, including avohilmo

167

1375

1.22

1.75

1.5

1.3

246.84

231.42

u/ml

0.23

833

Malignant neoplasm of eye, brain and central nervous system

322

1.47

1.75

1.3

1.4

242.85

243.40

u/ml

0.00

192

Endometriosis ASRM stages 1,2

205

1720

1.20

1.74

1.1

1.2

288.57

264.18

u/ml

0.40

127

1113

Viral conjunctivitis

186

1.63

1.74

1.6

1.3

172.87

247.88

u/ml

1.22

112

Other congenital malformations of heart

111

1.87

1.74

2.4

2.1

195.33

169.45

u/ml

0.15

Tinnitus

239

2033

1.18

1.73

1.2

1.3

295.73

274.63

u/ml

0.33

147

1306

Cerebral palsy and other paralytic syndromes

122

971

1.26

1.73

1.5

1.3

252.15

258.75

u/ml

0.10

579

Disorders of globe

140

1.73

1.4

1.2

194.75

271.26

u/ml

0.84

Congenital malformations of the musculoskeletal system, not elsewhere classified

164

1.68

1.71

1.6

1.4

215.06

183.31

u/ml

0.29

Congenital ovarian cysts

416

1.41

1.70

1.3

1.2

261.17

251.04

u/ml

0.10

276

Contact with blunt object, undetermined intent

2.24

1.70

1.2

262.14

192.03

u/ml

—

Prepatellar bursitis

349

1.44

1.70

1.3

1.2

266.54

252.19

u/ml

0.10

227

Adenocarcinoma and ductal carcinoma of pancreas

156

1.68

1.69

1.1

1.2

284.79

258.07

u/ml

0.19

Benign neoplasm: Kidney

219

1.57

1.69

1.1

1.2

265.10

271.74

u/ml

0.05

123

Brain meningioma, including Hilmo

259

1.52

1.68

1.3

1.2

274.33

270.79

u/ml

0.03

143

Distal bite

680

1.32

1.68

2.8

1.6

195.05

188.29

u/ml

0.06

342

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

192

1599

1.20

1.68

1.4

1.5

239.20

226.63

u/ml

0.25

120

928

Benign neoplasm: Liver

180

1.63

1.68

1.3

215.54

252.68

u/ml

0.36

108

Other sexually transmitted chlamydial diseases, including avohilmo

195

1637

1.20

1.68

1.2

1.3

210.66

224.25

u/ml

0.36

136

1038

Scarlet fever

2.09

1.68

2.2

1.4

243.13

201.47

u/ml

—

Artificial joint operation, meniscal resection

834

5805

0.92

1.68

1.3

267.91

271.60

u/ml

0.12

513

3741

Paralytic strabismus

468

1.38

1.67

1.3

240.76

266.24

u/ml

0.35

274

HSIL lesion of the cervix uteri, vagina or vulva

252

2161

1.17

1.67

1.3

1.2

279.41

263.88

u/ml

0.45

183

1418

Urticaria due to cold and heat

2.02

1.67

1.0

1.3

275.49

213.17

u/ml

—

Periodontal disease, other/unspecified

212

1.57

1.66

1.3

1.2

357.10

265.90

u/ml

0.63

122

Other specified and unspecified disorders of conjunctiva

2.01

1.66

1.4

1.3

258.00

222.35

u/ml

—

Carbimazole or st.post thyroidectomy, condition for graves disease

222

1885

1.18

1.66

1.3

1.2

267.39

274.10

u/ml

0.15

153

1178

Pediculosis, acariasis and other infestations, including avohilmo

268

2311

1.16

1.66

1.3

1.4

242.96

239.70

u/ml

0.07

168

1415

Gonarthrosis,primary

737

4862

0.91

1.66

1.3

275.01

279.24

u/ml

0.14

440

3130

Deep bite

208

1542

1.19

1.65

2.0

1.5

229.69

218.76

u/ml

0.19

101

849

Impingement syndrome of shoulder

220

1867

1.18

1.65

1.2

1.3

248.13

275.16

u/ml

0.88

120

1179

Inguinal hernia

688

4160

1.10

1.65

1.5

1.3

261.15

254.59

u/ml

0.26

456

2626

Benign neoplasm: Parotid gland

521

1.35

1.64

1.3

1.2

294.90

273.29

u/ml

0.25

313

Ankylosing spondylitis, ICD10

103

810

1.28

1.63

1.2

268.10

262.08

u/ml

0.08

518

Endocrine disorders, other/unspecified

143

1.70

1.63

1.6

1.2

284.60

243.39

u/ml

0.30

Superficial injury of thorax

165

1368

1.21

1.62

1.4

1.3

292.83

262.99

u/ml

0.62

110

858

Other hearing loss

221

1820

1.18

1.61

1.3

258.93

277.97

u/ml

0.53

129

1137

Other/unspecified disorders of vestibular function

262

1.50

1.61

1.2

224.08

257.07

u/ml

0.36

150

Melanoma in situ of other and unspecified parts of face

2.09

1.61

1.4

1.1

246.25

320.67

u/ml

—

Other specified congenital malformation syndromes affecting multiple systems

280

1.49

1.60

2.1

1.9

262.24

184.44

u/ml

0.69

144

Follow-up care involving plastic surgery

206

1.56

1.60

1.2

1.1

197.50

257.09

u/ml

0.49

121

Hypermetropia

107

848

1.27

1.59

2.1

1.5

242.73

230.20

u/ml

0.18

469

Other and unspecified glaucoma

345

1.43

1.59

1.5

1.2

294.95

296.21

u/ml

0.01

197

Fracture of skull and facial bones

264

2283

1.16

1.58

1.3

243.09

259.78

u/ml

0.40

169

1445

Malignant neoplasm of breast, ER-positive, including Hilmo

176

1562

0.84

1.56

1.1

1.2

276.93

283.84

u/ml

0.10

103

1003

Congenital malformations of ovaries, fallopian tubes and broad ligaments

535

1.34

1.56

1.2

261.08

257.07

u/ml

0.04

354

Use of selegiline

234

0.51

1.56

1.3

1.2

225.67

273.24

u/ml

—

125

Malignant neoplasm of corpus uteri

330

1.43

1.56

1.1

1.2

268.69

277.66

u/ml

0.07

192

Mental disorders, not otherwise specified

118

950

1.25

1.56

1.3

280.11

247.12

u/ml

0.76

609

Chronic Coagulation defects

208

1.56

1.6

1.3

231.35

243.78

u/ml

0.11

125

Lactose intolerance

273

1.48

1.55

1.3

238.42

235.75

u/ml

0.03

158

Renal cell carcinoma of kidney

122

1.73

1.55

1.4

1.2

249.33

241.65

u/ml

0.04

Left bundle-branch block

381

1.40

1.55

1.2

253.83

267.50

u/ml

0.16

230

Perforation of tympanic membrane

109

870

1.26

1.54

1.6

1.3

275.04

256.46

u/ml

0.26

512

Other localized connective tissue disorders

130

1.71

1.54

1.4

1.3

301.47

221.78

u/ml

0.49

Other diseases of peritoneum

265

1.48

1.54

1.3

1.2

261.70

257.87

u/ml

0.03

150

Bullous pemphigoid

100

1.82

1.54

1.2

214.77

295.79

u/ml

0.62

Exclusion endpoint for clefts

324

1.44

1.53

2.0

1.8

241.75

201.04

u/ml

0.33

165

Malignant neoplasm of breast, HER-positive

176

1560

0.84

1.53

1.1

1.2

276.93

283.84

u/ml

0.10

103

1003

Other chronic obstructive pulmonary disease, including avohilmo

464

3418

1.12

1.53

1.2

1.3

291.31

278.13

u/ml

0.40

292

2118

Other superficial mycoses, including avohilmo

155

1287

1.21

1.52

1.3

229.66

243.45

u/ml

0.24

810

Disorder of pancreatic internal secretion, other and/or unspecified

2.20

1.52

1.9

1.5

324.00

249.76

u/ml

—

Burns and corrosions confined to eye and internal organs

270

0.55

1.52

1.6

1.2

181.25

236.68

u/ml

—

161

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

451

1.36

1.52

1.4

1.2

325.62

269.89

u/ml

0.61

288

Bicuspidal aortic valve syndrome

375

1.40

1.52

1.4

279.17

258.26

u/ml

0.21

222

Unspecified chronic bronchitis

185

1.58

1.52

1.5

1.2

273.33

265.95

u/ml

0.05

104

Other and unspecified injuries of lower leg

106

846

1.26

1.51

1.4

1.3

263.17

239.73

u/ml

0.34

516

Assault by other specified means

116

1.76

1.51

1.3

258.00

230.69

u/ml

0.17

Amoebiasis, including avohilmo

1.99

1.51

1.3

1.4

163.43

218.72

u/ml

—

Brachial plexus disorders

110

882

1.25

1.51

1.2

1.3

286.90

263.05

u/ml

0.46

563

Tic disorders

227

1.53

1.50

1.3

1.6

321.20

182.69

u/ml

1.11

129

Other disorders of the musculoskeletal system and connective tissue

138

1134

1.22

1.50

1.2

287.48

280.69

u/ml

0.06

705

Guillain-Barre syndrome

116

1.75

1.50

1.4

1.3

245.64

273.55

u/ml

0.21

Personal history of certain other diseases

186

1.58

1.50

1.4

1.2

346.63

214.77

u/ml

0.76

109

Family history of malignant neoplasm

114

918

1.25

1.50

1.1

257.99

262.25

u/ml

0.06

570

Premature rupture of membranes

233

1924

0.86

1.50

1.2

261.05

250.21

u/ml

0.15

144

1254

Benign neoplasm: Tongue

178

1.59

1.50

1.4

1.2

442.19

281.31

u/ml

0.56

Diffuse brain injury

267

1.47

1.49

1.2

1.3

293.83

255.02

u/ml

0.35

173

Other acute skin changes due to ultraviolet radiation

210

1.54

1.49

1.3

275.33

277.12

u/ml

0.01

118

Pemphigoid

139

1.67

1.49

1.2

1.3

293.88

309.81

u/ml

0.06

Alopecia areata

243

1.50

1.48

1.3

1.4

290.65

218.46

u/ml

0.73

143

Benign neoplasm of major salivary glands

644

1.29

1.48

1.3

1.2

334.14

278.19

u/ml

0.75

385

Other and unspecified trigeminal disorders

109

1.77

1.48

1.2

241.09

250.99

u/ml

0.06

Polycystic ovarian syndrome

752

1.27

1.47

1.2

228.34

238.89

u/ml

0.18

497

Sudden idiopathic hearing loss

698

1.28

1.47

1.3

1.2

246.29

280.64

u/ml

0.61

442

Other blood glucose lowering drugs, excl. Insulins

118

957

1.24

1.46

1.3

1.2

269.61

283.93

u/ml

0.22

589

Other abnormal findings in urine

102

1.79

1.46

1.4

1.2

273.92

290.17

u/ml

0.08

Congenital stenosis of pulmonary valve

103

1.80

1.45

2.8

2.0

204.92

147.58

u/ml

0.47

Other noninflammatory disorders of vagina

638

1.29

1.45

1.4

1.2

229.55

280.35

u/ml

1.13

404

Early lumbar disc prolapse operation

101

1257

0.80

1.44

1.3

234.54

252.89

u/ml

0.27

850

Injury of muscle and tendon at lower leg level

169

1423

1.19

1.44

1.3

264.59

265.04

u/ml

0.01

114

894

Female infertility

354

1878

1.13

1.44

1.2

251.74

258.79

u/ml

0.15

226

1242

Perichondritis of external ear

1.81

1.44

1.2

171.78

285.75

u/ml

—

Fracture at wrist and hand level

467

4203

1.11

1.44

1.3

235.42

257.11

u/ml

1.03

290

2668

Restless leg syndrome

142

1177

1.21

1.43

1.2

309.81

271.72

u/ml

0.44

725

Unspecified human immunodeficiency virus [HIV] disease, including avohilmo

103

1.78

1.43

1.1

1.3

217.22

226.11

u/ml

—

Scabies, including avohilmo

240

2081

1.16

1.43

1.3

1.4

232.27

237.87

u/ml

0.13

145

1271

Alcohol abuse counselling and surveillance

149

1.63

1.43

1.2

1.3

226.70

266.05

u/ml

—

Other and unspecified nerve root and plexus disorders, also in other diseases

221

1904

1.16

1.43

1.2

1.3

257.23

273.65

u/ml

0.27

149

1217

Precocious puberty

104

1.80

1.42

1.7

1.6

199.27

183.05

u/ml

0.15

Tularaemia, including avohilmo

157

1.61

1.42

1.1

1.3

276.00

263.98

u/ml

0.06

Rheumatic valve diseases

103

1.76

1.41

1.6

1.2

203.42

266.72

u/ml

0.45

Unspecified human immunodeficiency virus [HIV] disease

1.81

1.41

1.1

1.3

219.38

227.61

u/ml

—

Oral lichen planus

165

1.59

1.41

1.5

1.2

337.50

261.69

u/ml

0.65

Intussusception

126

1.68

1.41

1.2

1.4

170.62

214.08

u/ml

0.49

Macular cyst

173

1.57

1.41

1.2

268.13

276.62

u/ml

0.05

Urethral stricture

363

1.39

1.41

1.4

1.2

287.31

252.34

u/ml

0.45

208

Sequelae of other and unspecified infectious and parasitic diseases

449

1.35

1.41

1.4

1.2

325.62

270.60

u/ml

0.60

287

Other congenital malformations of skin, including avohilmo

108

873

1.24

1.40

1.3

1.4

218.40

245.41

u/ml

0.62

528

Infections of genitourinary tract in pregnancy

105

846

1.25

1.40

1.2

219.66

267.33

u/ml

1.26

533

Golimumab

347

1.40

1.2

1.3

273.36

235.23

u/ml

0.23

215

Acetic acid derivatives and related substances

364

1670

1.13

1.39

1.1

1.4

256.56

265.21

u/ml

0.22

229

1135

Dermatitis herpetiformis

119

1.70

1.39

1.3

204.35

262.48

u/ml

0.50

Other and unspecified syphilis

2.69

1.38

1.2

1.4

172.33

192.60

u/ml

—

Other misadventures during surgical and medical care

182

1.55

1.38

1.3

234.25

257.71

u/ml

0.17

108

Alzheimer disease, excluding more controls

596

0.77

1.38

1.1

1.2

253.83

264.51

u/ml

0.13

375

Blepharochalasis

219

1891

1.16

1.38

1.2

284.80

288.58

u/ml

0.07

141

1143

Spirochaetal infections, other/unspecified

705

1.27

1.38

1.1

1.3

269.98

273.32

u/ml

0.03

419

Superficial injury of neck

215

1.51

1.37

1.2

1.4

235.32

231.30

u/ml

0.03

128

Benign intracranial hypertension

120

1.70

1.36

1.7

1.4

176.43

200.52

u/ml

0.22

Social disorders starting during childhood or adolecense, excluding more controls

136

1.66

1.36

1.3

1.5

197.00

204.63

u/ml

0.07

Seminoma of testis

1.91

1.36

1.4

1.2

256.13

297.46

u/ml

—

Use of rivastigmine

652

0.73

1.36

1.1

279.00

300.33

u/ml

0.18

361

Lateral epicondylitis

137

1139

1.21

1.36

1.2

1.3

287.60

271.59

u/ml

0.28

729

Toxic effect of alcohol

175

1.56

1.36

1.4

1.3

344.05

269.85

u/ml

0.67

106

Neonatal jaundice from other and unspecified causes

382

1.38

1.36

2.5

2.2

130.41

165.15

u/ml

0.56

164

Alcohol-induced acute pancreatitis

290

1.43

1.35

1.5

1.2

305.04

291.20

u/ml

0.10

173

Other and unspecified injuries of ankle and foot

505

1.32

1.35

1.3

192.18

237.03

u/ml

0.92

301

Dissection of aorta

167

1.57

1.35

1.1

1.2

328.57

265.53

u/ml

0.32

Exposure to other and unspecified forces of nature

2.08

1.35

1.3

1.2

141.17

203.50

u/ml

—

Propionic acid derivatives

444

2010

1.11

1.35

1.3

1.5

234.30

254.02

u/ml

0.72

250

1277

Lesion of lateral popliteal nerve

375

1.37

1.35

1.5

1.2

316.42

270.09

u/ml

0.54

230

Psychotic depression

505

1.31

1.34

1.3

247.64

259.23

u/ml

0.12

316

Congenital malformations of pulmonary and tricuspid valves

145

1.64

1.34

3.0

2.0

165.53

157.92

u/ml

0.06

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

1.99

1.34

1.4

1.5

289.43

201.52

u/ml

—

Dislocation, sprain and strain of joints and ligaments of head

471

1.33

1.5

1.4

190.70

244.58

u/ml

1.32

283

Exclusions for E4_PCOS_CONSORTIUM

946

5503

1.07

1.33

1.3

253.83

257.05

u/ml

0.14

606

3493

Ehlers-Danlos syndrome

1.77

1.33

1.3

240.36

202.16

u/ml

0.23

Other intervertebral disc disorders

949

5273

1.07

1.32

1.2

1.3

271.81

260.10

u/ml

0.55

624

3439

Malignant neoplasm of brain, including Hilmo

351

1.38

1.31

1.4

251.22

241.97

u/ml

0.06

203

Conductive hearing loss, unspecified

719

1.26

1.31

1.6

1.3

249.03

259.54

u/ml

0.13

434

Felty syndrome

2.54

1.31

1.5

1.2

186.00

283.25

u/ml

—

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

106

1.73

1.31

1.1

1.3

385.58

203.52

u/ml

—

Personal history of risk-factors, not elsewhere classified

145

1.61

1.31

1.8

1.2

243.00

215.47

u/ml

0.19

Testicular hypofunction

369

1.37

1.31

1.4

1.3

274.27

258.02

u/ml

0.16

233

Cramp and spasm

421

1.34

1.30

1.3

230.78

249.44

u/ml

0.22

253

Otorrhagia

1.98

1.29

2.6

1.6

176.50

265.24

u/ml

—

Crowding of teeth, including avohilmo

208

1490

1.16

1.29

2.2

1.5

186.21

202.57

u/ml

0.45

109

826

Tongue abnormality

421

1.34

1.29

1.6

1.3

243.76

274.57

u/ml

0.35

235

therapeutic use

161

1.56

1.29

1.4

1.2

266.89

275.92

u/ml

0.05

Disorders of brain, other and unspecified

1.97

1.29

1.4

1.2

368.75

246.91

u/ml

0.71

Protein-energy malnutrition of moderate and mild degree

1.82

1.29

2.7

2.0

349.40

217.05

u/ml

—

Female infertility, cervical, vaginal, other or unspecified origin

320

1817

1.13

1.29

1.2

254.51

260.54

u/ml

0.12

208

1204

Synovial cyst of popliteal space [Baker]

482

1.31

1.29

1.1

1.2

380.23

288.43

u/ml

1.06

296

Simple and mucopurulent chronic bronchitis

251

1.44

1.29

1.6

1.5

332.44

231.10

u/ml

0.99

135

Malignant neoplasm of colon, including Hilmo

109

887

1.23

1.29

1.2

276.36

274.61

u/ml

0.02

542

Other ill-defined and unspecified causes of mortality

482

1.31

1.28

1.5

1.2

304.49

291.08

u/ml

0.12

278

Parkinson's disease, excluding more controls

658

0.75

1.28

1.1

1.3

282.34

263.88

u/ml

0.17

410

Pyothorax

285

1.41

1.28

1.5

1.2

327.57

281.04

u/ml

0.39

161

Leisure time condition

215

1868

1.15

1.28

1.5

1.3

260.05

252.92

u/ml

0.14

134

1164

Muscle strain

311

1.39

1.27

1.2

1.3

321.89

249.81

u/ml

0.66

199

Post-traumatic wound infection, not elsewhere classified

244

1.45

1.27

1.4

1.3

304.83

249.47

u/ml

0.63

148

Other specified/unspecified deforming dorsopathies

115

1.67

1.26

1.3

1.2

263.09

302.38

u/ml

0.35

Malignant neoplasm of stomach

219

1.47

1.25

1.1

1.2

325.65

260.89

u/ml

0.49

126

Other retinal artery occlusion

115

1.67

1.25

1.3

1.2

364.15

288.39

u/ml

0.37

Labour and delivery complicated by fetal stress [distress]

287

2104

0.88

1.24

1.2

231.11

247.90

u/ml

0.65

197

1387

Reiter disease

2.09

1.24

1.2

483.60

236.57

u/ml

—

Birth trauma

101

1.74

1.23

2.3

1.9

183.00

169.64

u/ml

—

Acute epiglottitis

108

1.69

1.23

1.4

1.2

319.27

276.19

u/ml

0.24

Other abnormal products of conception

428

2543

1.11

1.23

1.2

235.00

256.78

u/ml

1.13

308

1653

Presbycusis

575

1.27

1.23

1.2

1.1

271.53

293.57

u/ml

0.27

347

Acute alcohol intoxication

291

2588

1.13

1.22

1.3

279.11

255.36

u/ml

0.86

190

1644

Melanocytic naevi of scalp and neck

221

1.46

1.22

1.3

249.57

244.00

u/ml

0.03

125

Dislocation, sprain and strain of joints and ligaments of thorax

305

1.39

1.22

1.1

1.2

221.03

226.42

u/ml

0.06

183

Spinal stenosis

419

2795

1.11

1.22

1.2

1.3

275.33

278.09

u/ml

0.07

247

1774

Other and unspecified injuries of head

628

1.26

1.22

1.3

246.52

262.57

u/ml

0.19

362

Benign neoplasm: Skin, unspecified

288

1.40

1.22

1.6

1.2

297.50

259.73

u/ml

0.28

169

Car occupant injured in noncollision transport accident

374

1.35

1.22

1.2

289.66

248.24

u/ml

0.38

228

Thyrotoxicosis with diffuse goitre

145

1227

1.19

1.22

1.2

1.3

255.47

274.44

u/ml

0.44

767

Examination and encounter for administrative purposes

469

1.31

1.21

1.4

1.3

243.16

269.57

u/ml

0.25

305

Congenital deformities of hip, including avohilmo

297

1.40

1.21

1.5

1.8

250.32

187.09

u/ml

0.60

152

124

1.63

1.21

1.1

1.2

403.60

314.37

u/ml

—

Other bursopathies

116

962

1.21

1.3

1.2

324.27

272.59

u/ml

0.86

607

Idiopathic urticaria

205

1.48

1.21

1.5

1.2

221.30

232.53

u/ml

0.09

123

Additional codes for the location of defect, injury or illness

505

1.29

1.21

1.2

1.3

236.91

254.63

u/ml

0.27

301

Medical treatment for female infertility

272

2389

1.13

1.21

1.2

226.94

253.48

u/ml

1.22

183

1613

Viral conjunctivitis, including avohilmo

357

1.35

1.21

1.7

1.3

188.44

245.08

u/ml

1.18

208

Congenital deformities of hip

272

1.42

1.21

1.5

1.8

248.27

188.97

u/ml

0.52

134

Other injuries of lower limb, level unspecified

1.77

1.20

1.3

236.86

250.02

u/ml

—

Other abnormal auditory perceptions

1.77

1.20

1.3

257.72

228.13

u/ml

—

Other secondary coxarthrosis

230

1.45

1.20

1.2

302.70

265.87

u/ml

0.32

129

Hyperfunction of pituitary gland

471

1.30

1.19

1.4

1.3

276.94

243.66

u/ml

0.39

288

Endometriosis ASRM stages 3,4

226

1982

1.14

1.19

1.2

276.43

271.74

u/ml

0.06

141

1280

Hereditary retinal dystrophy

117

1.65

1.19

1.3

1.4

219.58

250.97

u/ml

0.18

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

648

1.26

1.19

1.2

274.49

278.46

u/ml

0.04

386

Other diseases of spinal cord

231

1.44

1.18

1.7

1.3

269.46

247.03

u/ml

0.21

132

Chondropathies

187

1621

1.16

1.17

1.3

261.42

251.96

u/ml

0.13

108

1016

Macular hole

290

1.39

1.17

1.3

1.1

315.74

299.70

u/ml

0.15

164

Embolic stroke with flimmer

1.71

1.17

1.1

262.50

327.48

u/ml

—

Other and unspecified primary disorders of muscles

1.85

1.17

1.7

1.5

100.71

268.05

u/ml

—

Varicose veins of other sites

552

1.27

1.17

1.3

282.56

248.10

u/ml

0.43

336

Gonarthrosis, primary, with knee surgery

400

3428

0.91

1.16

1.2

1.3

305.83

286.07

u/ml

0.53

221

2157

Parapsoriasis

158

1.54

1.16

1.5

1.3

229.62

238.24

u/ml

0.07

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

369

1.34

1.15

1.2

1.3

301.81

240.03

u/ml

0.68

224

Other noninflammatory disorders of uterus, except cervix

168

961

1.17

1.15

1.1

1.2

315.74

288.87

u/ml

0.28

608

Procedures for purposes other than remedying health state

126

1.60

1.15

1.3

1.1

162.41

230.99

u/ml

1.22

Gilbert syndrome

1.79

1.15

1.3

1.4

225.25

194.28

u/ml

—

Tic and related disorders

242

1.43

1.14

1.3

1.8

321.20

192.64

u/ml

1.00

135

Complications following myocardial infarction

0.00

1.14

0.0

1.1

—

374.75

—

Other congenital malformations of intestine, including avohilmo

103

1.68

1.14

2.0

1.5

257.88

216.43

u/ml

—

336

1.36

1.14

1.6

1.4

204.34

182.76

u/ml

0.23

178

Other strabismus

290

2583

1.12

1.14

1.4

224.78

250.78

u/ml

1.10

176

1586

Contusion of other and unspecified parts of foot

671

1.25

1.14

1.4

215.02

242.33

u/ml

0.58

395

Other and unspecified paralytic syndromes

103

1.67

1.14

1.6

1.3

337.40

243.99

u/ml

—

Postpartum hemorraghe, all women as controls

279

3045

0.89

1.14

1.2

246.29

251.02

u/ml

0.09

177

2033

Benign neoplasm: Conjunctiva

233

1.43

1.13

1.2

305.92

268.09

u/ml

0.35

131

Malignant neoplasm of breast

259

1882

0.89

1.13

1.1

1.2

271.71

279.16

u/ml

0.14

156

1225

Benign neoplasm: Parathyroid gland

1.92

1.13

1.5

1.1

301.17

265.93

u/ml

—

Plantar fascial fibromatosis

752

1.23

1.13

1.3

1.2

252.10

273.04

u/ml

0.36

473

Malignant neoplasm of breast, ER-negative, including Hilmo

141

1121

1.18

1.13

1.1

1.2

276.42

285.94

u/ml

0.15

704

Complications following abortion and ectopic and molar pregnancy

200

1.46

1.12

1.2

233.76

290.22

u/ml

0.76

111

Septal defects

107

871

1.21

1.12

1.7

282.53

210.68

u/ml

1.51

458

Malignant neoplasm of breast, HER2-negative

259

1881

0.89

1.12

1.1

1.2

271.71

279.16

u/ml

0.14

156

1225

Benign neoplasm: Skin of scalp and neck

201

1.46

1.10

1.8

1.4

259.25

244.78

u/ml

0.11

115

Malignant neoplasm of breast, HER-negative

127

1030

1.19

1.10

1.1

1.2

278.45

285.44

u/ml

0.10

635

Respiratory tuberculosis, confirmed, including avohilmo

104

1.65

1.10

1.3

1.2

338.90

274.35

u/ml

—

Overjet

485

1.29

1.10

3.0

1.8

133.18

184.23

u/ml

0.94

245

Right bundle-branch block

193

1.46

1.09

1.5

1.2

444.93

246.95

u/ml

1.39

110

Later onset COPD

121

1151

0.84

1.09

1.2

275.78

284.73

u/ml

0.13

671

Malignant neoplasm of brain

269

1.39

1.09

1.3

1.4

249.48

248.87

u/ml

0.00

158

Burns classified according to extent of body surface involved

1.71

1.09

1.3

1.4

262.30

252.07

u/ml

—

Malignant neoplasm of bladder

243

1.40

1.09

1.3

1.2

240.14

279.75

u/ml

0.38

135

Extrapyramidal and movement disorders

346

3133

1.11

1.08

1.2

1.3

296.80

275.35

u/ml

0.49

202

1951

L02BG Aromatase inhibitors

175

1985

0.87

1.08

1.1

1.2

285.33

289.79

u/ml

0.06

104

1200

Other disorders of binocular movement

219

1.43

1.08

1.6

1.3

232.31

227.17

u/ml

0.04

126

Oter anti-inflammatory and antirheumatic agents, non-steroids

164

1044

0.86

1.08

1.2

1.4

284.52

285.17

u/ml

0.01

718

Acute alcohol intoxication, ICD10

247

2197

1.13

1.08

1.3

262.61

255.96

u/ml

0.16

163

1396

Premenstrual syndrome

153

1.52

1.07

1.2

230.23

227.22

u/ml

0.02

104

Spinal enthesopathy

1.69

1.07

1.2

372.10

331.89

u/ml

—

Respiratory and cardiovascular disorders specific to the perinatal period

542

1.26

1.06

2.7

2.0

178.62

161.49

u/ml

0.16

249

Cervicocranial syndrome

104

867

1.20

1.06

1.2

358.49

281.28

u/ml

0.75

540

Lactose intolerance, other/unspecified

228

1.41

1.06

1.3

256.10

230.46

u/ml

0.25

131

Other deformities of toe(s)

211

1.43

1.06

1.1

1.2

237.93

255.00

u/ml

0.15

119

Other menopausal disorders

243

1199

1.13

1.06

1.2

290.00

289.28

u/ml

0.01

162

777

Other and unspecified thalassaemias

2.38

1.05

1.4

2.9

254.00

136.00

u/ml

—

Lumbar disc prolapse

713

4929

1.07

1.05

1.2

1.3

270.24

262.23

u/ml

0.28

478

3219

Parkinson's disease, strict definition, excluding more controls

603

0.77

1.05

1.1

1.3

287.98

259.18

u/ml

0.28

376

Alcoholic cardiomyopathy

2.09

1.04

1.0

1.2

348.86

274.75

u/ml

—

Dermatitis due to ingested food

694

1.22

1.03

1.7

167.35

185.50

u/ml

0.31

374

Chronic suppurative otitis media

607

1.24

1.03

1.2

1.3

214.95

232.91

u/ml

0.29

349

Hypertrophy of breast

136

1582

0.86

1.02

1.2

297.72

267.67

u/ml

0.35

995

Stenosis and insufficiency of lacrimal passages

653

1.23

1.02

1.2

277.94

259.87

u/ml

0.21

370

Gonococcal infection

273

1.37

1.01

1.1

1.3

200.21

227.95

u/ml

0.36

174

HSIL lesion of the cervix uteri

229

2038

1.13

1.01

1.3

1.2

280.76

259.57

u/ml

0.64

167

1347

Ventricular septal defect, a heart condition

404

1.30

1.01

1.9

263.84

189.80

u/ml

0.95

196

Early syphilis

107

1.61

1.01

1.0

1.2

329.67

266.91

u/ml

0.42

Abscess of external ear

123

1.56

1.01

1.2

1.3

172.62

239.19

u/ml

0.70

Hypersomnia

123

1.56

1.01

1.2

205.22

254.14

u/ml

0.49

Open wound of wrist and hand

603

5426

1.08

1.00

1.3

261.07

254.90

u/ml

0.21

376

3503

Tuberculosis

282

1.35

1.00

1.3

1.2

291.15

275.10

u/ml

0.10

150

Artrosis, including avohilmo

890

5169

0.94

0.99

1.2

1.3

273.93

268.92

u/ml

0.19

530

3449

Systemic sclerosis,strict definition

1.83

0.99

1.2

1.4

225.00

225.35

u/ml

—

Residual foreign body in soft tissue

485

1.26

0.99

1.2

229.31

255.97

u/ml

0.44

303

Malignant neoplasm of breast, HER2-negative, including Hilmo

271

1932

0.90

0.99

1.1

1.2

269.45

278.49

u/ml

0.19

163

1262

Calculus of lower urinary tract

326

1.33

0.99

1.4

1.2

361.59

275.17

u/ml

0.67

188

Disorder of visual pathways, unspecified

0.00

0.99

0.0

1.8

—

223.73

—

Other obstructed labour

684

0.79

0.99

1.3

1.2

236.09

276.44

u/ml

0.52

446

Malignant neoplasm of breast, including Hilmo

271

1931

0.90

0.99

1.1

1.2

269.45

278.23

u/ml

0.18

163

1261

LSIL lesion of the cervix uteri

141

1217

1.16

0.98

1.3

1.2

292.80

259.09

u/ml

0.68

805

Sexual dysfunction

190

1.44

0.98

1.7

1.2

281.21

235.89

u/ml

0.47

120

Acute otitis externa, noninfective

132

1.53

0.98

1.6

1.2

254.64

252.44

u/ml

0.01

Benign thyroid growths and nodules

275

2301

1.11

0.98

1.3

1.2

271.84

277.84

u/ml

0.11

172

1435

Other disorders of central nervous system

108

1.59

0.98

1.2

1.5

335.40

253.28

u/ml

—

Mixed disorders of conduct and emotions

461

1.27

0.97

1.5

197.77

196.28

u/ml

0.02

269

Inflammation of lacrimal passages (acute and unspecified)

116

1.57

0.97

1.6

1.2

354.62

213.36

u/ml

—

Respiratory tuberculosis, confirmed

100

1.61

0.97

1.3

1.2

355.11

269.63

u/ml

—

Fall involving bed

190

1.43

0.97

1.3

1.4

256.47

248.80

u/ml

0.04

Other/unspecified enthesopathies, not elsewhere classified

594

1.23

0.97

1.3

1.2

299.78

275.13

u/ml

0.19

377

Congenital malformations and deformations of the musculoskeletal system

153

1324

1.15

0.97

1.5

1.6

245.34

214.55

u/ml

0.68

753

Non-small cell lung cancer, including Hilmo

616

1.22

0.97

1.2

279.27

282.30

u/ml

0.03

365

Nontoxic goitre/thyroid nodule

233

2082

1.12

0.97

1.3

1.2

266.94

284.67

u/ml

0.36

143

1282

Meralgia paraesthetica

250

1.37

0.96

1.1

1.2

243.36

261.23

u/ml

0.17

147

Contact with sharp glass

452

1.27

0.96

1.2

1.3

219.12

238.37

u/ml

0.24

281

malignant neoplasm of female genital organs

750

1.20

0.96

1.2

280.61

280.18

u/ml

0.00

470

Other disorders of choroid

1.70

0.96

1.5

1.2

252.14

248.09

u/ml

—

Nasal polyp

174

1529

1.14

0.95

1.2

1.3

254.21

277.67

u/ml

0.47

979

Early syphilis, including avohilmo

125

1.54

0.95

1.0

1.2

315.85

259.03

u/ml

0.41

Unspecified mental disorder

430

4658

0.92

0.95

1.2

1.3

269.08

256.47

u/ml

0.47

258

3051

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

224

2001

1.12

0.95

1.3

247.19

248.03

u/ml

0.02

139

1279

Benign neoplasm: Connective and other soft tissue of head, face and neck

125

1.54

0.95

1.3

276.92

245.00

u/ml

0.18

Myopia

188

1662

1.14

0.95

1.6

1.3

265.85

246.31

u/ml

0.37

118

1034

Postpartum haemorrhage

279

2544

0.90

0.94

1.2

1.3

246.29

258.48

u/ml

0.28

177

1669

Other disorders of penis

112

952

1.18

0.94

1.5

1.4

242.11

240.59

u/ml

0.02

595

Viral infections of central nervous system, not elsewhere classified/unspecifie, including avohilmod

109

1.58

0.94

1.2

1.3

272.67

243.39

u/ml

0.20

!Aliquae complicationes praecoces traumatis

382

1.29

0.94

1.4

1.3

291.62

248.84

u/ml

0.61

235

Early complications of trauma

382

1.29

0.94

1.4

1.3

291.62

248.84

u/ml

0.61

235

Disorders of orbit

338

1.31

0.94

1.3

237.77

249.47

u/ml

0.09

201

Suicide or other Intentional self-harm

310

2819

1.10

0.94

1.3

258.51

255.63

u/ml

0.07

196

1805

Malignant neoplasm of respiratory system and intrathoracic organs

122

865

1.17

0.94

1.2

1.3

261.38

278.54

u/ml

0.30

524

Central retinal artery occlusion

101

1.60

0.94

1.3

1.2

215.18

312.47

u/ml

0.47

Anorexia (incl.atypical)

715

1.21

0.94

1.3

219.03

240.86

u/ml

0.41

431

Female infertility, associated with anovulation

111

945

1.18

0.93

1.2

216.14

252.00

u/ml

0.93

642

Spontaneous rupture of synovium and tendon

552

1.24

0.93

1.2

228.42

276.91

u/ml

0.95

347

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

725

1.21

0.93

1.4

1.2

221.86

262.79

u/ml

0.83

484

Glaucoma, exfoliation

454

0.75

0.93

1.2

1.1

300.86

300.70

u/ml

0.00

252

Scarlet fever, including avohilmo

110

1.57

0.92

2.0

1.6

243.89

198.87

u/ml

—

Infections specific to the perinatal period

280

1.35

0.92

2.4

2.0

179.65

162.32

u/ml

0.15

123

Melanoma in situ

261

1.35

0.91

1.7

1.2

221.84

284.87

u/ml

0.81

138

Other disorders of amniotic fluid and membranes

145

1603

0.87

0.91

1.2

242.68

252.47

u/ml

0.23

1049

Early lumbar disc prolapse, operated

1156

0.84

0.91

1.3

237.15

246.80

u/ml

0.13

769

Maternal care for other known or suspected fetal problems

356

2042

1.10

0.91

1.2

1.3

229.24

246.66

u/ml

0.70

238

1330

Congenital musculoskeletal deformities of head, face, spine and chest, including avohilmo

206

0.62

0.90

1.8

1.6

188.00

209.15

u/ml

—

105

Bicipital tendinitis

349

1.30

0.90

1.3

1.2

264.24

259.92

u/ml

0.03

219

Dependent personality disorder

143

1.48

0.90

1.2

1.3

302.42

256.81

u/ml

0.27

Primary angle-closure glaucoma

210

1.39

0.90

1.4

1.1

373.86

294.99

u/ml

0.52

111

Coxibs

367

1761

1.09

0.90

1.1

1.4

251.36

260.70

u/ml

0.25

214

1179

Gonococcal infection, including avohilmo

332

1.30

0.90

1.1

1.3

191.00

225.11

u/ml

0.57

207

Postpartum haemorrhage due to anatomy

112

1305

0.86

0.90

1.2

258.02

239.99

u/ml

0.31

911

Other specified disorders of muscle

202

1.40

0.90

1.1

1.2

343.43

249.71

u/ml

0.90

114

Carcinoma in situ of other and unspecified digestive organs

271

1.34

0.89

1.2

332.85

302.05

u/ml

0.21

158

Psoriatic arthropathies, ICD10

104

885

1.18

0.89

1.2

318.15

273.50

u/ml

0.70

555

Somnolence

119

1.53

0.89

1.3

1.4

191.42

242.22

u/ml

0.75

Family history of other conditions

152

1.46

0.89

1.6

1.2

234.60

239.68

u/ml

0.03

Chronic suppurative otitis media, including avohilmo

775

1.19

0.89

1.3

1.4

207.35

242.12

u/ml

0.83

447

Adenomyosis (Endometriosis of uterus)

113

967

1.17

0.88

1.2

230.37

284.24

u/ml

1.75

622

Injuries involving multiple body regions

342

1.29

0.88

1.2

1.3

303.93

247.27

u/ml

0.57

196

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

511

1.24

0.88

2.0

1.7

213.16

199.32

u/ml

0.13

272

Motor disorders, excluding more controls

305

1.31

0.88

2.8

1.8

171.43

152.86

u/ml

0.17

153

Multiple gestation

113

970

1.17

0.88

1.3

1.2

243.89

263.95

u/ml

0.36

635

Disorders of puberty

317

1.31

0.88

2.0

1.6

174.28

184.08

u/ml

0.15

165

Other disorders of prostate

186

1.40

0.87

1.2

275.18

269.32

u/ml

0.04

108

Injury of urinary and pelvic organs

178

1.42

0.87

1.4

1.3

211.45

273.72

u/ml

0.74

Sequelae of injuries, of poisoning and of other consequences of external causes

262

2375

1.11

0.87

1.2

1.3

238.82

265.49

u/ml

1.15

169

1533

Malignant neoplasm of stomach, including Hilmo

255

1.34

0.86

1.1

1.2

313.10

282.26

u/ml

0.20

150

Diastasis of muscle

1.69

0.86

1.2

246.14

215.88

u/ml

—

Other peripheral vertigo

622

1.21

0.86

1.1

1.2

353.84

281.27

u/ml

0.49

380

Testicular dysfunction

415

1.26

0.85

1.3

282.88

257.20

u/ml

0.30

265

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

325

1.29

0.85

1.3

1.2

261.84

287.10

u/ml

0.22

174

Disorders of puberty, all

354

1.29

0.85

1.9

1.7

191.90

194.19

u/ml

0.03

185

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

1.58

0.85

1.2

163.00

243.57

u/ml

—

Congenital malformations of breast, including avohilmo

179

1.41

0.85

1.1

1.3

288.07

216.34

u/ml

0.81

113

Respiratory tuberculosis, bacteriologically and histologically confirmed

104

1.55

0.85

1.3

1.2

355.11

260.94

u/ml

—

Use of glatiramer acetate

137

1.47

0.85

1.1

1.2

274.54

223.10

u/ml

0.31

Hereditary corneal dystrophies

196

1.39

0.84

1.1

1.2

225.50

249.61

u/ml

0.17

110

Other puerperal infections

109

937

1.17

0.84

1.2

218.53

257.45

u/ml

1.20

612

Maternal care for cervical incompetence

283

1.31

0.84

1.3

1.2

255.32

251.03

u/ml

0.03

182

Haemangioma, any site

725

1.19

0.83

1.4

1.3

263.42

257.12

u/ml

0.07

443

Ill-defined and unknown causes of mortality

542

1.22

0.83

1.5

1.2

308.70

292.95

u/ml

0.15

314

Injury of nerves at wrist and hand level

354

1.28

0.83

1.3

1.2

331.60

260.69

u/ml

0.49

226

Respiratory tuberculosis, confirmed and not-confirmed

257

1.33

0.83

1.3

1.2

293.92

273.93

u/ml

0.11

135

Respiratory tuberculosis

257

1.33

0.83

1.3

1.2

293.92

273.93

u/ml

0.11

135

Adenocarcinoma of pancreas

121

1.50

0.83

1.1

1.2

315.62

258.25

u/ml

0.33

Failed attempted abortion

105

1.54

0.82

1.1

1.4

185.50

182.00

u/ml

—

Cardiovascular disorders originating in the perinatal period

106

1.57

0.82

2.8

2.0

227.17

143.24

u/ml

—

Mental and behavioural disorders due to sedatives or hypnotics

681

1.19

0.82

1.2

1.3

281.79

241.65

u/ml

0.63

433

Progressive vascular leukoencephalopathy

138

1.45

0.81

1.2

250.82

320.78

u/ml

0.56

Benign neoplasm: Other and unspecified parts of mouth

232

1.34

0.81

1.3

1.2

241.76

268.89

u/ml

0.24

129

Deforming dorsopathies

301

2756

1.09

0.81

1.3

293.89

261.71

u/ml

1.11

188

1704

Hypothermia

130

1.47

0.81

1.3

1.2

222.67

272.51

u/ml

0.30

Congenital iodine-deficiency syndrome/hypothyroidism

172

1.40

0.81

1.2

1.4

253.00

263.93

u/ml

0.06

Other psoriatic arthropathies

100

857

1.17

0.81

1.2

326.97

274.55

u/ml

0.84

533

Macrocephaly

0.00

0.80

0.0

2.5

—

108.22

—

Peroneal tendinitis

122

1.49

0.80

1.2

299.69

262.98

u/ml

0.18

Bilateral sagittal split ramus osteotomy operation

317

0.72

0.80

1.3

195.94

242.87

u/ml

0.54

200

Guttate psoriasis

114

1.51

0.80

1.1

1.2

311.45

203.85

u/ml

1.00

Other and unspecified water transport accidents

0.00

0.80

0.0

1.1

—

141.92

—

Normal-pressure hydrocephalus

212

0.66

0.80

1.1

167.80

310.32

u/ml

—

110

Use of riluzole

0.00

0.80

0.0

1.1

—

377.30

—

Other maltreatment syndromes

321

1.29

0.80

1.2

303.11

245.18

u/ml

0.46

206

Use of galantamine

294

0.71

0.80

1.0

1.1

290.00

314.48

u/ml

—

153

Spondylolisthesis/Spondylolysis

159

1410

1.13

0.80

1.2

1.3

287.48

282.41

u/ml

0.08

883

Complications predominantly related to the puerperium

298

2733

1.09

0.79

1.2

247.88

261.15

u/ml

0.45

192

1783

Other specified/unspecified hearing loss

573

1.21

0.79

1.4

1.3

262.23

273.71

u/ml

0.16

340

Entropion and trichiasis of eyelid

401

1.25

0.79

1.3

1.2

257.34

282.10

u/ml

0.33

215

Malignant neoplasm of tongue

106

1.52

0.79

1.3

1.2

242.45

294.53

u/ml

0.50

Social disorders starting during childhood or adolescence

157

1.43

0.79

1.3

1.6

197.00

181.17

u/ml

0.16

Hereditary ataxia

1.57

0.79

1.4

224.14

256.70

u/ml

—

Superficial injury of forearm

134

1177

1.14

0.79

1.4

1.3

253.93

240.00

u/ml

0.25

721

Non-allergic asthma

785

1.18

0.78

1.5

273.40

246.06

u/ml

0.34

460

Other fall from one level to another

296

2716

1.09

0.78

1.3

1.4

230.56

248.45

u/ml

0.53

175

1664

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

349

0.74

0.77

1.1

1.2

277.84

278.84

u/ml

0.01

223

Abnormal findings on diagnostic imaging of central nervous system

439

1.24

0.77

1.3

248.81

231.23

u/ml

0.17

268

Open wound of shoulder and upper arm

200

1.36

0.77

1.6

1.3

173.02

241.98

u/ml

1.42

114

Other specified disorders of external ear

252

1.32

0.77

1.4

1.3

222.69

279.76

u/ml

0.59

141

Malignant neoplasm of bronchus and lung, including Hilmo

115

833

1.15

0.77

1.2

284.47

284.51

u/ml

0.00

498

Hyperprolactinaemia

323

1.28

0.76

1.4

1.3

210.38

241.05

u/ml

0.38

209

Intermittent heterotropia

824

1.17

0.76

1.6

1.5

187.76

215.34

u/ml

0.69

459

Other contact dermatitis

677

1.19

0.76

1.7

1.2

286.54

264.31

u/ml

0.27

435

Sacrococcygeal disorders, not elsewhere classified

235

1.33

0.76

1.2

214.44

275.46

u/ml

0.75

137

Use of dimethyl fumarate

1.66

0.76

1.0

1.2

293.83

208.28

u/ml

—

Arnold-Chiari syndrome

116

1.49

0.75

1.9

1.5

222.10

200.45

u/ml

—

Pemphigus

1.87

0.74

1.1

238.57

254.95

u/ml

—

Toxic effects of substances chiefly nonmedicinal as to source

142

1259

1.13

0.74

1.3

260.98

242.11

u/ml

0.34

785

Malignant neoplasm of oral cavity

167

1.38

0.73

1.2

316.67

266.80

u/ml

0.39

Maternal care for known or suspected fetal abnormality and damage

218

1676

1.10

0.73

1.2

1.3

221.14

249.81

u/ml

1.32

160

1101

Burns and corrosions of external body surface, specified by site

140

1242

1.13

0.72

1.3

1.4

232.83

236.91

u/ml

0.08

770

Infective bursitis

218

0.68

0.72

1.6

1.2

206.89

277.27

u/ml

—

133

Family history of certain disabilities and chronic diseases leading to disablement

498

1.21

0.72

1.5

1.1

272.13

243.94

u/ml

0.32

313

Malignant neoplasm of nasal cavity and sinuses

1.94

0.71

1.2

150.80

132.18

u/ml

—

Benign leiomyoma with endometriosis

113

990

1.14

0.71

1.3

1.2

265.88

283.59

u/ml

0.32

604

Biological medicines for asthma

221

1.32

0.70

1.1

1.2

203.94

244.81

u/ml

0.61

131

Coarctation of the aorta

152

1.40

0.70

2.0

1.9

278.55

172.36

u/ml

0.56

Ectropion of eyelid

160

1.38

0.70

1.2

1.1

215.33

295.78

u/ml

0.85

Superficial injury of shoulder and upper arm

133

1180

1.13

0.69

1.2

1.3

238.01

258.18

u/ml

0.31

747

Impacted cerumen

861

1.15

0.69

1.7

1.3

223.58

267.66

u/ml

0.78

498

Unspecified multiple injuries

1.89

0.69

1.2

1.3

349.40

233.38

u/ml

—

Follicular adenocarcinoma of thyroid gland, including Hilmo

1.66

0.69

1.2

1.3

277.20

202.77

u/ml

—

Twin gestation

108

946

1.15

0.69

1.3

1.2

240.17

265.43

u/ml

0.48

619

Congenital malformations of breast

161

1.38

0.69

1.1

1.3

305.67

221.15

u/ml

0.78

100

malignant neoplasm of male genital organs, including Hilmo

215

1173

1.10

0.68

1.2

1.3

273.64

274.31

u/ml

0.01

130

763

Postprocedural musculoskeletal disorders, not elsewhere classified

446

1.21

0.68

1.1

1.2

260.08

280.86

u/ml

0.24

259

Maternal care for known or suspected abnormality of pelvic organs

327

2045

1.08

0.68

1.2

1.3

240.01

253.15

u/ml

0.46

225

1339

Obstructed labour due to maternal pelvic abnormality

1113

0.87

0.68

1.3

248.31

284.74

u/ml

0.88

717

Shoulder region

102

1.48

0.68

1.1

1.3

334.70

275.96

u/ml

—

Congenital absence, atresia and stenosis of large intestine

1.86

0.68

4.4

1.7

144.60

203.62

u/ml

—

Exposure to smoke, fire and flames

238

0.71

0.68

1.9

1.2

199.18

251.60

u/ml

0.38

132

Achalasia of cardia

102

1.48

0.68

1.0

1.2

259.29

264.05

u/ml

—

Ethmoidectomy

134

1192

1.13

0.68

1.1

1.3

296.77

265.22

u/ml

0.54

763

Haemangioma and lymphangioma, any site

808

1.15

0.67

1.4

1.3

263.76

256.14

u/ml

0.08

489

Other neurotic disorders

303

1.26

0.66

1.1

1.2

300.84

266.48

u/ml

0.24

185

Optic atrophy

154

1.38

0.65

1.4

1.5

238.08

274.90

u/ml

0.27

Mixed conductive and sensorineural hearing loss

800

1.15

0.65

1.3

311.97

279.70

u/ml

0.42

497

Sequelae of injuries of lower limb

838

1.15

0.65

1.3

1.2

204.28

265.89

u/ml

2.49

532

Endometriosis diagnosis and infertility diagnosis occurring together

121

1073

1.13

0.65

1.2

273.99

260.89

u/ml

0.12

708

Specific development disorders of speech and language

115

980

1.14

0.65

2.2

1.6

196.05

196.10

u/ml

0.00

551

Problems related to social environment

215

1.31

0.65

1.2

255.40

256.04

u/ml

0.00

130

Other disorders of cornea

754

1.16

0.65

1.3

1.2

274.39

267.73

u/ml

0.07

467

164

1270

1.11

0.65

1.4

1.2

279.49

282.67

u/ml

0.05

745

Cysts of oral region, not elsewhere classified

523

1.19

0.64

1.4

1.3

230.28

254.21

u/ml

0.36

316

Divergent concomitant strabismus

699

1.16

0.64

1.3

240.26

259.20

u/ml

0.30

417

Colon adenocarcinoma

541

1.18

0.64

1.1

1.2

335.84

275.15

u/ml

0.62

324

Eustachian salpingitis and obstruction

105

924

1.14

0.64

1.3

261.90

249.93

u/ml

0.15

603

Pyoderma

146

1.38

0.64

2.2

1.4

254.08

247.39

u/ml

0.03

Recurrent dislocation and subluxation of joint

653

1.17

0.64

1.1

1.3

283.12

236.12

u/ml

0.83

423

Malignant neoplasm of colon

727

1.16

0.64

1.3

1.2

315.31

279.11

u/ml

0.40

447

Acute and transient psychotic disorders

103

1169

0.88

0.64

1.3

293.06

254.33

u/ml

0.74

756

Benign neoplasm: Connective and other soft tissue, unspecified

1.53

0.63

1.2

1.3

305.14

255.67

u/ml

—

Wide developmental disorders

704

0.84

0.63

1.6

1.7

243.43

199.12

u/ml

0.43

400

Inflammatory diseases of prostate (prostatitis)

109

963

1.13

0.63

1.2

1.3

239.61

258.75

u/ml

0.39

623

Brain glioblastoma and astrocytoma

121

1.41

0.62

1.1

1.2

169.45

245.48

u/ml

0.75

Bicornuate uterus

1.61

0.62

1.4

1.2

146.20

216.04

u/ml

—

111

916

1.13

0.62

1.3

1.1

271.47

287.77

u/ml

0.24

541

Fracture of neck

406

1.21

0.62

1.2

264.37

272.22

u/ml

0.07

240

Poisoning by narcotics and psychodysleptics [hallucinogens]

182

1.33

0.62

1.4

1.3

251.88

241.01

u/ml

0.05

106

Other/unspecified enthesopathies of lower limb, excluding foot

637

1.17

0.61

1.2

208.96

285.77

u/ml

2.35

391

Ménière disease

588

0.83

0.61

1.1

1.2

278.63

282.58

u/ml

0.03

361

Mental retardation, excluding more controls

490

1.19

0.61

1.7

1.6

232.96

206.42

u/ml

0.31

248

Acute appendicitis, with complications

182

1658

1.10

0.61

1.2

1.3

270.29

273.78

u/ml

0.05

115

1053

Foreign body in alimentary tract

500

0.82

0.61

1.3

292.39

247.18

u/ml

0.42

286

Melanocytic naevi of upper limb, including shoulder

200

1.31

0.61

1.7

1.3

268.69

243.23

u/ml

0.12

118

Thyrotoxicosis with toxic multinodular goitre

325

1.23

0.61

1.2

270.43

270.05

u/ml

0.00

181

ICD 8 haemorrhage (epidural, subarachnoid, subduralis)

0.00

0.61

0.0

1.2

—

166.89

—

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

358

0.78

0.61

3.3

2.2

141.29

159.89

u/ml

0.18

159

Other congenital malformations of integument, including avohilmo

0.00

0.60

0.0

1.8

—

213.36

—

Demyelinating diseases of the central nervous system

844

1.14

0.60

1.2

287.05

265.19

u/ml

0.24

553

Injury of blood vessels at hip and thigh level

0.00

0.60

0.0

1.4

—

153.00

—

Other mental disorders due to brain damage and dysfunction and to physical disease

694

1.16

0.60

1.3

1.2

285.45

285.12

u/ml

0.00

411

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

335

1.23

0.60

1.1

1.3

288.64

240.95

u/ml

0.45

207

Desensitization to allergens

770

1.15

0.60

1.2

1.4

218.63

228.41

u/ml

0.15

473

Other infestations

0.00

0.60

0.0

1.1

—

167.50

—

Injury of intra-abdominal organs

254

1.27

0.60

1.7

1.3

269.72

246.61

u/ml

0.15

146

Palmar fascial fibromatosis [Dupuytren]

105

929

1.13

0.60

1.4

1.2

242.92

284.69

u/ml

0.87

581

Wet age-related macular degeneration

696

1.15

0.60

1.4

1.1

301.70

288.25

u/ml

0.15

399

Congenital malformations of trachea and bronchus

1.54

0.59

2.4

1.9

90.90

213.07

u/ml

—

Imperforate hymen

0.00

0.59

0.0

1.4

—

147.64

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

445

1.20

0.59

1.2

1.3

153.50

256.16

u/ml

4.83

272

Other and/or unspecified nontoxic goitre

537

1.18

0.59

1.3

1.2

342.89

276.62

u/ml

0.55

309

Effects of other external causes

345

1.22

0.59

1.4

1.3

221.95

214.25

u/ml

0.07

211

Alcohol abuse, main dg

186

1701

1.10

0.59

1.2

1.3

244.69

251.56

u/ml

0.15

119

1082

Focal brain injury

436

1.20

0.59

1.4

1.3

241.39

263.15

u/ml

0.30

273

Disorders of sphingolipid metabolism and other lipid storage disorders

0.00

0.59

0.0

1.3

—

130.56

—

Obstructed labour due to malposition and malpresentation of fetus

234

2343

0.92

0.58

1.3

245.21

262.14

u/ml

0.56

162

1566

Other specified/unspecified dorsopathies

228

1.28

0.58

1.1

1.2

294.95

265.71

u/ml

0.22

130

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

585

1.17

0.58

1.3

1.2

277.12

276.15

u/ml

0.01

351

Dysplastic lesion of unknown severity of the cervix uteri

1.50

0.57

1.2

1.3

182.86

216.88

u/ml

—

Chronic mastoiditis

158

1.34

0.57

1.3

1.2

228.54

290.55

u/ml

0.49

Delivery, wide proxy

332

1883

0.93

0.57

1.2

1.3

216.76

256.51

u/ml

2.32

214

1096

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

389

3664

1.06

0.57

1.3

219.99

254.63

u/ml

2.30

239

2328

Transitory endocrine and metabolic disorders specific to fetus and newborn

365

0.79

0.57

3.2

2.2

137.86

159.02

u/ml

0.22

161

Carcinoma in situ of other and unspecified sites

220

1.28

0.57

1.2

277.45

306.95

u/ml

0.12

118

Artificial joint re-operation

374

1.21

0.56

1.3

1.2

264.48

288.07

u/ml

0.26

217

Benign neoplasm: Skin of lower limb, including hip

194

1.30

0.56

1.7

1.2

286.94

264.11

u/ml

0.16

108

Maternal care for known or suspected disproportion

385

0.80

0.56

1.4

1.2

186.57

267.19

u/ml

1.89

258

Lesion of plantar nerve

374

0.80

0.56

1.1

1.2

343.06

281.02

u/ml

0.43

212

Respiratory distress of newborn

366

1.21

0.55

2.5

2.2

144.33

149.35

u/ml

0.03

158

Focal epilepsy

228

2110

1.08

0.55

1.3

1.4

246.27

253.79

u/ml

0.18

139

1284

Meniscus derangement

519

3269

1.05

0.55

1.3

256.26

273.28

u/ml

0.56

332

2142

Optic neuritis

385

1.20

0.55

1.2

1.3

350.28

246.59

u/ml

1.33

238

Lichen sclerosus et atrophicus

814

1.13

0.54

1.3

1.2

279.48

263.13

u/ml

0.21

487

Other and unspecified injuries of thorax

151

1.33

0.54

1.5

1.2

328.64

238.44

u/ml

0.54

Placenta praevia

470

0.83

0.54

1.1

1.3

221.96

263.76

u/ml

0.63

320

Ganglion

216

1999

1.08

0.53

1.3

1.2

244.35

262.01

u/ml

0.44

137

1278

Mild mental retardation

371

0.80

0.53

2.0

1.6

181.50

210.90

u/ml

0.59

188

1.44

0.53

1.3

322.88

219.79

u/ml

—

Fenamates

162

1006

1.10

0.53

1.2

1.4

313.02

275.66

u/ml

0.77

112

703

Epiphora

134

1.35

0.53

1.1

1.3

287.80

241.58

u/ml

—

Anomalies of pupillary function

187

1.29

0.53

1.3

1.4

200.58

226.99

u/ml

0.22

109

Open wound of abdomen, lower back and pelvis

341

1.21

0.53

1.2

1.4

189.00

236.15

u/ml

0.61

203

Subacute thyroiditis

277

1.23

0.53

1.3

1.2

364.87

260.40

u/ml

0.36

168

Primary gonarthrosis, bilateral

375

3324

0.94

0.52

1.2

1.3

285.60

285.75

u/ml

0.00

215

2095

Other disorders of ear

1058

6602

1.04

0.52

1.4

1.3

267.06

263.59

u/ml

0.13

634

4198

Focal epilepsy, strict definition

204

1887

1.08

0.52

1.3

1.4

247.49

254.44

u/ml

0.16

129

1146

Benign neoplasm of middle ear and respiratory system

536

1.16

0.51

1.1

1.2

205.10

271.17

u/ml

1.40

325

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

489

0.84

0.51

1.1

1.2

342.32

273.80

u/ml

0.51

293

Scissor bite

569

1.16

0.51

2.3

1.7

225.33

180.74

u/ml

0.46

270

Alzheimer’s disease (Atypical or mixed)

375

0.81

0.50

1.1

337.05

324.31

u/ml

0.08

201

Foreign body on external eye

170

1564

1.09

0.50

1.3

268.72

251.41

u/ml

0.33

113

1020

Mental and behavioural disorders due to cannabinoids

433

0.83

0.50

1.1

1.3

214.27

212.30

u/ml

0.03

278

Spermatocele

491

1.16

0.50

1.3

387.03

270.16

u/ml

1.02

313

Other osteochondropathies

660

1.14

0.50

1.3

232.94

256.89

u/ml

0.41

403

Superficial injuries involving multiple body regions

243

1.24

0.50

1.2

1.3

296.33

227.96

u/ml

0.55

135

Oesophageal obstruction

180

1.28

0.49

1.3

1.2

317.43

268.87

u/ml

0.37

102

Non-small cell lung cancer, adenocarcinoma

252

1.23

0.49

1.2

263.50

277.01

u/ml

0.12

136

Other spirochaetal diseases, including avohilmo

346

3268

1.06

0.49

1.2

1.3

252.10

266.86

u/ml

0.42

225

2040

Other bursal cyst

110

1.37

0.49

1.4

1.2

258.56

263.88

u/ml

—

Type 1 diabetes, strict definition, subgroup 1

125

1133

1.10

0.49

1.6

1.5

242.69

216.13

u/ml

0.57

682

Injury of muscle and tendon at shoulder and upper arm level

327

3085

1.06

0.49

1.2

1.3

258.05

279.35

u/ml

0.81

201

1980

Ankylosing spondylitis, strict definition

437

1.17

0.48

1.2

278.69

259.81

u/ml

0.16

273

Other and unspecified injuries of forearm

1.46

0.48

1.3

239.17

184.71

u/ml

—

Hirsutism in women

190

1.27

0.48

1.1

1.3

216.31

235.84

u/ml

0.18

127

Other specified/unspecified disorders of bone/cartilage

199

1.26

0.48

1.2

342.11

248.43

u/ml

0.49

117

Occupant of pick-up truck or van injured in other and unspecified transport accidents

1.51

0.48

1.7

1.3

180.57

180.77

u/ml

—

Carcinoma in situ, bladder

208

1.25

0.48

1.2

275.20

312.18

u/ml

—

112

Malignant neoplasm of ovary

217

1.25

0.48

1.1

1.2

263.47

257.33

u/ml

0.03

132

Retinoschisis and retinal cysts

128

1.33

0.48

1.2

238.25

275.86

u/ml

—

Complications of the puerperium, not elsewhere classified

410

1.18

0.48

1.1

1.2

262.00

250.60

u/ml

0.12

276

Epidural haemorrhage

1.48

0.47

1.1

1.3

245.20

219.06

u/ml

—

Intentional self-harm by unspecified means

164

1.29

0.47

1.3

276.33

218.82

u/ml

0.41

Disorders of synovium and tendon in diseases classified elsewhere

164

1.29

0.47

1.6

1.2

293.17

259.69

u/ml

0.16

Bacterial sepsis of newborn

165

1.30

0.47

2.9

2.0

139.82

165.25

u/ml

0.17

Contact with heat and hot substances

598

1.14

0.47

1.3

1.4

222.77

246.11

u/ml

0.37

344

Pustulosis palmaris et plantaris

299

0.80

0.47

1.2

326.62

275.55

u/ml

0.20

176

Other congenital malformations of nervous system

129

1.33

0.46

1.9

1.6

222.10

204.92

u/ml

—

Transient synovitis

103

1.37

0.46

2.1

1.7

202.25

203.42

u/ml

—

Multiple delivery

788

1.12

0.46

1.2

1.3

241.87

286.80

u/ml

0.86

514

Psoriasis (vulgaris), strict definition

301

1.20

0.45

1.2

267.59

260.23

u/ml

0.07

187

FESS (DNB20)

127

1160

1.10

0.45

1.1

1.3

302.05

264.01

u/ml

0.64

739

Nontoxic single thyroid nodule

524

1.15

0.45

1.4

1.2

238.51

262.22

u/ml

0.33

310

Other disorders of Eustachian tube

237

1.23

0.45

1.5

1.2

300.86

249.80

u/ml

0.30

138

Other degenerative diseases of the nervous system

192

1506

0.93

0.45

1.1

1.2

274.07

267.35

u/ml

0.11

123

974

Optic atrophy, wide definition

165

1.28

0.45

1.4

1.5

238.08

268.18

u/ml

0.22

Other disorders of male genital organs

394

1.17

0.45

1.7

1.3

272.31

238.06

u/ml

0.27

238

Pedal cyclist injured in collision with motor vehicle

308

0.81

0.45

1.1

1.3

240.19

244.98

u/ml

0.03

183

Dystonia

450

1.16

0.45

1.2

1.3

284.43

249.60

u/ml

0.48

278

Other and unspecified injuries of wrist and hand

438

0.84

0.45

1.2

1.4

196.84

236.43

u/ml

0.54

257

Allergic contact dermatitis

138

1267

1.09

0.44

1.2

1.3

238.16

271.04

u/ml

0.82

816

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

742

1.12

0.44

1.1

1.3

291.81

243.61

u/ml

0.85

483

Other inflammation of vagina/vulva

348

1.18

0.44

1.3

208.11

245.40

u/ml

0.66

228

Congenital deformities of feet, including avohilmo

488

1.15

0.44

1.3

1.4

220.91

227.36

u/ml

0.08

270

False labour

406

2396

1.05

0.44

1.2

1.3

228.99

254.39

u/ml

1.45

281

1563

Other abnormal uterine and vaginal bleeding

204

1365

1.07

0.44

1.2

246.71

277.98

u/ml

0.54

124

875

Injury of muscle and tendon at wrist and hand level

145

1335

1.09

0.44

1.2

1.3

262.80

266.15

u/ml

0.04

862

Malignant neoplasm of ovary, including Hilmo

302

1.19

0.44

1.2

269.48

261.97

u/ml

0.05

182

Other spirochaetal diseases

339

3215

1.06

0.44

1.2

1.3

253.60

267.85

u/ml

0.40

220

2009

Congenital malformations of eye, ear, face and neck

883

0.89

0.44

1.8

1.5

194.08

219.02

u/ml

0.49

507

Von Willebrand disease

1.38

0.44

1.1

1.2

140.00

231.03

u/ml

—

Benign neoplasm of other and unspecified female genital organs

238

1.22

0.44

1.2

1.3

268.20

249.47

u/ml

0.18

146

220

1.23

0.44

1.2

289.47

220.05

u/ml

0.69

142

Hypertrichosis

211

1.24

0.44

1.2

1.3

209.43

238.24

u/ml

0.30

139

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

157

1.28

0.44

1.4

1.3

198.27

242.77

u/ml

0.49

Malignant neoplasm of tongue, including Hilmo

139

1.30

0.44

1.2

243.38

278.83

u/ml

0.34

Benign neoplasm: Skin of upper limb, including shoulder

148

1.29

0.44

1.4

1.2

377.64

259.80

u/ml

0.90

Unequal limb length (acquired)

104

1.36

0.43

1.6

1.4

218.33

194.83

u/ml

—

Autoimmune thyroiditis

157

1.28

0.43

1.4

283.92

208.44

u/ml

0.63

Rubella [German measles]

266

1.21

0.43

1.2

1.3

274.30

258.35

u/ml

0.17

173

Congenital malformations of the nervous system

294

1.20

0.43

1.7

1.6

235.55

204.08

u/ml

0.23

150

Pustular psoriasis

339

0.82

0.43

1.2

378.07

272.79

u/ml

0.51

204

Oral leukoplakia, including avohilmo

207

0.77

0.43

1.1

1.2

221.64

274.95

u/ml

0.43

121

Focal epilepsy, mode (most common among epilepsy diagnosis)

193

1800

1.07

0.42

1.2

1.4

248.98

257.51

u/ml

0.19

120

1096

Caries in Clefts patients

140

1.30

0.42

1.8

1.4

107.17

195.77

u/ml

2.35

Congenital malformations of uterus and cervix

203

1.24

0.42

1.4

1.3

177.53

230.84

u/ml

0.74

134

Sequelae of poliomyelitis

1.57

0.42

1.2

1.1

152.00

388.50

u/ml

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

165

1777

0.93

0.42

1.2

272.27

279.63

u/ml

0.11

1115

malignant neoplasm of male genital organs

203

1140

1.07

0.42

1.2

1.3

279.61

276.09

u/ml

0.06

121

738

Long labour

264

2371

0.94

0.42

1.2

267.46

259.19

u/ml

0.21

171

1559

Lesion of radial nerve

267

1.20

0.42

1.2

285.35

280.86

u/ml

0.03

157

Congenital absence of the vagina

0.00

0.42

0.0

2.5

—

141.11

—

Aggressive periodontitis

167

1.26

0.42

1.3

1.2

263.83

250.10

u/ml

0.08

Polyp of middle ear

0.00

0.41

0.0

1.4

—

138.50

—

Digeorge syndrome

0.00

0.41

0.0

2.0

—

118.10

—

Benign neoplasm: Penis

0.00

0.41

0.0

1.3

—

145.67

—

Plasmodium falciparum malaria, including avohilmo

0.00

0.41

0.0

1.4

—

215.86

—

Multiple system atrophy (rare forms of Parkinsonism)

0.00

0.41

0.0

1.1

—

250.83

—

Abnormal findings on antenatal screening of mother

109

995

1.10

0.41

1.2

249.98

252.56

u/ml

0.04

646

Fetus and newborn affected by maternal complications of pregnancy

182

0.75

0.41

2.9

2.2

427.33

165.81

u/ml

—

Sequelae of injuries of upper limb

890

1.10

0.41

1.2

1.3

257.85

266.92

u/ml

0.13

572

Rubella [German measles], including avohilmo

268

1.20

0.41

1.2

1.3

274.30

258.34

u/ml

0.17

175

Contusion of toe(s) with damage to nail

123

1.31

0.41

1.3

1.4

261.82

244.89

u/ml

0.07

Benign neoplasm: Vulva

114

1.32

0.41

1.3

264.75

244.58

u/ml

—

Mucinous and mucinous cystic tumor of rectum

0.00

0.41

0.0

1.1

—

157.29

—

Pediculosis and phthiriasis

1.49

0.41

1.8

1.2

462.20

142.17

u/ml

—

Profound mental retardation

0.00

0.41

0.0

1.9

—

186.38

—

Pleural plaque

426

1.15

0.41

1.2

351.28

288.31

u/ml

0.83

244

Injury of nerves at ankle and foot level

1.34

0.40

1.5

1.3

220.59

255.27

u/ml

—

Pleural plaque with presence of asbestos

333

1.17

0.40

1.2

327.33

293.11

u/ml

0.36

191

Excessive earwax

630

5915

0.96

0.40

1.4

1.3

264.45

262.07

u/ml

0.08

390

3687

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

347

0.83

0.40

1.2

252.58

257.69

u/ml

0.04

204

Respiratory tuberculosis, clinically confirmed

1.34

0.40

1.3

1.1

266.13

284.27

u/ml

—

Foreign body in respiratory tract

497

0.86

0.40

1.3

1.4

245.17

232.31

u/ml

0.14

275

286

1.19

0.40

1.3

1.2

208.97

260.91

u/ml

0.60

162

Open bite that required surgery (Lefort1 or BSSO)

102

0.68

0.40

1.0

1.2

229.43

228.49

u/ml

—

Benign neoplasm of ovary

122

1122

1.09

0.39

1.2

223.05

283.95

u/ml

2.18

693

Assault by unspecified means

251

1.20

0.39

1.2

1.3

226.33

230.54

u/ml

0.03

157

Sequelae of poliomyelitis, including avohilmo

1.43

0.39

1.2

1.1

152.00

358.00

u/ml

—

Phakomatoses, not elsewhere classified

115

1.32

0.39

1.3

1.8

201.00

213.35

u/ml

—

Polycystic ovarian syndrome, broad definition

159

1480

1.08

0.39

1.2

218.17

247.58

u/ml

0.89

994

Postpartum care and examination

197

1157

1.07

0.39

1.2

243.06

255.72

u/ml

0.29

135

708

Use of biperiden

410

0.85

0.39

1.3

1.2

270.82

256.56

u/ml

0.14

256

Cholesteatoma of middle ear

316

1.17

0.39

1.4

1.2

257.79

263.11

u/ml

0.05

181

Venous complications and haemorrhoids in pregnancy

160

1.26

0.39

1.3

170.62

253.72

u/ml

2.04

103

Malignant neoplasm of cervix uteri, including Hilmo

151

1.26

0.38

1.2

298.73

231.11

u/ml

0.50

100

Colorectal adenocarcinoma

110

995

1.09

0.38

1.1

1.2

276.67

284.40

u/ml

0.09

609

Colorectal cancer, including Hilmo

156

1352

1.08

0.38

1.2

264.30

280.27

u/ml

0.28

101

847

Other complications of labour and delivery, not elsewhere classified

179

1483

1.07

0.38

1.2

245.82

238.52

u/ml

0.18

133

975

Labour and delivery complicated by umbilical cord complications

457

1.14

0.38

1.2

239.85

263.70

u/ml

0.33

311

Malignant neoplasm of floor of mouth, including Hilmo

1.40

0.38

1.2

1.1

308.60

163.14

u/ml

—

Impacted maxillary molar

1051

0.91

0.38

1.5

1.3

193.31

220.74

u/ml

0.67

640

LeFortI or BSSO operation

409

0.85

0.38

1.2

1.3

218.55

252.24

u/ml

0.39

257

Dislocation, sprain and strain of joint and ligaments of hip

261

1.19

0.38

1.3

202.75

267.59

u/ml

1.22

147

Mental and behavioural disorders due to use of other stimulants, including caffeine

373

1.16

0.38

1.2

1.3

248.05

223.66

u/ml

0.28

244

Torsion of ovary, ovarian pedicle and fallopian tube

206

1.22

0.38

1.2

207.12

247.19

u/ml

0.49

132

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

360

0.84

0.38

2.7

2.2

221.61

159.98

u/ml

0.52

169

Lesion of sciatic nerve

197

1.22

0.37

1.1

1.2

250.45

287.02

u/ml

0.22

101

Deviated nasal septum

330

3143

1.05

0.37

1.2

1.3

265.75

268.97

u/ml

0.06

205

2070

Nontoxic multinodular goitre

134

1242

1.08

0.37

1.2

286.06

288.08

u/ml

0.02

741

Lichen planus, including avohilmo

136

1465

0.93

0.37

1.2

274.04

282.13

u/ml

0.11

903

Dislocation, sprain and strain of joints and ligaments of elbow

767

0.90

0.37

1.4

176.74

233.90

u/ml

1.62

443

Other sexually transmitted chlamydial diseases

101

926

1.09

0.37

1.2

221.25

223.55

u/ml

0.04

609

Malignant neoplasm of rectum, including Hilmo

572

1.12

0.36

1.2

1.3

233.37

273.15

u/ml

0.55

355

Benign neoplasm: Larynx

207

1.21

0.36

1.1

1.2

198.93

281.05

u/ml

1.23

114

Coxarthrosis, primary, with hip surgery

307

2987

0.95

0.36

1.2

284.98

288.15

u/ml

0.07

178

1844

Cyst of Bartholin Gland

281

1.18

0.36

1.2

1.3

294.38

254.68

u/ml

0.38

177

Malignant neoplasm of gum, including Hilmo

1.47

0.36

1.0

1.1

407.00

244.06

u/ml

—

Type 1 diabetes, strict definition

130

1203

1.08

0.36

1.7

1.5

238.74

215.31

u/ml

0.50

728

Paranoid personality disorder

157

0.76

0.36

1.4

1.2

234.00

258.91

u/ml

—

Contact with other hot metals

153

1.25

0.35

1.5

1.4

232.36

210.89

u/ml

0.14

Normotensive glaucoma

432

1.14

0.35

1.3

1.2

342.59

304.10

u/ml

0.42

240

Open wound of hip and thigh

376

1.15

0.35

1.2

1.3

208.00

244.33

u/ml

0.43

220

Polypectomy (DHB20)

501

0.88

0.35

1.1

1.2

331.15

274.01

u/ml

0.41

311

Type1 diabetes, definitions combined, early onset

119

1098

1.08

0.35

1.7

1.5

242.79

210.34

u/ml

0.71

641

Oligomenorrhoea

367

1.15

0.34

1.4

1.2

234.65

255.26

u/ml

0.26

239

Bursitis of shoulder

172

1.23

0.34

1.2

290.31

270.14

u/ml

0.10

102

Kyphosis

1.33

0.34

1.5

1.4

317.14

304.14

u/ml

—

Toxic effect of contact with venomous animals

403

0.87

0.33

1.1

1.4

232.76

253.92

u/ml

0.17

231

596

1.11

0.33

1.1

1.3

254.07

281.05

u/ml

0.41

362

Vestibular neuronitis

644

1.10

0.33

1.2

256.84

276.98

u/ml

0.26

389

Congenital malformations of genital organs

136

1262

1.07

0.33

1.6

1.4

230.06

231.18

u/ml

0.02

760

Schizotypal disorder

231

0.82

0.33

1.2

1.3

157.45

247.60

u/ml

2.22

150

Contact with machinery

968

0.92

0.32

1.2

1.3

286.34

260.01

u/ml

0.31

617

Burn and corrosion of hip and lower limb, except ankle and foot

229

1.18

0.32

1.4

1.3

217.44

244.35

u/ml

0.26

134

Calcific tendinitis of shoulder

417

1.13

0.32

1.4

1.2

288.90

283.04

u/ml

0.05

259

Manic episode

276

1.16

0.32

1.2

267.92

251.73

u/ml

0.12

165

Retained placenta and membranes, without haemorrhage

112

1040

1.08

0.32

1.2

224.49

275.49

u/ml

1.76

662

Hallux valgus (acquired)

233

1752

0.95

0.31

1.2

1.3

289.66

280.56

u/ml

0.23

155

1133

Burn and corrosion of trunk

295

1.16

0.31

1.1

1.3

223.54

236.64

u/ml

0.12

164

Lyme disease, including avohilmo

331

3176

1.04

0.31

1.1

1.3

254.11

267.98

u/ml

0.38

217

1986

Lyme disease

331

3176

1.04

0.31

1.1

1.3

254.11

267.98

u/ml

0.38

217

1986

Other infective otitis externa

513

1.11

0.31

1.7

1.3

220.86

247.67

u/ml

0.42

312

Pregnancy, childbirth and the puerperium

293

1600

0.95

0.31

1.3

216.55

253.08

u/ml

1.73

186

910

Crushed, pushed or stepped on by crowd or human stampede

108

1004

1.08

0.30

1.1

1.4

192.83

227.41

u/ml

1.04

612

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

296

1.15

0.30

1.1

1.2

182.65

268.31

u/ml

1.20

172

Pedestrian injured in other and unspecified transport accidents

1.32

0.30

2.4

1.3

314.17

264.26

u/ml

—

Primary coxarthrosis, bilateral

171

1809

0.94

0.30

1.2

293.46

288.19

u/ml

0.08

100

1107

Event of undetermined intent

735

1.09

0.30

1.4

1.3

185.52

247.77

u/ml

1.94

454

Melanocytic naevi of other and unspecified parts of face

505

1.11

0.30

1.5

1.2

218.03

250.69

u/ml

0.65

316

Laparoscopic right hemicolectomy

306

1.15

0.30

1.0

1.2

248.40

288.21

u/ml

0.43

171

Alcohol withdrawal state with delirium

525

1.11

0.29

1.2

1.3

278.59

279.29

u/ml

0.01

339

Spirochaetal infections, other/unspecified, including avohilmo

333

3203

1.04

0.29

1.2

1.3

253.82

267.56

u/ml

0.37

218

2004

Slow fetal growth and fetal malnutrition

171

0.80

0.29

2.4

1.9

120.90

146.50

u/ml

—

Pedal cyclist injured in other and unspecified transport accidents

110

1178

0.93

0.29

1.5

1.3

238.47

245.57

u/ml

0.12

742

Disorders of acoustic nerve

184

0.81

0.28

1.5

1.2

201.60

273.59

u/ml

—

103

Benign neoplasm of thyroid gland

204

1.18

0.28

1.5

1.2

284.60

248.52

u/ml

—

113

Contraceptive management

523

3543

1.03

0.28

1.3

263.30

265.50

u/ml

0.07

338

2253

Postpartum hemorraghe, parous women as controls

279

2433

0.96

0.28

1.2

246.29

249.60

u/ml

0.06

177

1678

Hydrocephalus

450

0.89

0.28

1.4

1.3

212.10

264.33

u/ml

0.56

252

Other, unspecified and serous retinal detachments

195

1.18

0.28

1.3

1.2

278.56

269.33

u/ml

0.07

115

Endometriosis of rectovaginal septum and vagina

555

1.10

0.28

1.1

1.2

267.84

271.68

u/ml

0.05

360

Malignant neoplasm of oral cavity, including Hilmo

242

1.16

0.28

1.2

293.04

266.63

u/ml

0.23

140

Non-small cell lung cancer

417

1.11

0.27

1.2

262.48

292.92

u/ml

0.34

247

Malignant neoplasm of prostate, including Hilmo

185

1036

1.05

0.27

1.3

278.09

277.80

u/ml

0.00

110

671

Use of disulfiram, acamprosate or naltrexone

854

0.92

0.27

1.2

1.3

276.37

257.03

u/ml

0.27

556

Failed induction of labour

769

1.08

0.27

1.2

233.79

249.07

u/ml

0.26

508

Other congenital malformations of male genital organs

170

0.81

0.26

2.3

1.9

161.43

173.56

u/ml

—

Unspecified lump in breast

125

1178

1.06

0.25

1.3

1.2

239.76

280.76

u/ml

1.18

735

Behavioural disorders

351

0.88

0.25

1.4

1.5

220.00

209.51

u/ml

0.10

197

Medial epicondylitis

301

1.13

0.25

1.3

1.2

272.20

266.35

u/ml

0.05

187

Dislocation, sprain and strain of joints and ligaments of knee

756

6988

0.98

0.25

1.2

1.3

230.58

254.28

u/ml

2.09

497

4470

Contact with sharp object, undetermined intent

277

0.86

0.25

1.3

165.57

238.01

u/ml

1.95

166

Secondary parkinsonism, excluding more controls

123

1.22

0.25

1.1

1.2

284.60

251.66

u/ml

—

Other diseases caused by chlamydiae, including avohilmo

151

1.20

0.25

1.3

1.4

229.00

198.84

u/ml

0.16

Colorectal cancer

134

1215

1.06

0.25

1.2

270.51

280.73

u/ml

0.14

760

Pedal cyclist injured in transport accident

247

2570

0.96

0.24

1.4

1.3

251.80

254.53

u/ml

0.04

157

1614

Autism

496

0.90

0.24

1.4

1.5

200.67

201.02

u/ml

0.00

289

Subarachnoid haemorrhage

618

1.09

0.24

1.4

1.2

257.93

288.15

u/ml

0.39

372

Heterophoria

928

1.07

0.24

1.5

1.4

240.70

236.77

u/ml

0.05

544

Enterobiasis, including avohilmo

293

1.13

0.24

1.3

1.6

244.50

201.14

u/ml

0.36

162

Toxic effect of ethanol

417

1.11

0.24

1.4

1.3

278.31

257.80

u/ml

0.19

253

Persistent delusional disorders

569

0.91

0.24

1.2

300.00

264.45

u/ml

0.40

348

Anisometropia and aniseikonia

286

0.87

0.24

2.1

1.4

156.66

237.43

u/ml

2.22

157

Noise effects on inner ear

328

0.88

0.23

1.2

300.82

293.49

u/ml

0.05

205

Autism spe, excluding more controls

398

1.11

0.23

1.5

1.4

200.67

202.19

u/ml

0.02

242

Ovarian hyperstimulation (induction)

171

1.17

0.23

1.3

216.09

221.55

u/ml

0.03

118

Feeding problems of newborn

125

1.22

0.23

2.0

2.3

184.23

193.18

u/ml

—

Postmenopausal atrophic vaginitis

186

968

1.05

0.23

1.2

1.3

266.49

293.87

u/ml

0.70

108

611

Erosion and ectropion of cervix uteri

162

1.18

0.23

1.1

1.2

183.91

258.51

u/ml

1.16

108

Habitual aborter

228

1.14

0.23

1.4

1.2

207.42

258.20

u/ml

0.57

153

Congenital malformations of eyelid, lacrimal apparatus and orbit

146

0.82

0.22

2.6

1.8

113.83

170.28

u/ml

—

Autism spe

483

0.91

0.22

1.5

1.6

200.67

206.11

u/ml

0.07

280

Liveborn infants according to place of birth

177

1.16

0.22

2.0

1.9

169.17

152.86

u/ml

0.22

Exposure to excessive natural cold

1.27

0.22

1.5

1.2

441.00

264.05

u/ml

—

Mumps, including avohilmo

189

0.84

0.22

1.4

1.2

234.49

254.64

u/ml

—

116

Other osteochondrodysplasias, including avohilmo

116

1.21

0.22

1.5

1.6

239.00

217.44

u/ml

—

Other and unspecified hydrocephalus

116

1.21

0.22

1.4

175.13

255.46

u/ml

—

Mumps

178

0.84

0.22

1.4

1.2

259.43

254.02

u/ml

—

106

Congenital dislocation of hip, unilateral

107

1.23

0.22

2.0

1.6

291.29

182.80

u/ml

—

Isolated patent ductus arteriosus

217

0.86

0.22

2.2

2.1

157.60

160.89

u/ml

—

102

Carcinoma in situ of breast, intraductal

524

0.91

0.22

1.1

1.2

288.54

287.22

u/ml

0.01

307

Generalized epilepsy, strict definition

273

0.88

0.22

1.4

1.6

290.21

201.87

u/ml

0.52

149

Unspecified abortion

372

1.10

0.21

1.4

1.2

197.14

284.82

u/ml

1.98

229

Occupant of three-wheeled motor vehicle injured in other and unspecified transport accidents

0.00

0.21

0.0

1.1

—

122.50

—

Extreme obesity with alveolar hypoventilation

273

0.88

0.21

1.1

1.2

334.33

269.62

u/ml

0.34

161

Benign neoplasm: Cranial nerves

188

0.85

0.21

1.5

1.3

201.60

274.49

u/ml

—

103

Foreign body in ear

220

1.14

0.21

1.8

1.4

191.09

230.14

u/ml

0.28

114

Other cestode infections

0.00

0.21

0.0

1.2

—

434.20

—

Presbyopia

633

1.08

0.21

1.3

1.2

306.33

283.24

u/ml

0.19

389

Varicose veins

457

3540

0.97

0.21

1.3

1.2

285.99

274.83

u/ml

0.40

269

2247

Benign lipomatous neoplasm

251

2424

1.04

0.21

1.2

1.3

266.42

277.01

u/ml

0.25

159

1549

Other specified and unspecified disorders of eyelid

1.24

0.21

1.3

1.1

196.17

237.22

u/ml

—

Plasmodium falciparum malaria

0.00

0.21

0.0

1.4

—

267.80

—

Cerebral arteritis

0.00

0.21

0.0

1.3

—

195.20

—

Pterygium

173

1.16

0.21

1.3

1.2

245.38

254.81

u/ml

0.06

Diseases caused by chlamydiae, including avohilmo

145

1.18

0.20

1.3

1.4

189.09

204.45

u/ml

0.08

Endometriosis of intestine

166

0.84

0.20

1.0

1.2

317.23

227.41

u/ml

—

112

Malignant neoplasm of bronchus and lung

716

1.06

0.20

1.2

280.33

285.07

u/ml

0.06

427

Patent foramen ovale

297

1.12

0.20

2.1

1.8

328.68

196.25

u/ml

1.35

163

Lumbosacral spina bifida and hydrocephalus

0.00

0.20

0.0

1.1

—

135.00

—

Postprocedural disorders of eye and adnexa, not elsewhere classified

0.00

0.20

0.0

1.0

—

211.20

—

Deep endometriosis

751

1.07

0.20

1.1

1.2

272.84

270.24

u/ml

0.03

485

Other specified and unspecified strabismus

108

1.21

0.20

1.1

1.6

411.57

227.63

u/ml

—

Amblyopia ex anopsia

552

0.92

0.20

1.9

1.6

143.07

208.85

u/ml

2.83

292

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

355

0.90

0.20

1.1

1.2

203.04

279.14

u/ml

0.97

208

Foreign body or object entering through skin

635

1.07

0.20

1.2

1.3

257.27

249.99

u/ml

0.08

387

Polyp of the female genital tract

259

1417

1.04

0.20

1.3

1.2

279.52

285.93

u/ml

0.12

167

911

Sequelae of injuries of head

469

0.92

0.20

1.3

252.92

260.59

u/ml

0.07

292

Benign neoplasm of eye and adnexa

781

1.06

0.20

1.3

1.2

289.11

275.05

u/ml

0.19

470

Mental retardation, wide definition

649

0.93

0.20

1.7

1.8

232.96

204.90

u/ml

0.34

331

Benign neoplasm of breast

820

1.06

0.20

1.1

1.2

275.72

266.95

u/ml

0.09

515

Cleft lip, lip and palate or palate

193

1.14

0.20

1.7

1.5

129.69

214.48

u/ml

1.57

109

Postmenopausal bleeding

180

904

1.04

0.19

1.2

297.87

298.75

u/ml

0.01

118

563

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

333

0.90

0.19

1.3

1.4

263.17

243.17

u/ml

0.12

192

Benign lipomatous neoplasm of other sites/unspecified

530

0.92

0.19

1.3

1.2

249.19

272.94

u/ml

0.29

307

Congenital malformations of great arteries

398

1.09

0.18

2.6

2.0

222.16

171.64

u/ml

0.47

186

Benign neoplasm: Lip

132

0.83

0.18

1.1

1.3

205.00

286.17

u/ml

—

Unspecified maternal hypertension

100

1.21

0.18

1.2

1.3

100.43

221.59

u/ml

—

Female infertility, tubal origin

425

0.92

0.18

1.4

1.3

288.74

281.47

u/ml

0.06

282

Colon adenocarcinoma, helper endpoint

683

0.94

0.18

1.1

1.2

335.84

293.81

u/ml

0.38

407

Injury of other and unspecified intrathoracic organs

518

0.93

0.18

1.3

1.2

234.46

254.45

u/ml

0.18

317

Motorcycle rider injured in noncollision transport accidents

383

0.91

0.18

1.2

1.3

257.46

220.14

u/ml

0.40

226

Carcinoma in situ of colon

176

1.14

0.17

1.3

1.2

280.31

316.19

u/ml

0.26

Other and unspecified intracranial injuries

247

0.89

0.17

1.2

1.3

284.64

267.51

u/ml

0.14

141

Benign neoplasm: Choroid

413

0.92

0.17

1.3

1.2

303.95

266.22

u/ml

0.35

234

Other congenital malformations of circulatory system

205

1.12

0.17

1.3

256.33

261.13

u/ml

0.03

113

Contact with nonpowered hand tool

392

0.92

0.17

1.6

1.3

255.83

270.21

u/ml

0.11

244

Habit and impulse disorders

194

0.87

0.17

1.2

1.4

222.44

219.31

u/ml

—

119

Mental retardation

633

0.94

0.16

1.7

1.9

232.96

206.64

u/ml

0.31

325

Hypertrophy of breast in women and men

180

1863

0.97

0.16

1.2

294.23

267.33

u/ml

0.38

115

1156

Hypogonadotropic hypogonadism

350

0.91

0.16

1.3

248.85

254.17

u/ml

0.04

219

Specific developmental disorder of motor function

378

1.09

0.16

2.8

2.0

171.43

157.12

u/ml

0.12

188

Other and unspecified degenerative diseases of nervous system

141

0.85

0.16

1.3

1.1

331.00

312.83

u/ml

—

Other disorders originating in the perinatal period

235

1.11

0.16

2.5

2.3

197.02

172.32

u/ml

0.20

108

Abnormalities of forces of labour

986

0.95

0.16

1.2

1.3

293.70

268.52

u/ml

0.27

663

Alzheimer’s disease (Atypical or mixed), excluding more controls

246

0.91

0.16

1.1

1.2

337.05

274.42

u/ml

0.50

147

Biguanides

1026

6106

1.01

0.16

1.2

1.3

277.80

261.66

u/ml

1.03

592

4027

Other and unspecified mononeuropathies of upper limb

235

0.89

0.16

1.2

243.00

251.97

u/ml

—

142

Infections of breast associated with childbirth

370

1.08

0.16

1.2

195.12

249.22

u/ml

0.86

245

Injury of muscle and tendon at forearm level

172

0.87

0.16

1.3

264.33

233.71

u/ml

—

100

Convergence insufficiency and excess

130

1.16

0.15

1.3

284.90

226.07

u/ml

—

Other disorders of the genitourinary system

760

1.05

0.15

1.3

1.2

292.77

287.02

u/ml

0.06

451

Mandibular prognathia

226

1.11

0.15

1.5

1.6

175.73

212.57

u/ml

0.53

114

Contact with other sharp object(s)

849

1.05

0.15

1.4

1.3

246.43

236.22

u/ml

0.17

536

Burn and corrosion of head and neck

234

0.89

0.15

1.4

1.2

171.42

243.48

u/ml

1.46

132

Chronic conjunctivitis

255

1.10

0.15

1.7

1.5

213.04

241.42

u/ml

0.23

146

Puerperal sepsis

947

1.05

0.15

1.2

291.87

282.29

u/ml

0.13

613

Transient global amnesia

507

1.07

0.15

1.2

290.55

290.72

u/ml

0.00

294

Hyperkinetic disorders (excl. ADHD)

385

1.08

0.15

1.6

1.8

253.67

181.79

u/ml

0.69

193

Other and unspecified injuries of neck

1.19

0.14

1.5

1.3

152.17

180.35

u/ml

—

Wide developmental disorders, excluding more controls

553

1.06

0.14

1.6

1.5

243.43

200.10

u/ml

0.42

319

Pedal cyclist injured in noncollision transport accidents

122

1267

0.96

0.14

1.3

267.09

249.52

u/ml

0.17

793

Antepartum haemorrhage, not elsewhere classified

949

1.04

0.14

1.2

219.99

259.19

u/ml

1.19

633

Lichen planus

910

0.96

0.14

1.3

1.2

288.16

291.59

u/ml

0.04

550

Burns and corrosions

164

1589

1.03

0.14

1.3

1.4

230.39

241.29

u/ml

0.27

101

988

Chondromalacia

208

1.11

0.14

1.3

275.80

252.65

u/ml

—

126

Other symptoms and signs involving general sensations and perceptions

363

1.08

0.14

1.5

1.3

284.16

255.52

u/ml

0.25

205

Complications associated with artificial fertilization

189

1.11

0.14

1.3

1.2

216.09

262.51

u/ml

0.33

131

Left hemicolectomy

122

1.15

0.14

1.1

1.3

327.00

290.71

u/ml

—

Other disorders of breast and lactation associated with childbirth

170

0.88

0.13

1.3

353.12

224.26

u/ml

—

116

Scoliosis

921

1.04

0.13

1.3

1.4

276.89

240.89

u/ml

0.46

532

Pathological resorption of teeth

354

1.08

0.13

1.3

289.84

256.68

u/ml

0.19

207

Spasmodic torticollis

228

1.10

0.13

1.2

1.3

333.93

235.33

u/ml

1.09

135

Effects of foreign body entering through natural orifice

282

2758

1.02

0.13

1.4

262.10

252.95

u/ml

0.21

175

1726

Other obstetric trauma

608

1.05

0.13

1.2

239.28

255.84

u/ml

0.15

405

Exposure to other specified electric current

267

1.09

0.13

1.6

1.4

165.60

214.67

u/ml

0.78

158

Burn and corrosion of shoulder and upper limb, except wrist and hand

209

1.10

0.13

1.3

1.4

199.00

239.99

u/ml

—

116

Foreign body entering into or through eye or natural orifice

834

1.04

0.13

1.4

1.3

227.70

248.63

u/ml

0.38

508

Gender identity disorders

248

1.09

0.13

1.2

1.5

151.56

196.17

u/ml

1.00

130

Maternal care related to the fetus and amniotic cavity and possible delivery problems

532

3068

1.02

0.13

1.2

1.3

259.59

258.75

u/ml

0.02

369

1957

Toxic effect of other and unspecified substances

142

1.13

0.13

1.1

1.3

319.27

234.33

u/ml

0.41

Benign neoplasm of bone and articular cartilage

766

1.05

0.12

1.4

1.3

238.06

262.80

u/ml

0.28

463

Use of interferon beta-1a

200

1.10

0.12

1.2

1.3

354.67

242.35

u/ml

1.05

131

Exposure to other and unspecified man-made environmental factors

181

1.11

0.12

1.2

1.4

257.13

243.09

u/ml

0.12

105

Malignant neoplasm of rectum

467

0.94

0.12

1.1

1.3

220.42

277.74

u/ml

0.91

286

Hallux rigidus

826

1.04

0.12

1.3

1.2

302.38

289.85

u/ml

0.13

516

Primary open-angle glaucoma

173

1709

0.97

0.12

1.3

1.2

305.86

284.57

u/ml

0.48

101

1032

Other and unspecified corneal deformities and disorders

249

1.09

0.12

1.4

1.3

250.65

225.58

u/ml

0.17

154

Universal erythroderma, KELA reimbursement

1.16

0.11

1.2

226.33

259.56

u/ml

—

Conduct disorder

343

0.93

0.11

1.3

1.6

218.00

204.42

u/ml

0.14

198

Accidental poisoning by and exposure to alcohol

201

1.10

0.11

1.6

1.3

221.71

223.10

u/ml

0.01

117

Other disorders of patella

168

1636

1.03

0.11

1.2

1.3

306.63

264.06

u/ml

0.56

1071

Malignant neoplasm of prostate

175

1008

1.03

0.11

1.3

285.64

276.09

u/ml

0.16

101

647

Alcohol dependence

252

2468

1.02

0.11

1.2

1.3

296.72

266.33

u/ml

1.08

168

1605

Congenital deformities of feet

318

1.07

0.11

1.3

1.4

259.00

217.04

u/ml

0.47

174

Other secondary gonarthrosis

357

1.07

0.11

1.3

1.2

245.74

282.15

u/ml

0.36

216

Sensorineural hearing loss

693

4673

0.99

0.11

1.3

267.34

272.38

u/ml

0.15

407

2974

Coxarthrosis, primary

445

3748

0.98

0.11

1.2

1.3

289.18

284.52

u/ml

0.11

263

2320

Chalazion

104

1075

0.97

0.11

1.2

1.3

251.20

268.39

u/ml

0.28

667

Injury of muscle and tendon at ankle and foot level

202

1.09

0.10

1.1

1.3

214.92

259.24

u/ml

0.51

118

Other osteochondrodysplasias

1.15

0.10

1.6

1.7

252.60

183.94

u/ml

—

Graves disease, strict definition

938

1.03

0.10

1.2

261.40

263.03

u/ml

0.02

582

Femoral hernia

241

1.08

0.10

1.2

283.07

278.84

u/ml

0.03

142

Atrial septal defect, secundum type

401

0.94

0.10

1.8

1.9

285.76

193.52

u/ml

0.89

195

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

154

1.11

0.10

1.6

1.7

183.90

188.07

u/ml

—

Convergent concomitant strabismus

657

0.96

0.10

1.3

1.4

197.09

235.66

u/ml

1.01

387

Otosclerosis

486

1.05

0.10

1.2

272.74

275.48

u/ml

0.03

290

Pedestrian injured in transport accident

604

1.04

0.10

1.6

1.3

257.32

245.29

u/ml

0.17

368

Recurrent dislocation of patella

614

1.04

0.10

1.3

210.99

223.69

u/ml

0.16

393

Other lack of coordination

135

0.89

0.10

1.3

1.4

144.29

249.86

u/ml

—

Other or unspecified paralytic strabismus

1.11

0.10

1.8

1.3

316.00

280.68

u/ml

—

Other specified/unspecified nutritional deficiencies

1.11

0.10

1.2

154.00

234.75

u/ml

—

Primary amenorrhea

116

1.13

0.09

1.2

1.5

278.57

199.45

u/ml

—

Inflammatory disease of cervix uteri

360

0.94

0.09

1.2

278.78

283.74

u/ml

0.03

210

Bacterial meningitis

278

0.93

0.09

1.2

1.3

234.18

262.43

u/ml

0.29

167

Abnormal spermatozoa

817

0.97

0.09

1.5

1.3

264.95

289.38

u/ml

0.27

513

Primary open-angle glaucoma, strict

150

1462

1.02

0.09

1.3

1.2

294.55

287.01

u/ml

0.13

879

Atrial septal defect

524

1.04

0.09

1.9

1.7

277.37

211.36

u/ml

0.83

267

Secondary parkinsonism+Parkinsonism in other disease

165

0.91

0.09

1.1

1.2

284.60

313.36

u/ml

—

Other congenital malformations of tongue, mouth and pharynx

266

0.93

0.08

1.7

1.8

84.30

172.20

u/ml

—

135

Atrioventricular septal defect

1.05

0.08

3.0

1.8

181.00

164.76

u/ml

—

Other and unspecified mental retardation

299

1.06

0.08

1.5

2.2

253.23

191.25

u/ml

0.42

143

Other and unspecified injuries of abdomen, lower back and pelvis

144

0.90

0.08

1.2

219.63

229.14

u/ml

—

Mental and behavioural disorders due to hallucinogens

0.82

0.08

1.0

1.3

172.60

200.63

u/ml

—

Occupational exposure to risk-factors

263

1.07

0.08

1.3

1.2

177.25

269.11

u/ml

3.13

158

Undescended testicle

225

0.93

0.08

2.8

2.0

165.71

176.28

u/ml

0.10

100

Nystagmus and other irregular eye movements

146

1.10

0.08

1.3

1.7

239.00

199.08

u/ml

—

Achilles tendinitis

866

0.97

0.08

1.4

1.3

229.54

282.42

u/ml

1.25

549

L02BB Anti-androgens

450

0.96

0.08

1.1

1.2

305.38

288.41

u/ml

0.17

270

Congenital malformations of eyelid, lacrimal apparatus and orbit, including avohilmo

164

0.91

0.08

2.3

1.8

166.64

177.20

u/ml

—

Other and unspecified disorders of psychological development

238

0.93

0.08

2.0

166.93

177.77

u/ml

0.12

118

Uterine polyps

226

1343

0.98

0.08

1.2

273.72

287.37

u/ml

0.31

143

863

Other and unspecified injuries of shoulder and upper arm

293

1.06

0.08

1.3

286.72

229.52

u/ml

0.42

174

Motorcycle rider injured in other and unspecified transport accidents

774

0.97

0.08

1.2

1.3

190.94

225.27

u/ml

0.70

484

Secondary parkinsonism

164

0.91

0.08

1.1

1.2

284.60

315.24

u/ml

—

Unspecified dementia

367

0.95

0.08

1.0

1.1

295.72

319.50

u/ml

0.18

204

Pediculosis and phthiriasis, including avohilmo

0.85

0.07

1.7

1.4

401.67

180.77

u/ml

—

Injury of nerves and spinal cord at neck level

174

0.92

0.07

1.1

1.2

246.00

274.31

u/ml

0.23

Oral lichen planus, including avohilmo , including avohilmo

500

1.04

0.07

1.3

1.2

275.03

270.61

u/ml

0.04

293

Mandibular retrognathia

892

0.97

0.07

2.2

1.5

205.69

230.02

u/ml

0.34

502

Constitutional tall stature

112

0.89

0.07

1.0

1.7

308.60

176.75

u/ml

—

Other infections specific to the perinatal period

147

1.09

0.07

1.7

2.0

211.60

165.22

u/ml

—

Benign neoplasm: Long bones of lower limb

304

1.05

0.07

1.5

1.3

180.21

232.85

u/ml

0.93

190

Other benign neoplasms of connective and other soft tissue

798

1.03

0.07

1.2

1.3

284.49

270.56

u/ml

0.16

493

Organic, including symptomatic, mental disorders

358

2546

0.99

0.07

1.2

280.72

277.97

u/ml

0.06

211

1557

Traumatic amputation of wrist and hand

336

0.95

0.06

1.1

1.2

226.59

291.58

u/ml

0.88

206

Inflammatory disorders of breast

660

1.03

0.06

1.3

1.2

278.53

250.44

u/ml

0.39

430

Chromosomal abnormalities, not elsewhere classified

365

0.95

0.06

1.4

1.9

259.88

191.81

u/ml

0.42

187

Graves ophthalmopathy, strict

138

1.09

0.06

1.1

1.3

292.22

249.88

u/ml

—

Schizophrenia or delusion, excluding more controls

315

3074

1.01

0.06

1.3

272.90

252.32

u/ml

0.66

186

2005

Benign mammary dysplasia

922

0.98

0.06

1.2

321.07

273.81

u/ml

0.59

562

Combinations of oral blood glucose lowering drugs

211

2140

0.99

0.06

1.1

1.3

297.72

277.38

u/ml

0.43

121

1383

Benign neoplasm of brain and other parts of central nervous system

487

0.96

0.06

1.4

1.3

243.84

255.61

u/ml

0.15

281

Anxious personality disorder

207

1.06

0.06

1.3

255.17

231.71

u/ml

0.14

126

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

414

1.04

0.06

1.2

211.59

253.65

u/ml

0.57

264

Other appendicitis

711

1.03

0.06

1.2

262.27

269.99

u/ml

0.10

435

Ectopic testis

131

0.91

0.06

2.5

2.1

126.80

149.07

u/ml

—

Conductive and sensorineural hearing loss

768

5127

0.99

0.05

1.4

1.3

268.64

270.12

u/ml

0.04

454

3241

Torsion of testis

277

1.05

0.05

1.9

1.4

173.24

206.46

u/ml

0.34

164

Premature separation of placenta [abruptio placentae]

208

1.06

0.05

1.1

1.3

349.57

264.90

u/ml

0.37

140

Glaucoma-related operations

293

0.96

0.05

1.2

283.21

283.92

u/ml

0.00

155

Adenocarcinoma and papilloma adenocarcinoma of rectum

455

1.03

0.05

1.2

1.3

209.21

277.78

u/ml

1.29

280

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

112

1100

1.02

0.05

1.2

253.74

279.55

u/ml

0.53

689

Undefined dementia

373

0.96

0.05

1.0

1.1

295.73

312.89

u/ml

0.13

200

Other congenital malformations of tongue, mouth and pharynx, including avohilmo

331

0.96

0.05

1.6

1.7

94.06

179.04

u/ml

3.25

162

Supervision of normal pregnancy

270

1556

0.99

0.05

1.2

1.3

217.70

260.99

u/ml

2.75

191

955

Vertical strabismus

278

1.04

0.04

1.3

1.2

243.71

264.42

u/ml

0.14

161

Leiomyoma of uterus

548

3053

1.01

0.04

1.3

1.2

274.42

280.98

u/ml

0.23

345

1975

Cerebral palsy

219

1.05

0.04

2.2

1.7

190.15

208.67

u/ml

0.14

112

Precocious central puberty

1.10

0.04

1.2

1.5

478.00

210.33

u/ml

—

Ankyloglossia

331

0.96

0.04

1.6

1.8

108.52

181.57

u/ml

2.64

174

Non-small cell lung cancer, adenocarcinoma, helper endpoint

322

0.96

0.04

1.2

263.50

296.78

u/ml

0.36

174

Sequelae of injuries of neck and trunk

241

0.95

0.04

1.2

269.44

244.20

u/ml

0.32

143

Benign neoplasm: Skin of ear and external auricular canal

239

1.05

0.04

1.3

1.2

185.74

275.61

u/ml

1.18

128

MS-disease / Multiple Sclerosis

725

1.02

0.04

1.2

264.02

261.03

u/ml

0.03

470

Blood alcohol or alcohol intoxication level

249

1.05

0.04

1.5

1.3

264.74

257.45

u/ml

0.05

147

Disorders of speech understanding and production

711

1.02

0.04

2.5

1.6

205.20

196.66

u/ml

0.09

368

Oxicams

225

1290

0.99

0.04

1.1

1.4

252.64

277.05

u/ml

0.76

135

896

Systemic atrophies primarily affecting the central nervous system

279

1.04

0.04

1.2

1.4

254.44

274.98

u/ml

0.24

147

Cervical polyps

694

0.98

0.04

1.2

1.3

316.29

283.10

u/ml

0.31

454

Acute alcohol intoxication ICD-9

200

1.05

0.03

1.1

1.2

404.71

292.28

u/ml

0.96

110

Burns and corrosions of multiple and unspecified body regions

230

1.04

0.03

1.3

1.4

228.79

244.64

u/ml

0.11

129

Mesial bite

149

0.94

0.03

1.4

1.6

154.60

199.86

u/ml

—

Hemiplegia

349

1.03

0.03

1.8

1.3

202.70

264.11

u/ml

0.79

204

Fourth [trochlear] nerve palsy

149

0.94

0.03

1.0

1.2

225.00

284.06

u/ml

—

Dementia in other diseases classified elsewhere

260

0.96

0.03

1.1

1.2

364.15

291.40

u/ml

0.39

148

Single delivery by caesarean section

259

1489

0.99

0.03

1.2

1.3

229.66

254.78

u/ml

1.06

188

935

Other congenital malformations of male genital organs, including avohilmo

179

0.95

0.03

2.1

1.9

156.40

180.42

u/ml

—

Major anomalies of jaw size

300

0.97

0.03

1.3

1.5

284.90

224.35

u/ml

0.58

171

Female genital prolapse

225

1241

1.01

0.02

1.3

1.2

283.54

289.67

u/ml

0.08

145

802

Keratoconus

239

0.96

0.02

1.4

1.3

272.56

238.15

u/ml

0.24

147

Mixed specific developmental disorders

490

0.98

0.02

2.3

1.9

188.22

165.98

u/ml

0.32

253

Complications of labour and delivery

670

3734

1.00

0.02

1.2

260.22

260.62

u/ml

0.01

438

2366

Vascular dementia (subcortical)

132

1.06

0.02

1.3

1.1

335.33

358.96

u/ml

—

Benign neoplasm: Skin of eyelid, including canthus

105

1062

0.99

0.02

1.3

1.2

283.60

278.32

u/ml

0.06

644

Delayed puberty

168

0.95

0.02

2.2

1.5

165.63

191.49

u/ml

—

Disorders of breast

485

4283

1.00

0.02

1.2

282.03

263.89

u/ml

0.59

310

2748

Generalized epilepsy, mode (most common among epilepsy diagnosis)

349

0.97

0.02

1.4

1.5

284.38

220.33

u/ml

0.41

206

Delayed milestone in childhood

448

0.98

0.02

3.2

2.2

160.07

157.15

u/ml

0.03

202

Pedestrian injured in collision with car, pick-up truck or van

202

1.04

0.02

1.4

1.2

259.60

257.44

u/ml

0.01

113

Benign neoplasm: Rectosigmoid junction

232

1.04

0.02

1.5

1.2

324.29

291.44

u/ml

0.21

120

Vasomotor rhinitis (mode)

549

0.98

0.02

1.1

1.3

173.66

258.76

u/ml

2.53

334

Cellulitis of external ear

117

0.94

0.01

1.2

1.4

332.67

234.75

u/ml

—

Contact with other hot fluids

348

0.98

0.01

1.2

1.5

224.77

227.35

u/ml

0.02

199

Unspecified event, undetermined intent

267

0.97

0.01

1.3

1.4

212.82

232.63

u/ml

0.21

163

Ectopic pregnancy

152

1529

0.99

0.01

1.2

279.90

269.02

u/ml

0.13

107

967

Motor disorders

410

1.02

0.01

2.8

2.1

171.43

174.44

u/ml

0.02

199

Maternal care for known or suspected malpresentation of fetus

240

1704

1.00

0.01

1.2

1.3

249.80

250.33

u/ml

0.01

170

1129

Torticollis

174

1.04

0.00

1.7

1.3

329.00

243.24

u/ml

0.66

101

Benign neoplasm of other and unspecified sites

224

1.03

0.00

1.3

218.63

267.31

u/ml

0.38

129

Maxillary retrognathism

256

0.98

0.00

1.9

1.6

189.01

192.80

u/ml

0.03

133

Other congenital malformations of face and neck

324

1.02

0.00

1.6

1.4

264.68

223.77

u/ml

0.36

190

Fall on and from ladder

564

1.01

0.00

1.3

220.59

274.11

u/ml

0.87

347

Struck by thrown, projected or falling objec

574

1.01

0.00

1.4

1.3

258.82

244.43

u/ml

0.17

347

Spontaneous abortion

479

3207

1.00

0.00

1.2

255.82

261.81

u/ml

0.15

327

2036

Vascular dementia

323

0.98

0.00

1.3

1.1

281.71

321.57

u/ml

0.26

176

Other vitreous opacities

285

1.02

0.00

1.2

301.80

252.17

u/ml

—

160

Other noninflammatory disorders of cervix uteri

285

1.02

0.00

1.3

1.2

208.61

281.63

u/ml

1.19

178

Other acquired deformities of musculoskeletal system and connective tissue

365

1.01

0.00

1.3

366.15

260.44

u/ml

0.31

217

Benign neoplasm: Anus and anal canal

177

1.02

0.00

1.4

1.2

288.33

268.53

u/ml

—

Vascular syndromes of brain in cerebrovascular disorders

219

1.00

0.00

1.2

341.08

288.11

u/ml

0.30

119

Behavioural disorders, excluding more controls

304

1.02

0.00

1.4

220.00

212.95

u/ml

0.06

177

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

472

1.00

0.00

1.2

1.3

209.21

279.69

u/ml

1.35

291

Melanoma in situ of trunk

103

0.97

0.00

1.7

1.2

183.80

304.07

u/ml

—

Sixth [abducent] nerve palsy

226

1.02

0.00

1.3

213.47

262.77

u/ml

0.39

119

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

147

1.02

0.00

1.9

1.3

84.44

239.67

u/ml

—

Intentional self-harm by sharp object

366

1.01

0.00

1.6

1.3

242.75

226.94

u/ml

0.14

217

Other disorders of binocular vision

122

0.98

0.00

1.1

1.3

315.14

219.61

u/ml

—

Caught, crushed, jammed or pinched in or between objects

596

1.01

0.00

1.4

240.12

248.22

u/ml

0.10

355

Disorders of lacrimal system and orbit in diseases classified elsewhere

162

0.99

0.00

1.2

264.10

236.46

u/ml

—

Other and unspecified mononeuropathies of lower limb

172

0.99

0.00

1.6

1.2

218.44

232.63

u/ml

—

Exclusion endpoint for supernumerary teeth

177

1.02

0.00

1.9

1.7

136.60

179.54

u/ml

—

L02BX Other hormone antagonists and related agents

322

0.99

0.00

1.2

347.56

295.50

u/ml

0.48

189

Antenatal screening

290

1625

1.00

0.00

1.2

1.3

220.04

258.19

u/ml

2.18

193

989

Burn and corrosion of wrist and hand

428

1.00

0.00

1.2

1.3

243.75

228.99

u/ml

0.16

236

Benign neoplasm: Peripheral nerves and autonomic nervous system

119

1.01

0.00

1.1

1.3

243.99

280.82

u/ml

—

Other lesions of median nerve

149

1.01

0.00

1.4

1.2

583.29

265.34

u/ml

—

Isolated growth hormone deficiency

179

1.01

0.00

2.6

2.4

187.54

198.97

u/ml

0.09

Other hammer toe(s) (acquired)

854

1.00

0.00

1.2

268.10

291.18

u/ml

0.45

527

Periapical abscess

508

5082

1.00

0.00

1.3

264.35

264.45

u/ml

0.00

338

3241

Other benign neoplasms of uterus

202

0.99

0.00

1.2

1.1

296.00

273.19

u/ml

0.18

115

Graves ophthalmopathy

163

0.98

0.00

1.2

1.3

264.10

248.46

u/ml

—

Personality and behavioural disorders due to brain disease, damage and dysfunction

116

1.03

0.00

1.1

1.3

309.40

233.92

u/ml

—

Juvenile osteochondrosis

413

0.99

0.00

1.6

1.3

405.87

217.99

u/ml

1.13

236

Allergic contact dermatitis due to drugs in contact with skin

145

1.04

0.00

1.1

1.2

194.88

260.64

u/ml

—

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

155

0.97

0.00

1.2

288.00

263.90

u/ml

—

Cleft palate

135

0.96

0.00

2.0

1.5

95.00

219.82

u/ml

—

Inguinal hernia, unilateral

155

1.03

0.00

1.1

1.2

279.91

274.64

u/ml

0.03

Inguinal of femoral hernia, unilateral

155

1.03

0.00

1.1

1.2

279.91

274.64

u/ml

0.03

Femoral hernia, unilateral

155

1.03

0.00

1.1

1.2

279.91

274.64

u/ml

0.03

Toxic effect of metals

0.00

0.0

1.0

—

Generalized epilepsy

480

1.00

-0.00

1.3

1.5

265.38

222.01

u/ml

0.39

277

Calcific tendinitis

0.95

-0.00

1.7

1.2

211.83

277.32

u/ml

—

Bus occupant injured in other and unspecified transport accidents

0.98

-0.00

1.6

1.3

160.80

250.68

u/ml

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS